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Diversity-oriented fluorescent libraries (DOFL) approach has been used as 
a powerful method to discover novel fluorescent sensors. FRET is also one of 
the most widely used sensing mechanisms for fluorescent probes. This thesis 
using diversity-oriented approach introduces the successful examples of sensor 
development. 
    In chapter 2 and chapter 3, a new strategy for constructing large Stokes shift 
RET dyes were designed. By coupling low quantum yield (less than 1%) 
donor (BDN) with tunable high quantum yield acceptors (BDM), an 80-
member library (BNM) were synthesized. These RET dyes show high 
efficiency of light harvesting, no fluorescence leaks from the donor, tunable 
emission wavelength and high quantum yield. Theoretical study by ultrafast 
dynamic experiment demonstrated that the absorbed energy was transferred to 
the acceptor (BDM) with a high energy transfer rate before quenched by non-
radiatively intramolecular rotations. Later, one of the BNM compounds were 
chosen to design and synthesize a red-emitting turn-on FRET-based molecular 
probe for selective detection of cysteine and homocysteine. By introducing 
DNBS to the end of BNM153, I constructed a novel turn-on Cys and Hcy 
sensor. Also, HPLC-MS study and DFT calculations give strong support for 
the mechanism of Cys detection. Bioimaging results show that probe 1 can 
easily penetrate cell membrane for detection of thiol species in living cells. 
    In chapter 4, the DOFL were applied to high-throughput screening systems 
in cell-based screening. Two Aβ oligomer-specific sensors, BDO-1 and MK-
H4, were discovered from in vitro screening system. Oligomeric soluble Aβ is 
principally responsible for the pathogenesis of AD and its levels are more 
XII 
 
important in the disease progression. These novel fluorescent chemical probes 
could preferentially recognize Aβ oligomeric assemblies over monomers and 
fibrils, and displays an increase in fluorescence. The probes also show 
oligomer-sensing ability on-fibril pathway, as Aβ was induced to form fibrils 
over time. And the tissue imaging shows that BDO-1 can be used as oligomer-
specific fluorescent sensor. 
In chapter 5, I constructed the zwitterionic library, CyZW, using the famous 
Zwitterionic Near-Infrared dye, ZW800-1. The photostability test shows that 
CyZW compounds consist of very good photostability. Then, we screened 
these compounds against rat aortas tissue and found out an elastin fibers probe 
CyZW-599. Further studies show that this compound can be used as a 
fluorescent probe for imaging of elastin in aorta sections and outer ear sections 
in the living animal after an intravenous injection or in vitro tissue staining. 
    In chapter 6, I introduced solid phase route to the synthesis of fluorescent 
library (BID), and its respective chloroacetyl (CA) and acetyl derivatives (AC).  
Solid phase synthesis has been successfully applied into the synthesis of 
fluorescent libraries. Over all, I designed solid phase route to secure a pure 
benzimidazole (BID) library in high efficiency by minimizing the crucial 
purification step and these compounds can be used in the evaluation of 
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 Chapter 1 
1.1 Overview of Fluorescent Probes 
During the past several decades, fluorescence spectroscopy has been widely 
used in the biological science.
1
 Fluorescence is the emission of light by a 
molecule which has absorbed light including ultraviolet, visible, or near 
infrared radiation. There are two main stages for the emission process. First, 
when the molecules absorb light, it is usually excited to some higher electronic 
states. Following this, the higher excited energy will be relaxed to the ground 
state in the form of light emission. Mostly, the energy relaxed during 
relaxation can be lost in other ways like bond rotation or vibration or other 
formats of electron transfer, that make the emitted light possess a longer 
wavelength and lower energy than the absorbed light.
2
 
The fluorescence molecule has been used for common practice in 
biological researches and applications for decades due to their adaptability, 
sensitivity and quantitative capabilities.
1a, 3
 Among their numerous uses, 
fluorescence probe is booming development for the use of identifying protein 
location and activation, discovering protein complex formation and 
conformational changes and monitoring biological process in vivo.
4
 Biological 
fluorophores, quantum dots and organic dyes are the most commonly used 
fluorophores in research. The green fluorescent protein (GFP) is a well-known 
biological fluorophore, which was first used as a gene expression reporter in 
the 1990s.
5
 This work provided a new way for fluorescence technique in 
biology. However, in practical biological research, fluorescent proteins are 
slow in labeling and difficult to handle due to their bulky size.
6 
Another type 





 and widely used for fluorescence applications in biological research. 
Compared with other fluorophores, quantum dots show some advantages like 
multiple color and photostability.
8
 However, they have a significant drawback 
because cell toxicity of quantum dots increases in response to the breakdown 
of the particles and their use can be cost-prohibitive.
9
 In addition to biological 
fluorophores and quantum dots, fluorescence molecules were developed in the 
field of fluorescence labeling due to their sensitivity and easy visibility.
10
 This 
provides a powerful tool for the study of biology. From then on, many 
strategies have been explored to synthesize fluorescence molecules. Up to now, 
there are a number of scaffolds that are found to be used as fluorophores and 
these fluorescent scaffolds cover almost all colors in the spectra, from UV-
visible to near-infrared (NIR). Widely used fluorophores which are able to 
cover full range of the spectra include pyrenes, naphthalene derivatives, 
coumarins, xanthone, fluorescein, NBD, rhodol, BODIPY, dapoxyl, styryl, 
rhodamine, cyanines, quinolines, indoles and imidizoles (e.g., DAPI and 









1.2  Strategies to Discover Fluorescent Sensors and Probes 
1.2.1 Target-Oriented Approach 
The target-oriented synthesis approach (TOS)
12
 and the diversity-oriented 
fluorescence library approach (DOFLA) are the commonly used synthetic 
strategies in chemical biology. In TOS approach, the fluorescent sensor was 
constructed by connecting one selected fluorophore as signal amplifier and 
one binding motif based on target analytes (Figure 1.2). Based on this concept, 
we can see that the scope of sensor development is limited by the information 
on recognition motifs. That makes all the sensors for same analyte show 
almost same design and same experimental results. Also, in the TOS approach, 
the complex designed receptor structures usually need lengthy synthetic work 
for each individual sensor.  
 
Figure 1.2 Schematic representation of target-oriented approach for 
fluorescent probe development. 
 
1.2.2 Diversity-Oriented Approach 
In the diversity oriented approach, fluorescence molecules was constructed 
by one selected fluorophore and huge number of diverse structures to 
accelerate fluorescent sensor development. By introducing combinatorial 
chemistry techniques to the fluorescence sensor development, we can generate 
a great deal of chemical diversity of libraries to increase the chance of 
discovery of novel fluorescence sensors (Figure 1.3). This approach we call 
diversity-oriented fluorescence library approach (DOFLA). The fluorophores 
4 
 
used in DOFLA not only serve as signal reporters but also as recognition 
motifs for different biomolecules recognition. More importantly, fluorescent 
molecules prepared by DOFLA is unbiased to any specific target analyte and 
can be widely expanded to biological targets, such as proteins, cells and 
macromolecules, where it is more difficult to find the recognition binding 
knowledge.
13
 This is highly significant in the molecular recognition area.  
 
Figure 1.3 Schematic representation of diversity-oriented approach for 
fluorescent probe development. 
 
Fluorescent molecules prepared by DOFLA are synthesized by using 
similar strategy: construct known fluorophores with commercial available 
building blocks. With the help of the combinational chemistry, we can get a 
large library size, which is defined by availability of building block. 
Also, solid phase synthesis methodologies are introduced to the DOFL 
construction to increase chemical diversity and reduce purification process.
14
 
To get unique spectral properties of 2-alkylthioimidazocoumarins, Lam’s 
group designed a solid-phase synthesis of imidazocoumarins by attach key 
scaffold to Rink amide which can be modified by different amines. From this 
5 
 
synthesis method, the desired products were obtained in high purity and 
diverse photophysical properties.
15
 Later, Park’s group developed the solid-
phase method to construct of a 434-member polyheterocyclic benzopyran 
library with five discrete core skeletons (Suzuki coupling, Stille coupling and 




With the development of sensors, DOFL approach has been applied by 
Chang’s group. Some examples of DOFL constructed fluorescent molecules 














 most of which have been successfully applied in live 
cell imaging study. The analytes include β-amyloid,19, 22 human serum 
albumin,
13b
 embyronic stem cell probe
20, 23












1.3 Cell-based Screening for Sensor Development 
DOFL is best suitable for in vitro screening which performed in unbiased 
manner. Single type of analytes were screening against whole DOFL 
compounds, and several sensors were discovered by monitoring the 
fluorescence intensity change, such as ATP, GTP, glutathione, DNA, RNA, 
heparin or albumin. Compared to the in vitro screening, cell-based screening 
gives higher chance of cellular imaging probe development because it 
considers more complicated cell environment such as permeability, cellular 
uptake, and localization, which may affect the interaction between a 
fluorescent probe and its target biomolecule in cells.
29
 After the primary 
screening against a set of cell types, the specific cell imaging on certain type 
6 
 
of cell could be selected to help us to discover specific probes. Recently 
Chang and co-workers reported ESC selective imaging probes which has been 
developed through a high throughput cell-based screening.
30
 After screening 
280 rosamine compounds in mES cells, MEF and mixtures of the two cell 
types prepared side by side on 384-well microplates, they found that CDy1 
shows significant selectivity to mESC. And further study shows that CDy1 can 
be used for the identification and isolation of live ESC and iPSC at an earlier 
stage of the reprogramming and during the ESC differentiation.  
 
 
Figure 1.4 (a) Chemical structure of CDy1; (b) Upper panel: CDy1-stained 
mESC were immunostained with anti-Oct4 antibody; (c) Flow cytometry dot-




1.4 Tissue-Based Screening for Sensor Development 
Live tissue-based screening have also been gradually employed into high-
content screening. Tissue sections are the most close to the natural living 
organism and have been examined to understand the nature of life and disease 
by analyzing different phenomenon appeared in tissues. Tissue-based 
7 
 
screening can be used for special targets which do not show characteristic in 
cell culture or an artificial in vitro system. After incubating thin tissue sections 
with DOFL on a slide glass, we can selected the best staining dye by analyzing 
the tissue imaging quality. One of the best example is the discovery of β-
amyloid sensor by Chang and co-workers.
22
 By screening styryl-based neutral 
compounds directly in human Alzheimer’s disease patient’s brain sections, 
STB-8 was selected as the best hit compound which displays specific binding 




Figure 1.5 (a) Chemical structure of STB-8; (b) In vitro staining of β-amyloid 
plaques in AD human brain sections; (c) In vivo two-photon fluorescence 
microscopy of β-amyloid plaque staining with STB-8 A) and Congo Red (CR) 






1.5 FRET Dyes 
1.5.1 FRET Dyes Design 
Förster resonance energy transfer (FRET) is one of the most widely used 
sensing mechanisms for ratiometric fluorescent probes.
31
 A FRET pair is 
constituted by two chromophores, one acting as energy donor and the other as 
acceptor. The mechanism of fluorescence resonance energy transfer is the 
nonradiative transfer of energy from an excited donor fluorophore to an 
acceptor chromophore through long-range dipole-dipole interactions.
32
 The 
energy transfer efficiency is dependent on the distance between donor and 
acceptor. There are enough number of fluorophores can be used in FRET 
design and their conjugation to different types of molecules has been 
facilitated by the incorporation of a range of reactive groups.
32-33
 In order to 
design good FRET pairs, a few criteria must be satisfied. First of all, there 
should be a maximal overlap between the fluorescent emission spectra of the 
donor and the fluorescent absorption spectra of the acceptor. Secondary, the 
distance between the two fluorophore (donor and acceptor) must be in close 
proximity to one another (typically 1 to 10 nanometer). Thirdly, the transition 
dipole orientations of the donor and acceptor must be approximately parallel 
to each other. The rotation of the fluorophores is a factor that affects the 
energy transfer. The features of FRET makes us possible to synthesize FRET 
sensors that are able to follow in real time and with high sensitivity diverse 
processes. Compared with single fluorophore sensors, which use the change in 
fluorescence intensity as detection signal, FRET-based sensors are not 
interfered by environmental factors such as instrumental efficiency, 
environmental conditions, and the probe concentration.
34
 This makes it 
9 
 
possible to eliminate most or all ambiguities by monitoring the change of ratio 
of two emission bands.
35
 
1.5.2 Applications of FRET Dyes 
Some ratiometric fluorescent sensor molecules based on FRET have been 
developed and widely used, such as the calcium sensor cameleon and the β-
lactamase sensor CCF2. In 1998, Tsien’s group published a suitable 
ratiometric FRET probe to measure lactamase activity in cells: CCF2 (Figure 
1.6).
36
 By connecting 6-chloro-7-hydroxycoumarin and fluorescein with a 
cephalosporin derivative, they developed a FRET sensor which can attached to 
different positions of the molecule and stayed non-fluorescent until esterases 
cleave the protecting group in the cytoplasm allowing the monitoring of 
cellular uptake. The probe proved to be very sensitive and showed large ratio 
change of 70-fold permitted to detect picomolar concentrations of β‐lactamase. 
Nagano’s group developed a series of ratiometric fluorescent sensor based on 
FRET for phosphodiesterase activity detection.
37
 By connecting coumarin 
donor and a fluorescein acceptor with different type of linkers having the 
phosphodiester moiety interposed between them, they got a large shift in their 
emission spectrum after the hydrolysis of the phosphodiester group by the 
enzyme. This method should principally be applicable for measuring different 




Figure 1.6 The membrane-permeant probe CCF2/AM monitors lactamase 
activity in living cells after removal of the bioactivatable protecting groups by 
endogenous esterases. 
 
Beside enzyme, most of the small analytes (such as Cys, ClO‾ and NO‾) 
probes were designed based on FRET mechanism.
38
 Most type of FRET 
probes have the donor and acceptor positioned at the two ends and the reaction 
site for the analyte to be situated in the middle. When excited at the donor part 
of free probe, it should display the emission of the acceptor due to FRET. By 
contrast, when in the present of the analyte, the FRET dyad is cleaved and 
FRET is switched off due to the far distance between the donor and acceptor. 
One example is a new FRET-based ratiometric cysteine probe reported by Lin 
group.
39
 A reactive thioester group was placed in the middle of BODIPY and 
rhodamine fluorophore. 
The overlap of spectra between the rhodamine absorption and the BODIPY 
emission is strong enough and the emission windows of BODIPY and 
rhodamine are well separated, which make it possible to show the ratiometric 
measurement. Incubation of NRFTP with cysteine results in the cleavage of 
non-fluorescent acceptor, which is in the ring closed form. Also, they 
successfully applied the sensor for ratiometric imaging of thiols in living cells. 
11 
 
Similar researches have also been conducted towards other the small analytes, 




Figure 1.7 (A) The ratiometric sensing mechanism of NRFTP for cysteine. (B) 
The emission spectra of NRFTP incubated with varying concentrations of 
cysteine. (C) Confocal images of HeLa cells: (ac) bright-field and 
fluorescence images of HeLa cells incubated with NRFTP; (d) overlay the 
images of panels ac; (eg) bright-field and fluorescence images of HeLa cells 
incubated with N-ethylmaleimide and then with NRFTP; (h) overlay the 
images of panels eg. This picture has been copied from reference 39 under 
copyright permission. 
 
Table 1.1 Selected FRET sensor for small analytes. 
Chemical Structure Analyte Spectral information Ref 
 
NO‾ 473 nm/583 nm 40 
 




Cu 473 nm/581 nm 42 
 




458 nm/603 nm 44 
 
pH 365 nm/560 nm 45 
 
Hg 514 nm/589 nm 46 
 
Hg 510 nm/584 nm 47 
 








Hg 670 nm/720 nm 50 
 
Cys 510 nm/590 nm 39 
 
H2S 480 nm 51 
 













1.6 Scope and Outline 
It has been discussed earlier that diversity-oriented fluorescent libraries 
approach (DOFLA) is one of the most powerful methods to discover novel 
fluorescent sensors by combining with high-throughput screening. It has also 
been highlighted that FRET is an efficient strategy in the field of fluorescent 
sensor and labelling reagent development. Hence, we aim to design a unique 
RET based library and give proper theoretical explanation and apply them to 
sensor development. Also, we aim to design the novel DOFL for cell based 
and tissue based screening for discovering different sensors. 
The aims for this thesis project are: 
1) To design and synthesize a new strategy for constructing large Stokes shift 
RET dyes. By constructing low quantum yield donor with tunable high 
quantum yield acceptors, a RET based library (BNM) was synthesized. 
The design of using dark donor is rarely reported and BNM compounds 
show some unique photoproperties. Ultrafast dynamic study demonstrated 
that the absorbed energy was transferred to the acceptor with a high energy 
transfer rate before quenched by non-radiatively intramolecular rotations.   
2) To design and synthesize a red-emitting turn-on FRET-based molecular 
probe for selective detection of cysteine and homocysteine. By introducing 
DNBS to the end of the FRET-based BNM compound, I constructed a 
novel turn-on Cys and Hcy sensor. Also, HPLC-MS study and DFT 
calculations give strong support for the mechanism of Cys detection. 
Bioimaging results show that this probe can easily penetrate cell 
membrane for detection of thiol species in living cells. 
3) To discover novel Aβ oligomer sensors from DOF libraries through 
15 
 
unbiased cell-based screening. For this purpose, we conducted an unbiased 
cell-based screening to DOF libraries against 7PA2 cells and CHO cells. 
The fluorescence oligomer specific sensors show good selectivity in vitro 
and the binding proteinaceous aggregated species were confirmed by dot 
blots, pelleting assay and TEM. Also, BDO-1 can show clear A oligomer 
staining in the brain tissue. 
4) To develop in vivo bioimaging probes, first, I constructed the zwitterionic 
library, CyZW, using the famous Zwitterionic Near-Infrared dye, ZW800-
1. The photostability test shows that CyZW compounds consist of very 
good photostability. Then, we screened these compounds against rat aortas 
tissue and found out an elastin fibers probe CyZW-599 which can be used 
in ex vivo imaging of aorta sections and outer ear sections. 
5) To develop a benzimidazole based library to apply for amyloid imaging, I 
successfully synthesized BID library using solid phase method. Also, I 
have modified them with chloroacteyl and acetyl version (BIDCA and 













1.    (a) Goncalves, M. S., Fluorescent labeling of biomolecules with 
organic probes. Chem. Rev. 2009, 109, 190-212; (b) Lodeiro, C.; Capelo, J. L.; 
Mejuto, J. C.; Oliveira, E.; Santos, H. M.; Pedras, B.; Nunez, C., Light and 
colour as analytical detection tools: a journey into the periodic table using 
polyamines to bio-inspired systems as chemosensors. Chem. Soc. Rev. 2010, 
39, 2948-2976. 
2.    (a) Zelent, B.; Kusba, J.; Gryczynski, I.; Johnson, M. L.; Lakowicz, J. 
R., Time-resolved and steady-state fluorescence quenching of N-acetyl-L-
tryptophanamide by acrylamide and iodide. Biophys. Chem. 1998, 73, 53-75; 
(b) de Silva, A. P.; Gunaratne, H. Q.; Gunnlaugsson, T.; Huxley, A. J.; McCoy, 
C. P.; Rademacher, J. T.; Rice, T. E., Signaling Recognition Events with 
Fluorescent Sensors and Switches. Chem. Rev. 1997, 97, 1515-1566. 
3.    Sinkeldam, R. W.; Greco, N. J.; Tor, Y., Fluorescent analogs of 
biomolecular building blocks: design, properties, and applications. Chem. Rev. 
2010, 110, 2579-2619. 
4.    (a) Lakowicz, J. R., Principles of frequency-domain fluorescence 
spectroscopy and applications to cell membranes. Subcell. Biochem. 1988, 13, 
89-126; (b) Harendt, N.; Giese, K.; Kolmel, K., In vivo fluorescence 
spectroscopy of human skin: principles and application to penetration 
measurements. Pharmazie 1994, 49, 594-600. 
5.    Chalfie, M.; Tu, Y.; Euskirchen, G.; Ward, W. W.; Prasher, D. C., 
Green fluorescent protein as a marker for gene expression. Science 1994, 263, 
802-805. 
6.    Miyawaki, A.; Sawano, A.; Kogure, T., Lighting up cells: labelling 
proteins with fluorophores. Nat. Cell Biol. 2003, Suppl, S1-7. 
7.    Ekimov, A., Growth and optical properties of semiconductor 
nanocrystals in a glass matrix. J. Lumin. 1996, 70, 1-20. 
8.    Delehanty, J. B.; Bradburne, C. E.; Susumu, K.; Boeneman, K.; Mei, 
B. C.; Farrell, D.; Blanco-Canosa, J. B.; Dawson, P. E.; Mattoussi, H.; 
Medintz, I. L., Spatiotemporal multicolor labeling of individual cells using 
peptide-functionalized quantum dots and mixed delivery techniques. J. Am. 
Chem. Soc. 2011, 133, 10482-10489. 
17 
 
9.    Lovric, J.; Cho, S. J.; Winnik, F. M.; Maysinger, D., Unmodified 
cadmium telluride quantum dots induce reactive oxygen species formation 
leading to multiple organelle damage and cell death. Chem. Biol. 2005, 12, 
1227-1234. 
10.    Giepmans, B. N.; Adams, S. R.; Ellisman, M. H.; Tsien, R. Y., The 
fluorescent toolbox for assessing protein location and function. Science 2006, 
312, 217-224. 
11.    Lavis, L. D.; Raines, R. T., Bright ideas for chemical biology. ACS 
Chem. Biol. 2008, 3, 142-155. 
12.    Lee, J. S.; Kim, Y. K.; Vendrell, M.; Chang, Y. T., Diversity-
oriented fluorescence library approach for the discovery of sensors and probes. 
Mol. Biosyst. 2009, 5, 411-421. 
13.    (a) Min, J.; Lee, J. W.; Ahn, Y. H.; Chang, Y. T., Combinatorial 
dapoxyl dye library and its application to site selective probe for human serum 
albumin. J. Comb. Chem. 2007, 9, 1079-1083; (b) Ahn, Y. H.; Lee, J. S.; 
Chang, Y. T., Selective human serum albumin sensor from the screening of a 
fluorescent rosamine library. J. Comb. Chem. 2008, 10, 376-380; (c) Wang, S.; 
Chang, Y. T., Discovery of heparin chemosensors through diversity oriented 
fluorescence library approach. Chem. Commun. 2008, 1173-1175. 
14.    Merrifield, R. B., Solid Phase Peptide Synthesis. I. The Synthesis of 
a Tetrapeptide. J. Am. Chem. Soc. 1963, 85, 2149-2154. 
15.    Song, A.; Zhang, J.; Lebrilla, C. B.; Lam, K. S., Solid-phase 
synthesis and spectral properties of 2-alkylthio-6H-pyrano[2,3-
f]benzimidazole-6-ones: a combinatorial approach for 2-
alkylthioimidazocoumarins. J. Comb. Chem. 2004, 6, 604-610. 
16.    Oh, S.; Jang, H. J.; Ko, S. K.; Ko, Y.; Park, S. B., Construction of a 
polyheterocyclic benzopyran library with diverse core skeletons through 
diversity-oriented synthesis pathway. J. Comb. Chem. 2010, 12, 548-558. 
17.    Lee, J. S.; Kang, N. Y.; Kim, Y. K.; Samanta, A.; Feng, S.; Kim, H. 
K.; Vendrell, M.; Park, J. H.; Chang, Y. T., Synthesis of a BODIPY library 
and its application to the development of live cell glucagon imaging probe. J. 
Am. Chem. Soc. 2009, 131, 10077-10082. 
18.    (a) Ahn, Y. H.; Lee, J. S.; Chang, Y. T., Combinatorial rosamine 
library and application to in vivo glutathione probe. J. Am. Chem. Soc. 2007, 
18 
 
129, 4510-4511; (b) Li, J.; Ha, H. H.; Guo, L.; Coomber, D.; Chang, Y. T., 
Discovery of novel zebrafish neural tracers by organism-based screening of a 
rosamine library. Chem. Commun. 2010, 46, 2932-2934. 
19.    Li, Q. A.; Lee, J. S.; Ha, C.; Park, C. B.; Yang, G.; Gan, W. B.; 
Chang, Y. T., Solid-phase synthesis of styryl dyes and their application as 
amyloid sensors. Angew. Chem. Int. Edit. 2004, 43, 6331-6335. 
20.    Ghosh, K. K.; Ha, H. H.; Kang, N. Y.; Chandran, Y.; Chang, Y. T., 
Solid phase combinatorial synthesis of a xanthone library using click 
chemistry and its application to an embryonic stem cell probe. Chem. Commun. 
2011, 47, 7488-7490. 
21.    Samanta, A.; Vendrell, M.; Das, R.; Chang, Y. T., Development of 
photostable near-infrared cyanine dyes. Chem. Commun. 2010, 46, 7406-7408. 
22.    Li, Q.; Min, J.; Ahn, Y.-H.; Namm, J.; Kim, E. M.; Lui, R.; Kim, H. 
Y.; Ji, Y.; Wu, H.; Wisniewski, T.; Chang, Y.-T., Styryl-Based Compounds as 
Potential in vivo Imaging Agents for β-Amyloid Plaques. Chembiochem 2007, 
8, 1679-1687. 
23.    Lee, S. C.; Kang, N. Y.; Park, S. J.; Yun, S. W.; Chandran, Y.; 
Chang, Y. T., Development of a fluorescent chalcone library and its 
application in the discovery of a mouse embryonic stem cell probe. Chem. 
Commun. 2012, 48, 6681-6683. 
24.    Wang, S. L.; Chang, Y. T., Combinatorial synthesis of 
benzimidazolium dyes and its diversity directed application toward GTP-
selective fluorescent chemosensors. J. Am. Chem. Soc. 2006, 128, 10380-
10381. 
25.    Zhai, D.; Lee, S. C.; Yun, S. W.; Chang, Y. T., A ratiometric 
fluorescent dye for the detection of glutathione in live cells and liver cancer 
tissue. Chem. Commun. 2013, 49, 7207-7209. 
26.    Feng, S.; Kim, Y. K.; Yang, S.; Chang, Y. T., Discovery of a green 
DNA probe for live-cell imaging. Chem. Commun. 2010, 46, 436-438. 
27.    Li, Q.; Kim, Y.; Namm, J.; Kulkarni, A.; Rosania, G. R.; Ahn, Y. H.; 
Chang, Y. T., RNA-selective, live cell imaging probes for studying nuclear 
structure and function. Chem. Biol. 2006, 13, 615-623. 
19 
 
28.    Wang, S. L.; Chang, Y. T., Discovery of heparin chemosensors 
through diversity oriented fluorescence library approach. Chem. Commun. 
2008, 1173-1175. 
29.    Vendrell, M.; Lee, J. S.; Chang, Y. T., Diversity-oriented 
fluorescence library approaches for probe discovery and development. Curr. 
Opin. Chem. Biol. 2010, 14, 383-389. 
30.    Im, C. N.; Kang, N. Y.; Ha, H. H.; Bi, X.; Lee, J. J.; Park, S. J.; Lee, 
S. Y.; Vendrell, M.; Kim, Y. K.; Lee, J. S.; Li, J.; Ahn, Y. H.; Feng, B.; Ng, H. 
H.; Yun, S. W.; Chang, Y. T., A fluorescent rosamine compound selectively 
stains pluripotent stem cells. Angew. Chem. Int. Edit. 2010, 49, 7497-7500. 
31.    Ueno, T.; Nagano, T., Fluorescent probes for sensing and imaging. 
Nat. methods 2011, 8, 642-645. 
32.    Sapsford, K. E.; Berti, L.; Medintz, I. L., Materials for fluorescence 
resonance energy transfer analysis: beyond traditional donor-acceptor 
combinations. Angew. Chem. Int. Edit. 2006, 45, 4562-4589. 
33.    Sinev, M.; Landsmann, P.; Sineva, E.; Ittah, V.; Haas, E., Design 
consideration and probes for fluorescence resonance energy transfer studies. 
Bioconjug. Chem. 2000, 11, 352-362. 
34.    Kikuchi, K.; Takakusa, H.; Nagano, T., Recent advances in the 
design of small molecule-based FRET sensors for cell biology. Trends Anal. 
Chem. 2004, 23, 407-415. 
35.    Fan, J.; Hu, M.; Zhan, P.; Peng, X., Energy transfer cassettes based 
on organic fluorophores: construction and applications in ratiometric sensing. 
Chem. Soc. Rev. 2013, 42, 29-43. 
36.    Zlokarnik, G.; Negulescu, P. A.; Knapp, T. E.; Mere, L.; Burres, N.; 
Feng, L.; Whitney, M.; Roemer, K.; Tsien, R. Y., Quantitation of transcription 
and clonal selection of single living cells with beta-lactamase as reporter. 
Science 1998, 279, 84-88. 
37.    (a) Kawanishi, Y.; Kikuchi, K.; Takakusa, H.; Mizukami, S.; Urano, 
Y.; Higuchi, T.; Nagano, T., Design and Synthesis of Intramolecular 
Resonance-Energy Transfer Probes for Use in Ratiometric Measurements in 
Aqueous Solution. Angew. Chem. Int. Edit. 2000, 39, 3438-3440; (b) 
Takakusa, H.; Kikuchi, K.; Urano, Y.; Sakamoto, S.; Yamaguchi, K.; Nagano, 
T., Design and synthesis of an enzyme-cleavable sensor molecule for 
20 
 
phosphodiesterase activity based on fluorescence resonance energy transfer. J. 
Am. Chem. Soc. 2002, 124, 1653-1657. 
38.    Yuan, L.; Lin, W.; Zheng, K.; Zhu, S., FRET-based small-molecule 
fluorescent probes: rational design and bioimaging applications. Acc. Chem. 
Res. 2013, 46, 1462-1473. 
39.    Long, L.; Lin, W.; Chen, B.; Gao, W.; Yuan, L., Construction of a 
FRET-based ratiometric fluorescent thiol probe. Chem. Commun. 2011, 47, 
893-895. 
40.    Yuan, L.; Lin, W.; Xie, Y.; Chen, B.; Song, J., Development of a 
ratiometric fluorescent sensor for ratiometric imaging of endogenously 
produced nitric oxide in macrophage cells. Chem. Commun. 2011, 47, 9372-
9374. 
41.    Yuan, L.; Lin, W.; Xie, Y.; Chen, B.; Song, J., Fluorescent detection 
of hypochlorous acid from turn-on to FRET-based ratiometry by a HOCl-
mediated cyclization reaction. Chem.-Eur. J. 2012, 18, 2700-2706. 
42.    Yuan, L.; Lin, W.; Chen, B.; Xie, Y., Development of FRET-based 
ratiometric fluorescent Cu2+ chemodosimeters and the applications for living 
cell imaging. Org. Lett. 2012, 14, 432-435. 
43.    Albers, A. E.; Okreglak, V. S.; Chang, C. J., A FRET-based 
approach to ratiometric fluorescence detection of hydrogen peroxide. J. Am. 
Chem. Soc. 2006, 128, 9640-9641. 
44.    Yuan, L.; Lin, W.; Xie, Y.; Zhu, S.; Zhao, S., A native-chemical-
ligation-mechanism-based ratiometric fluorescent probe for aminothiols. 
Chem.-Eur. J. 2012, 18, 14520-14526. 
45.    Yuan, L.; Lin, W.; Cao, Z.; Wang, J.; Chen, B., Development of 
FRET-based dual-excitation ratiometric fluorescent pH probes and their 
photocaged derivatives. Chem.-Eur. J. 2012, 18, 1247-1255. 
46.    Zhang, X.; Xiao, Y.; Qian, X., A ratiometric fluorescent probe based 
on FRET for imaging Hg
2+
 ions in living cells. Angew. Chem. Int. Edit. 2008, 
47, 8025-8029. 
47.    Yu, H.; Xiao, Y.; Guo, H.; Qian, X., Convenient and efficient FRET 
platform featuring a rigid biphenyl spacer between rhodamine and BODIPY: 
transformation of 'turn-on' sensors into ratiometric ones with dual emission. 
Chem.-Eur. J. 2011, 17, 3179-3191. 
21 
 
48.    Suresh, M.; Mishra, S.; Mishra, S. K.; Suresh, E.; Mandal, A. K.; 
Shrivastav, A.; Das, A., Resonance energy transfer approach and a new 
ratiometric probe for Hg
2+
 in aqueous media and living organism. Org. Lett. 
2009, 11, 2740-2743. 
49.    Zhou, Z.; Yu, M.; Yang, H.; Huang, K.; Li, F.; Yi, T.; Huang, C., 
FRET-based sensor for imaging chromium(III) in living cells. Chem. Commun. 
2008, 3387-3389. 
50.    Atilgan, S.; Ozdemir, T.; Akkaya, E. U., Selective Hg(II) sensing 
with improved Stokes shift by coupling the internal charge transfer process to 
excitation energy transfer. Org. Lett. 2010, 12, 4792-4795. 
51.    Wei, C.; Wei, L.; Xi, Z.; Yi, L., A FRET-based fluorescent probe for 
imaging H2S in living cells. Tetrahedron Lett. 2013, 54, 6937-6939. 
52.    Shao, J. Y.; Sun, H. Y.; Guo, H. M.; Ji, S. M.; Zhao, J. Z.; Wu, W. T.; 
Yuan, X. L.; Zhang, C. L.; James, T. D., A highly selective red-emitting FRET 
fluorescent molecular probe derived from BODIPY for the detection of 
cysteine and homocysteine: an experimental and theoretical study. Chem. Sci. 











Chapter 2 A New Strategy for Large Stokes Shifts Dyes: 




2.1 Introduction  
Fluorescent molecules have been successfully applied in various 
bioimaging and medicinal applications for several decades due to their high 
sensitivity and easy visibility. Multiplexing,
1
 a method by which multiple 
fluorophore signals are combined into one single experiment, is well 
developed in the fields of DNA sequencing labeling,
2
 multicolor labeling of 
individual cells
3
 and multispectral labeling of proteins.
1a, 4
 The approach of 
complex multicolor fluorescent labeling exhibits the advantage of time 
resolved labeling, while it is hampered by the limited available of multicolor 
fluorescent molecules. Up to now, most of the multiplexing experiments have 
been done by using different structures of organic fluorophores for each color 
labeling, which may induce unpredictable interactions with various 
biopolymers during the experiments. Some new fluorescence libraries based 
on DOFLA (diversity-oriented fluorescence library approach) reported by our 
group have discovered series of novel sensors,
5
 which were constructed with 
same scaffold but different building blocks and can be used for multicolor 
labeling. The features of DOFLA libraries can potentially overcome some of 
the drawbacks caused by the fluorophores with different structures.
6
 
Recently, Park and coworkers reported a novel fluorescent core skeleton, 
named Seoul-Fluor, with tunable and predictable photophysical properties.
7
 





from which we got a number of new probes for fructose and immunoglobulin 
through the unbiased high-throughput fluorescent screenings. All of these 
reported libraries showed advantageous photophysical properties, such as high 
quantum yield, tunable fluorescence characteristics and high photostability. 
24 
 
However, for these published libraries, it is difficult to find one single 
excitation wavelength suitable for all these fluorophores with tunable emission. 
If excited by single wavelength light, the fluorescence intensities of the dyes, 
which emit at longer wavelengths, will be diminished due to the less effective 
energy absorb at the excitation wavelength.
10
 This will limit their applications 
in single excitation techniques, such as high-throughput screening or 
multiplexing. To further develop these techniques, it is necessary to design a 
library with single excitation wavelength but tunable, high intensity emission. 
Theoretically, the above mentioned problems can be solved by Förster 
resonance energy transfer (FRET) strategy. FRET-based libraries constructed 
with the same donor but different acceptors allow us to excite at the single 
excitation wavelength of the donor fluorophore and get tunable emissions 
according to different acceptors.
11
 Then, any dye from the library can absorb 
enough energy to give high fluorescence intensity output. A traditional FRET 
strategy always chooses high extinction coefficient and high quantum yield 






 However, one 
drawback is that using a high quantum yield dye as a donor will lead to 
fluorescence leaking from the donor part due to the energy transfer efficiency 
or the environment changes, and this may prevent it from being developed into 
a biological application. Furthermore, most of the reported FRET cases 
showed rather limited short emission wavelengths or relatively small pseudo-
Stokes shifts, especially for BODIPY compound.   
Burgess and coworkers developed the rational design of fluorescent labels 
based on through-bond energy transfer (TBET).
10, 15
 These kind of compounds 
show high energy transfer rate and tunable fluorescent outputs through a wide 
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emission window via cassettes composed of same donor and different 
acceptors. This excellent work explored a powerful gateway for the generation 
of desired emission spectra. However, these results also show some limitations. 
Some of them show fluorescence leaks from the donor part;
15d
 some of them 
show relatively small pseudo-Stokes shifts as well as the emission shifts (the 
emission wavelength shift between the donor and acceptor of FRET-based 
systems.
10, 15a
 In this regard, using dark donor to construct RET-based 
fluorescent dyads is an ideal design process. 
For robust and universal applications of the RET dyes, it is worthwhile to 
design and synthesize libraries containing new tunable organic fluorophores 
with unique photophysical properties. Several criteria must be satisfied for the 
high quality fluorescent dyes: 1) high fluorescence intensity and tunable 
emission wavelength for different signals of multiplex tags excited at one 
single excitation wavelength; 2) absorbance of light at a high extinction 
coefficient and emit no fluorescence from donor part to insure there is no 
background influence; 3) large pseudo-Stokes shifts and emission shifts to 
avoid serious self-quenching and fluorescence detection errors caused by 
excitation backscattering effects,
13b, 16
 and 4) high efficient RET energy 
transfer. Here, we report a new strategy for the design and synthesis of a 
BODIPY-based RET library, which uses a low quantum yield donor to 
generate high quantum yield, tunable emission wavelengths and extremely 
well resolved fluorescence. 
2.2 Results and Discussion 
2.2.1 Synthesis and Spectroscopic Properties of BNM Library 
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The synthetic scheme and the structure of BNM are shown in Scheme 2.1. 
BDN skeleton was chosen as donor due to the following reasons: 1) relatively 
high extinction coefficient, which indicates its high ability for light harvesting; 
2) the maximum absorption at around 490 nm, which is accordant with 
widespread used argon laser (488/514 nm); 3) quite low quantum yield, which 
is due to the intramolecular photoinduced electron transfer (PeT) process from 
the amine to the excited fluorophore, can reduce fluorescence leaks from the 
donor part. For acceptor, we chose another type of the BODIPY library, BDM, 
which shows different electrochemical and photochemical properties, such as 
tunable emission wavelengths and tunable quantum yield. Cyanuric chloride 
was chosen as linker part due to its high stability and high reaction activity.
17
 
And also, cyanuric chloride contained biological libraries have been 
demonstrated to be biocompatible with various biological effects.
18
 The 
synthesis of BDN-1 and BDM refer to our previous report.
9, 19 
As shown in 
Scheme 2.1, BDN-1, used as the donor, was reacted with the cyanuric chloride 
linker to get the key intermediate compound BDN-3, which can be easily 
purified via flash chromatography. After the key intermediate compound 
BDN-3 was synthesized, the acceptors, BDM, were introduced by the 
combinational synthesis method (Chart 2.1). 





Reagents and conditions: (a) DIEA, THF, 0 ºC., 1h, 90 %; (b) DIEA, THF, rt, 
2 h. *R is from 80 commercial aldehydes.
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2.2.2 Spectroscopic Properties of BNM Library 
Both the absorbance and fluorescence spectra were measured with EtOH as 
solvent. The broad chemical diversity of the aldehyde building blocks on 
acceptor part gave rise to very diverse spectral properties for BNM derivatives. 
The absorbance spectra of the BNM library show two distinguished peaks 
corresponding to the donor and acceptor respectively. And the absorbance 
intensities are different on the acceptor part due to the diversity of the BDM 
compounds. The fluorescence spectra were obtained by exciting at the 
maximum absorption of BDN-1 (490 nm), and the maximum emission varied 
in the range of 557 - 716 nm based on the emission of their corresponding 
acceptors (Figure 2.1). Also, it was demonstrated that upon excitation of the 
donor (BDN) at 490 nm, the absorbed energy can be transferred to the 
acceptor (BDM) with high efficiency and with a high quantum yield of up to 
0.8 (Table 2.1). Both of these phenomena indicated that the RET happened 
between the two fluorophores.  
 
 
Figure 2.1 Spectroscopic properties of BNM library. Absorbance (a) and 




Table 2.1 Spectroscopic properties and purity table for BNM library: 
absorbance maximum (λabs), fluorescent emission maximum (λem), extinction 















BNM-1 863.3 862.2 494/555 572 61169 0.32 90 
BNM-2 816.3 817.3 494/594 716 57652 0.02 91 
BNM-19 815.3 814.3 494/552 562 79522 0.42 91 
BNM-40 849.3 848.2 494/554 565 55311 0.40 86 
BNM-43 845.3 846.3 494/561 576 49680 0.33 92 
BNM-45 873.4 874.4 494/559 576 65109 0.38 90 
BNM-53 861.3 862.3 494/561 586 61765 0.42 99 
BNM-54 881.2 881.0 494/554 568 74195 0.44 82 
BNM-62 833.3 832.2 494/561 582 61765 0.47 93 
BNM-63 847.3 846.2 494/561 586 91254 0.41 90 
BNM-68 857.3 858.3 494/548 557 56300 0.47 99 
BNM-69 875.3 876.4 494/569 583 103329 0.51 96 
BNM-70 883.3 882.2 494/576 617 66298 0.19 92 
BNM-75 845.3 844.3 494/555 572 58136 0.39 88 
BNM-78 861.3 860.3 494/583 651 69380 0.01 96 
BNM-107 844.3 843.2 494/595 711 81103 0.02 90 
BNM-110 803.3 802.2 494/557 573 67470 0.46 90 
BNM-132 819.3 818.2 494/561 583 81692 0.15 99 
BNM-140 831.3 830.3 494/559 573 68094 0.46 90 
BNM-177 829.3 810.3 494/553 562 62674 0.42 86 
BNM-178 895.3 894.3 494/557 571 77863 0.45 88 
BNM-186 803.3 802.2 494/550 561 53540 0.43 89 
BNM-101 865.3 864.3 494/555 568 86069 0.36 86 
BNM-100 857.1 858.1 494/565 576 78504 0.47 88 
BNM-52 957.2 956.2 494/557 572 80610 0.55 89 
BNM-164 847.3 848.3 494/560 583 83940 0.43 97 
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BNM-206 833.3 834.3 494/565 587 78472 0.43 90 
BNM-216 801.3 802.3 494/552 563 85037 0.67 99 
BNM-223 939.3 938.3 494/572 628 85063 0.05 91 
BNM-242 959.2 958.2 494/554 566 87888 0.68 98 
BNM-294 867.3 868.2 494/553 564 83537 0.67 99 
BNM-296 825.2 826.2 494/547 558 64547 0.60 95 
BNM-329 821.3 822.3 494/549 560 84972 0.69 99 
BNM-349 801.3 802.3 494/547 562 72602 0.70 86 
BNM-361 801.3 802.3 494/549 560 79003 0.69 97 
BNM-370 801.3 802.3 494/553 566 68095 0.80 99 
BNM-375 812.3 812.3 494/576 616 70913 0.22 94 
BNM-441 890.3 891.4 494/577 617 94473 0.38 97 
BNM-446 902.3 883.3 494/582 616 78151 0.26 90 
BNM-449 907.3 888.3 494/549 560 85900 0.75 97 
BNM-455 812.3 813.3 494/558 565 55643 0.24 89 
BNM-456 812.3 813.3 494/571 557 56087 0.30 86 
BNM-468 901.3 882.3 494/576 560 62974 0.20 91 
BNM-472 828.3 813.3 494/549 561 57222 0.32 95 
BNM-474 801.3 802.3 494/549 562 76570 0.69 99 
BNM-483 909.3 890.3 494/557 574 76687 0.54 99 
BNM-486 831.3 832.3 494/559 575 74731 0.44 85 
BNM-487 911.2 894.2 494/562 578 80133 0.54 91 
BNM-489 801.3 802.3 494/551 562 68562 0.48 98 
BNM-490 863.3 864.3 494/554 570 78471 0.55 86 
BNM-491 812.3 813.3 494/565 587 83859 0.30 93 
BNM-495 853.3 854.3 494/563 580 98822 0.63 97 
BNM-498 858.3 859.4 494/572 702 81732 0.03 89 
BNM-505 903.3 882.3 494/559 592 83608 0.03 91 
BNM-506 859.3 860.4 494/557 571 78855 0.62 97 
BNM-507 817.3 818.3 494/550 562 82019 0.71 95 
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BNM-510 817.3 818.3 494/559 576 79322 0.49 86 
BNM-511 959.2 958.2 494/557 574 77110 0.65 93 
BNM-513 826.3 827.3 494/572 603 86842 0.30 97 
BNM-515 831.3 832.3 494/553 566 61765 0.60 99 
BNM-516 826.3 827.3 494/565 587 61765 0.32 90 
BNM-517 919.4 918.4 494/558 577 85761 0.38 97 
BNM-518 885.4 888.4 494/558 571 78928 0.64 99 
BNM-519 889.4 890.3 494/561 587 84056 0.41 93 
BNM-520 889.4 890.4 494/551 563 83016 0.72 99 
BNM-522 845.3 846.3 494/550 562 84907 0.78 97 
BNM-524 891.3 892.3 494/559 573 90672 0.36 86 
BNM-525 887.4 888.4 494/550 563 80831 0.79 98 
BNM-526 845.3 846.3 494/560 578 84565 0.57 99 
BNM-527 987.2 986.2 494/558 575 78302 0.64 96 
BNM-528 875.3 876.3 494/561 584 93895 0.48 99 
BNM-529 854.3 855.3 494/572 604 82420 0.30 96 
BNM-530 854.3 855.3 494/574 611 76304 0.18 97 
BNM-531 859.3 860.3 494/554 568 86484 0.66 99 
BNM-532 854.3 855.3 494/566 590 90153 0.40 97 
BNM-533 861.3 862.3 494/562 583 86692 0.50 93 
BNM-143 787.3 788.3 494/549 563 45834 0.42 89 
BNM-198 803.3 804.3 494/554 567 51689 0.39 89 
BNM-397 833.3 834.3 494/562 591 64421 0.20 90 
BNM-401 891.3 892.3 494/562 579 66165 0.48 96 
   aThe maximal absorption of the BDM part; bFluorescence quantum yields 
were determined using rhodamine B (Φ=0.7 in EtOH) as a standard. All 
absorbance and fluorescence excitation and emission data were recorded by 
SpectraMax M2, Molecular Devices, fluorescent plate reader (10 μM 
compounds in EtOH (100 μL) for λabs, 10 μM compounds in EtOH (100 μL) 
for λem in 96-well polypropylene plates (λex= 490 nm). Mass was calculated as 
(M+), and found in ESI-MS (M-F), or in the positive mode scan (M+H), or in 
the negative mode scan (M-H); Purity data was calculated on the basis of the 
integration in HPLC trace at 365 nm.  
32 
 
2.2.3 Rationalization of RET of BNM Library 
As we discussed before, the quantum yield of donor part BDN-1 is quite 
low, while the FRET-pair BNM show high quantum yield. These results 
displayed that using the low quantum yield donor BDN-1 can generate the 
high quantum yield emission spectra. In order to make it clear whether the 
linker part influences the quantum yield of the BDN-1 or not, several BDN-1 
derivatives were designed and synthesized (Figure 2.2a). The quantum yield 
values of these derivatives measured in the same condition are summarized in 
Table 2.2. The results show that all BDN-1 derivatives almost do not show any 
fluorescence, which means that the linker part in BNM does not obviously 
influence the quantum yield of the donor. However, after combining with the 
acceptor BDM449, the fluorescence intensity of BNM449 is around 300 times 
higher than donor BDN-1 with the quantum yield changed from 1% to 75% 
(Figure 2.2b). These results indicate that high quantum yield emission spectra 
can be generated by using low quantum yield dye as donor.  
It should also be noted that there is no observed fluorescence leaks from 
donor part. Based on all of the photophysical properties, BODIPY based RET-
pair, BNM, is expected to be outstanding RET-pair with high fluorescence 





Figure 2.2 (a) Structures of the BDN-1 donor derivatives and BNM449; (b) 
fluorescence emission spectra of donor derivatives and BNM449 (10 μM in 
EtOH, λex= 470 nm). 
 
Table 2.2. The quantum yield of the BDN derivatives. 
Compound  BDN-1 BDN-2 BDN-3 BDN-4 BDN-5 BNM449 





In this case, there are two crucial questions which needed to be clarified. 
One is why BDN donor shows such a low quantum yield, and the other one is 
why such a low quantum yield donor can be used as a donor of an efficient 
RET pair.  
To explain the reason of low quantum yield of BDN, compound 6 and 7 
were synthesized. We choose BDN-3 as objective of this study which can 
remove the influence of the PET observed in BDN-1. BDN-3 showed high 
extinction coefficient but low quantum yield which means that the absorbed 
energy was lost in other patterns rather than fluorescence. The fluorescence 
intensity of compound 7 is quite high with quantum yield of 0.57, 
contrastively, almost no fluorescence is observed from BDN-3 (Figure 2.2a). 
After a careful comparison the structures of BDN-3 and compound 7, we 
found that the mainly difference is the number of methyl groups on the 
BODIPY core structure. On this basis, we speculated that the reason of low 
quantum yield of BDN-3 is due to the intramolecular rotation of the phenyl 
rings around the axes of the single bonds linked to the BODIPY core.  
Rotational energy relaxation has been known to greatly affect emission 
properties by non-radiatively deactivate excited species.
20
 We supposed that in 
the solution at the room temperature, the active intramolecular rotations of the 
phenyl rings around the axes of the single bonds linked to the BODIPY core 
structure may effectively quenching the excitons, thus making the molecules 
nonemissive. To prove the proposed explanation, we designed some control 
experiments by increasing the viscosity or decreasing the temperature of 
solvent, which was expected to hamper the rotation of the phenyl rings and 
further restore the fluorescence of BDN-3. Using water and glycerol system, 
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we measured the fluorescence of BDN-3 in different solution viscosity. The 
results show that BDN-3 is highly sensitive to solution viscosity. As the 
viscosity increased, fluorescence intensity of BDN-3 was greatly enhanced by 
more than 100 fold and the quantum yield was change from 0.01 to 0.57 
(Figure 2.3).The quantitative relationship between the fluorescence intensity 
of a molecular rotor and the viscosity η of the solvent is well expressed by the 
Forster-Hoffmann eq 1: 
                                 log If =C+χlog η                                         (1) 
where C is a concentration- and temperature-dependent constant and χ is a 
dye- and temperature-dependent constant. BDN-3 fits the linear relationship 
between log If and logη (R
2=0.982, χ=0.635). 
 
Figure 2.3 Changes of fluorescence spectra of BDN-3 with the variation of 
solution viscosity (MeOH/glycerol system, glycerol change from 0 to 100%). 
Inset: The linearity of logIf versus logη plot of BDN-3 (10 μM, λex= 470 nm). 
 
Later, we studied the temperature effect on the BDN-3 emissions. Similar 
to the function of high-viscous solution, lowering the temperature could also 
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restrict the rotation of BDN-3.
21
 We checked the fluorescence intensity change 
of BDN-3 in 70% glycerol in MeOH by increasing or decreasing the 





C, the fluorescence intensity was decreased to half. When the 
temperature decreased to -20
 o
C, the fluorescence intensity was dramatically 
increased by 5 fold than that in 25
 o
C. From these data we can come to the 
conclusion that cooling has restricted the thermally susceptible intramolecular 
rotations. 
 
Figure 2.4 The fluorescence spectra of BDN-3 (10 μM, λex= 470 nm) at 
different temperatures in MeOH-glycerol (30/70, v/v). 
 
To study the relationship of temperature and rotation, we carried out 
dynamic nuclear magnetic resonance (DNMR) measurements to 
experimentally verify the restricted intramolecular rotations at the low 
temperatures. The DNMR analysis has been utilized in the studies of rotation-
induced conformational changes in many systems.
22
 When there is fast 
conformational exchanges caused by the fast intramolecular rotations upon the 
single-bond axes at room temperature, the DNMR will give sharp resonance 
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peaks. If the rotation was restricted by cooling down the temperature, the 
resonance peaks will be correspondingly broaden.
23
 For our case, at 25
o
C, the 
phenyl and pyrrole of BODIPY gives very sharp NMR peak in the solvent of 
dichloromethane-d2. With cooling down of temperature, the peaks are 
becoming broader gradually (Figure 2.5). The DNMR experiment thus 
confirms that the intramolecular rotations in BDN-3 have indeed been 
restricted at the low temperatures.   
Consider all the experimental results, we can get the conclusion that the 
reason of low quantum yield donor BDN-3 is due to the intramolecular 
rotation of the phenyl rings around the axes of the single bonds linked to the 
BODIPY core.  
 
 
Figure 2.5 Resonance peaks of BDN-3 in dichloromethane-d2 at different 
temperatures. 
 
To exemplify the photoproperties of the BNM, we chose one of the long 
emission, high quantum yield compounds BNM441 as example. The 
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structures of BNM441 and its relative donor BDN-3, acceptor BDM441 are 
shown in Figure 2.6.  
 
Figure 2.6 Structures and spectral properties of BNM441. (a)Structures of the 
donor BDN-3, acceptor BDM441 and BNM441; (b) Absorbance and (c) 
fluorescence spectra of BDM441 and BNM441 in EtOH (10 μM, λex= 470 
nm). 
 
The absorption spectra of BNM441 in Figure 2.6b displayed the 
characteristic absorption signal of donor BDN-3 around 494 nm and the 
typical absorption signal of BDM441 acceptor around 577 nm. Compared 
with the unconjugated BDN-3 and BDM441, the shape of BNM441 
absorption spectra did not show obvious change, which reveals that the 
electronic interactions between the donor and the acceptor are very weak.
16
 
Upon excitation the BNM441 at the donor absorption band (470 nm), only the 
characteristic emission band of the acceptor BDM441 around 617 nm was 
observed, while the emission of the donor BDN-3 was not observed (Figure 
2.6c). This indicates that the majority of the non-radiative energy loss of donor 
was converted to the acceptor’s fluorescence output with minimum leaks of 
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donor emission. The calculated quantum yield of BDN-3 is less than 1%. It is 
so low that the fluorescence leaks can be prevented. Furthermore, the pseudo-
Stokes shifts between the BDN-3 absorption and BDM441 emission in BNM 
RET-pair are more than 120 nm, which are much larger than that BDM441 
acceptor itself. This large pseudo-Stokes shifts can reduce self-quenching and 
fluorescence detection errors caused by excitation backscattering effects.
13b
 
For comparison, we also examined the fluorescence spectra of an equimolar 
BDM441, which was excited at the same wavelength as BNM441. The result 
in Figure 2.6c shows that the maximum emission wavelengths of the BDM441 
are almost same with BNM441, but the fluorescence intensity of BNM441 is 
almost 5-fold higher than BDM441. As we know, fluorescence intensity plays 
important role in the practical applications, thus, the BNM RET-pair with 
relatively higher fluorescence intensity may attract much attention for useful 
applications. The maximum wavelengths of absorbance, fluorescence 
emission, quantum yield, and Stokes shifts as discussed above are summarized 
in Table 2.3. 
 
Table 2.3 Photophysical data of BDN-1, BDM441 and BNM441 in EtOH. 
 λabs (nm)
a
 Log εmax λabs (nm)
b
 Log εmax λem (nm) Φ
c
 Δλd 
BDN-1 491 4.79 – – 511 <0.001 20 
BDM441 – – 576 4.98 614 0.45 38 
BNM441 494 4.79 577 4.98 617 0.38 123 
 
a
The maximal absorption of the BDN-1 part; 
b
The maximal absorption of the 
BDM part; 
c
Fluorescence quantum yields were determined using rhodamine B 
(Φ=0.7 in EtOH) as a standard; dPseudo-Stokes shifts of the BNM441 and the 




Femtosecond transient absorption (fs-TA) measurements were carried out 
for better understanding of the RET processes, occurring in the donor-acceptor 
pair in EtOH.
15c, 24 
For femtosecond transient absorption measurements and 
picosecond time-resolved fluorescence measurements, we use BDM441-Tri 
instead of BDM441 because of its much better stability than free amine 
version of BDM441. The absorption and emission spectra show no difference 
in the range of 450 nm to 750 nm when tested in EtOH. The structures and 
spectra can be seen in Figure 2.7. 
 
 
Figure 2.7 Structures and spectral properties of BDM441 and BDM441-Tri. 
 
 
Figure 2.8 The fluorescence decay profiles of (a) BDM441-Tri and (b) 
BNM441 in EtOH. The decay profiles are obtained by photoexcitation at 460 





The TA spectrum of BDN-3 shows a combination of ground state 
bleaching (GSB) and stimulated emission (SE) bands at around 500 nm, which 
quickly decays with a time constant of 33 ps due to the intramolecular rotation 
of meso-phenyl group as observed in the viscosity and temperature control 
experiment (Figure 2.8, Figure 2.9a and Table 2.4). In the case of acceptor 
moiety, excited-state absorption (ESA) band in the region of 450-530 nm and 
GSB and SE bands in 530-750 were observed, respectively. As a delay time 
increases, the SE band become red-shifted and broad, indicating a charge 
transfer (CT) behavior between BODIPY and carbazole moieties of the 
acceptor with a time component of 10 ps. Corresponds to the fluorescence 
lifetime, the GSB and SE bands exhibit exponential decay profiles with a time 
component of 3 ns. For the RET pair, BNM441, photoexcitations at 500 and 
580 nm were employed as a control experiment. Interestingly, while the TA 
spectrum of BNM441 by photoexcitation at 580 nm is similar to that of 
acceptor only (Figure 2.9b and 2.9c), that by photoexcitation at 500 nm 
exhibits additional GSB and SE bands at around 500 nm, which is thought to 





Figure 2.9 The fs-TA spectra (left) and decay profile (right) of (a) BDN-3, (b) 
BDM441-Tri and (c) BNM441 in EtOH. The 500 nm photoexcitation is 
employed for BDN-3 and 580nm for BDM441-Tri and BNM441. The ns time 
constants were obtained by the fluorescence lifetime based on the time-
correlated single photon counting (TSCPC) technique. 
 
As discussed in the absorption and fluorescence emission spectra, these TA 
spectra of BNM441 clearly demonstrate energy transfer processes. Moreover, 
the TA decay profile of donor only shows a single decay component, 33 ps, 
but that of RET pair is well-described by a much shorter time component of 
1.2 ps with two time components observed in that of acceptor (Figure 2.10b 
and 2.10c). These results indicate that a decay time of donor, 33 ps, is 
significantly reduced to 1.2 ps in the RET pair, BNM441, which can be a clear 




. The observed RET rate is 
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well-matched with our calculation based on the Förster-type energy transfer 
and the RET efficiency was estimated to be 96% (Table 2.5).
25
 Here, despite 
the low quantum yield and short excited-state lifetime of donor, the efficient 
RET process in BNM441 can be attained by the large spectral overlap of RET 
pair and the high extinction coefficient of acceptor. Considering all the data 
available, we can make a conclusion that the energy absorbed by the donor is 
transferred to the acceptor with a fast energy transfer rate before being 
quenched by non-radiative intramolecular rotations, suggesting that highly 





Figure 2.10 a) Transient absorption spectrum of BNM441. b) The excited-
state decay of donor (BDN-3) in the absence and presence of acceptor 
measured at probe wavelength of 515 nm. c) The excited-state dynamics of 
acceptor in RET pair BNM441 measured at probe wavelength of 675 nm. The 




Table 2.4 List of lifetime of BDN-3, BDM441-Tri and BNM441. 




















The time component obtained by the TA decay profile by photoexcitation at 
500 nm and monitoring at 515 and 675 nm; 
b
The time component obtained by 
the TA decay profile by photoexcitation at 580 nm and monitoring at 675 nm; 
c
The time component obtained by the fluorescence lifetime based on the time-
correlated single photon counting (TSCPC) technique. 
 





























1.477 2/3 10 ~ 18 1.36 0.96 
a
The value obtained by Förster-type energy transfer rate calculation equation 
; 
b
Spectral overlap value estimated by J = ∫F(λ)ε(λ)λ4dλ; 
c
Orientation factor which is chosen as randomized value, 2/3, based on non-
rigid molecular structure of BNM441; 
d
Maximum and minimum 
intermolecular distance between donor and acceptor in BNM441; 
e
Refractive 
index of EtOH; 
f
RET efficiency is calculated with equation, EffRET = 
kRET/(kRET+kD), where kD is the excited-state decay rate of donor. 
 
RET-pair with low quantum yield dye as donor is rarely reported. Based on 
our knowledge, only Lakowicz and coworkers has reported some similar 
design and gave proper theory explanation.
26
 Briefly, if the rate of energy 
transfer is fast enough and the acceptor absorbs weakly at the excitation 
wavelength, the acceptor emission intensity is proportional to the amount of 
light absorbed by the donor and the quantum yield of the acceptor.
26b
 From our 
fluorescence and pump-probe study we can get the information that the energy 
absorbed by donor BDN-3 is strong enough and can be transferred to acceptor 
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with a high energy transfer rate before quenched by non-radiatively 
intramolecular rotations. 
2.2.4 Tunable Emission Properties of BNM Library 
Tunable fluorescence emission is one of the most important features for 
fluorescence library design.
7, 27
 As we discussed above, BNM compounds 
showed good photophysical properties and unique RET properties. 
Comprehensively considering the whole BNM library, the emission spectra 
show tunable fluorescence emission which can be obtained by single 
wavelength excitation due to the same donor but different acceptors with 
varied building blocks.  
 




As shown in Figure 2.11 and Figure 2.12, six different emission compounds 
were chosen from the BNM library for comparison. When they are excited at 
470 nm (donor band), the maximum emission changed from 560 nm to 617 
nm with the corresponding emission color change from green to red. In other 
words, the BNM library can generate a broad range of the emission spectra 
excited by single excitation wavelength. Also, the pseudo-Stokes shifts of the 
selected BNM compounds changed from 66 nm to 123 nm, which shows 
benefit to improvement of resolutions for multiplexing experiments (Figure 
2.13). Like BNM441, all the compounds gave relatively high quantum yield 
and the extinction coefficients of the acceptors for all these selected 
compounds are relatively high (Table 2.6). 
 
Figure 2.12 Spectroscopic properties of the selected BNM compounds. 
Absorbance (a) and fluorescence spectra (b) of the selected BNM compounds 




Figure 2.13 a) The normalized fluorescence of donor only and BNM 
compounds with different maximum emission wavelength. All the emission of 
the BNM compounds were measured in EtOH (10 μM, λex= 470 nm). b) 
Pictures of donor and selected BNM compounds (10 μM) solutions under 
irradiation with a hand-held 365 nm lamp. 
 
Table 2.6 Photophysical data of the selected BNM compounds. 
λabs (nm) Log εmax
a
 λem (nm) Φ
b
 Δλc 
BNM449 494/549 4.93 560 0.75 66 
BNM490 494/554 4.89 570 0.55 76 
BNM495 494/563 4.99 580 0.63 86 
BNM532 494/566 4.96 590 0.40 96 
BNM513 494/572 4.94 603 0.30 109 
BNM441 494/577 4.98 617 0.38 123 
a
The maximal absorption of the BDM part; 
b
Fluorescence quantum yields 
were determined using rhodamine B (Φ=0.7 in EtOH) as a standard.28 
c
Pseudo-Stokes shifts of the selected BNM compounds. 
 
2.2.5 Systematic Evaluation of Relationship between Structures and 
Photophysical Properties 
To evaluate the relationship between quantum yield and the maximum 
emission wavelength of the BNM compounds, we converted those data into a 
scatter plot of quantum yield for emission wavelength shown in Figure 2.14. 
An obvious trend can be observed: the quantum yield decreased with the red 
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shift of the emission. This result is reasonable, with the red shift of the 
emission wavelength of the acceptors, the overlap between emission spectrum 
of the donor with the absorption spectrum of the acceptor was become less 
even though the donor has quite small emission intensity. Comparing the 
statistical results and the structures of BNM acceptors, we found that there are 
consequent relationships between the structure of BNM acceptors and the 
photophysical properties. As shown in Figure 2.14, we chose two 
representative types as example. The compounds in the red color show the 
highest quantum yield with the emission around 560 nm. And most of their 
structures show the similar feature containing the electron-donating group at 
the ortho position of the building block. This may be explained by the 
previous reports: the introduction of electro-donating group at the ortho 
positions can suppress non-radiative deactivation by restricting internal 
rotation of the phenyl ring, and then get relative high quantum yield.
20, 29
 The 
compounds which show quite low quantum yield, also show similar structure 
feature. All of them contain either an electron-rich benzene moiety 
dimethylamine or an electron-deficient benzene moiety nitro moiety. Because 
either electron-rich or electron-deficient benzene moieties can quench the 
fluorescence of a fluorophore via an intramolecular photoinduced electron 
transfer (PeT) process.
30
 This may be the main reason for the low quantum 
yield of these dyes. It should be noticed that based on the relationships 
between structures and photophysical data, we could predict and further 
design the fluorophore with featured photophysical properties for particular 
application. Like BNM441 in green color, it exhibits most of desired 
photophysical properties for bioimaging and other biological studies, such as 
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long emission wavelength, high quantum yield and large pseudo-Stokes shifts. 
This may be because the structure of BNM441 is more conjugated than those 
with dimethylamino substituent as building block. And the more conjugated 
structure can suppress the PeT process, consequently it still shows longer 
emission wavelength and relatively high quantum yield. 
 
Figure 2.14 Relationship between structures and photophysical properties of 
BNM library.  
 
As discussed above, the electronic character of the building block in the 
acceptor BDM may crucially determine the photophysical properties of BNM. 
Up to now, Hammett substituent constant (σ) has already been used as a 
numerical value to quantitatively evaluate the electronic effects of a 
substituent.
31
 To clarify the relationship between the structures and 
photophysical properties, we chose some compounds from BNM library 
whose building blocks contain single para-position of the phenyl group 
substituents as example. As shown in Table 2.5, Hammett substituent constant 
σp had a significant inverse correlation with the emission wavelength. The 
decrease in the Hammett substituent constant from highest ethyl (σp=-0.15) to 
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lowest dimethylamine (σp=-0.83), caused bathochromic emission wavelength 
shifts from 562 to 716 nm (Table 2.7). The similar result was also discovered 
by the previous report.
7
 These regular trends further confirm the determined 
relationship between the electronic character of the building block and 
photophysical properties. Actually, the building blocks for most of the BNM 
compounds are complicated, containing two or three phenyl groups or 
conjugated structures and the multiple electronic effects (ortho, meta and para) 
of substituents on the BDM acceptor may be responsible for the tunable 
emission wavelength of BNM library. 
Table 2.7 Electronic effect of substituents on the relationship between 
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2.2.6 Application of BNM Compounds in Live Cell 
Also, we examined the potential application of these new FRET 
compounds for fluorescence imaging in live cells. The result shows that the 
BNM compounds were well cell-permeable and can be employed for well 
resolved cell imaging when the BDN-3 absorption band was excited (data not 
shown). All BNM compounds were stained at the concentration of 2 µM and 
incubated for 1 h at 37 ºC. The localization of compounds seemed to be a 
Golgi apparatus at 490 nm of excitation. To further confirm the practical 
applications of RET-based BNM library for cell imaging, we performed 
double staining with Mito Tracker Green excited at 490 nm same as BNM 
compounds. Finally, we found the best compound, BNM490, as a new 
candidate for a FRET-based Golgi probe (Figure 2.15). The results show that 
the BNM compounds are penetrated into the cell and localized cell organelles 
like a Golgi apparatus. It suggests that the new designed RET-based BNM 
library are potentially useful for biological applications in living systems. 
 
Figure 2.15 BNM490 stains Golgi in live cell. Fluorescence image of live 
U2OS cells stained with 2 μM BNM490 (Red) (λex=490±20 nm, λem=605±52 
nm) and 0.5 µM of Mito Tracker Green (Green) (λex=490±20 nm, λem=525±36 
nm) at 37 ºC for 1 h. Nuclei staining of cells were performed with DAPI (blue). 
Three of taken images were merged. The images were taken using Nikon Ti 




By connecting one BODIPY donor and one BODIPY acceptor, we have 
shown the new strategy of design and synthesis of BODIPY-based RET library. 
The new RET strategy allows us to obtain a desired emission wavelength in 
biological experiments without considering the effective energy absorb at the 
excitation wavelength. The idea of using low quantum yield BODIPY dye as 
donor to reduce the fluorescence leaks from the donor part is challenging and 
breakthrough and it can potentially be applied to other donor-acceptor systems. 
The pump-probe measurement was applied to prove the probability of using 
low quantum yield dye as donor because of higher energy transfer rate in RET 
than self-quenched by non-radiatively intramolecular rotations. The BNM 
library is a novel BODIPY library with tunable emission wavelengths and high 
quantum yield using single excitation wavelength, which is particularly 
important for high-throughput screening or multiplexing technique. In addition, 
after analysis the relationship between building block structures and the 
photophysical properties, fluorescent compounds with desired photophysical 
properties can be designed and synthesized by simple synthesis scheme. Also, 
the cell imaging shows that the BNM compounds were well cell-permeable 
and can be employed as well resolved fluorescence probe. With its unique 
properties, we believe that BNM compounds can function as excellent 
fluorescent probes for fluorescence labeling in bioimaging. 
2.4 Experimental Section 
2.4.1 Reagents and Solvents 
The chemicals, including aldehydes and solvents, were purchased from 
Sigma Aldrich, Fluka, MERCK, Acros and Alfa Aesar. All the chemicals were 
53 
 
directly used without further purification. Normal phase column 
chromatography purification was carried using MERCK silica Gel 60 (Particle 
size: 230-400 mesh, 0.040-0.063 mm). 
2.4.2 Measurements and Analysis 
HPLC-MS was taken on an Agilent-1200 with a DAD detector and a single 
quadrupole mass spectrometer (6130 series). The analytical method, unless 
indicated, is A: H2O (0.1% HCOOH), B: CH3CN (0.1% HCOOH), gradient 
from 10 to 90% B in 10 min; C18 (2) Luna column (4.6 x 50 mm
2, 3.5 μm 
particle size). 
Spectroscopic and quantum yield data were measured on a SpectraMax M2 
spectrophotometer (Molecular Devices). Data analysis was performed using 




C-NMR spectra were recorded on Bruker ACF300 (300 
MHz) and AMX500 (500 MHz) spectrometers, and chemical shifts are 
expressed in parts per million (ppm) and coupling constants are reported as a J 
value in Hertz (Hz). Characterization details (NMR) are contained in the 
Supporting Information. 
2.4.3 Quantum Yield Measurements 
Quantum yields for all the fluorescent compounds were measured by 
dividing the integrated emission area of their fluorescent spectrum against the 
area of Rhodamine B in EtOH excited at 490 nm (Φrho-B = 0.7).
28
 Quantum 
yields were then calculated using equation (2), where F represents the 
integrated emission area of fluorescent spectrum, η represents the refractive 
index of the solvent, and Abs represents absorbance at excitation wavelength 
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2.4.4 Femtosecond Transient Absorption Measurements 
The femtosecond time-resolved transient absorption (fs-TA) spectrometer 
consisted of Optical Parametric Amplifiers (Palitra, Quantronix) pumped by a 
Ti:sapphire regenerative amplifier system (Integra-C, Quantronix) operating at 
1 kHz repetition rate and an optical detection system. The generated OPA 
pulses had a pulse width of ~ 100 fs and an average power of 100 mW in the 
range 280-2700 nm which were used as pump pulses. White light continuum 
(WLC) probe pulses were generated using a sapphire window (3 mm of 
thickness) by focusing of small portion of the fundamental 800 nm pulses 
which was picked off by a quartz plate before entering to the OPA. The time 
delay between pump and probe beams was carefully controlled by making the 
pump beam travel along a variable optical delay (ILS250, Newport). 
Intensities of the spectrally dispersed WLC probe pulses are monitored by a 
High Speed spectrometer (Ultrafast Systems). To obtain the time-resolved 
transient absorption difference signal (DA) at a specific time, the pump pulses 
were chopped at 500 Hz and absorption spectra intensities were saved 
alternately with or without pump pulse. Typically, 4000 pulses excite samples 
to obtain the fs-TA spectra at a particular delay time. The polarization angle 
between pump and probe beam was set at the magic angle (54.7°) using a 
Glan-laser polarizer with a half-wave retarder in order to prevent polarization-
dependent signals. Cross-correlation fwhm in pump-probe experiments was 
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less than 200 fs and chirp of WLC probe pulses was measured to be 800 fs in 
the 400-800 nm region. To minimize chirp, all reflection optics in the probe 
beam path and the 2 mm path length of quartz cell were used. After the 
fluorescence and fs-TA experiments, we carefully checked absorption spectra 
of all compounds to detect if there were artifacts due to degradation and 
photo-oxidation of samples. HPLC grade solvents were used in all steady-state 
and time-resolved spectroscopic studies. The three-dimensional data sets of 
ΔA versus time and wavelength were subjected to singular value 
decomposition and global fitting to obtain the kinetic time constants and their 
associated spectra using Surface Xplorer software (Ultrafast Systems). 
2.4.5 Picosecond Time-resolved Fluorescence Measurements 
Time-resolved fluorescence lifetime experiments were performed by the 
time-correlated single-photon-counting (TCSPC) technique. As an excitation 
light source, we used a Ti:sapphire laser (Mai Tai BB, Spectra-Physics) which 
provides a repetition rate of 800 kHz with ~ 100 fs pulses generated by a 
homemade pulse-picker. The output pulse of the laser was frequency-doubled 
by a 1 mm thickness of a second harmonic crystal (-barium borate, BBO, 
CASIX). The fluorescence was collected by a microchannel plate 
photomultiplier (MCP-PMT, Hamamatsu, R3809U-51) with a thermoelectric 
cooler (Hamamatsu, C4878) connected to a TCSPC board (Becker&Hickel 
SPC-130). The overall instrumental response function was about 25 ps (the 
full width at half maximum (fwhm)). A vertically polarized pump pulse by a 
Glan-laser polarizer was irradiated to samples, and a sheet polarizer, set at an 
angle complementary to the magic angle (54.7°), was placed in the 
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fluorescence collection path to obtain polarization-independent fluorescence 
decays. 
2.4.6 Cell Culture and Imaging Experiments 
U2OS cells were cultured in high-glucose (4500 mg/L) contained 
Dulbecco's Modified Eagle's medium (DMEM) supplemented with 10% fetal 
bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin. Cultureed cells 
were plated in 35 mm of glass bottom dishes for usage of 40 magnification 
lens. Next day, both 2 µM of BNM compounds and 0.5 µM of Mito Tracker 
Green were treated in 2 mL of fresh warm media and incubated for 1 h at 37 
ºC. Subsequently, 2 μM of Hoechst 33342 was added and further incubated for 
15 min at 37 ºC. Fluorescence images were acquired on ECLIPSE Ti 
microscope (Nikon Instruments Inc) for both BNM490 and Mito Tracker 
Green at 490 excitation. Images were analysed using NIS Elements 3.10 
software. 
2.4.7 Synthesis 
General procedure for the preparation of the BNM library. 
The BDN-1 and BDM were synthesized following our previous report.
9, 19
 
Compound 6 and 7 were synthesized following the reported method.
32
 
 BDN-3 (1 equiv), BDM compound (1 equiv) and DIEA (2 equiv) were 
dissolved in THF and stirred at room temperature for 2 h. After evaporation of 
the solvent, the crude product was purified by short silica column. The residue 
was purified by silica gel chromatography (eluents: DCM to DCM–MeOH (95: 
5)) to afford the corresponding BNM library compounds as red solid.  
Synthesis of the BDN derivatives 
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Synthesis of BDN-1: The synthesis of BDN-1 was following the reported 
literature.  
1
H-NMR (300 MHz, CDCl3): δ 7.65 (s, 1H), 7.13 (d, J = 8.3 Hz, 2H), 6.75 (d, 
J = 8.3, 2H), 6.52 (d, J = 3.2 Hz, 1H), 6.37 (d, J = 1.8 Hz, 1H), 6.12 (s, 1H), 
2.61 (s, 3H), 1.67 (s, 3H); 
13
C-NMR (75.5 MHz, CDCl3): 161.00, 147.64, 
146.70, 144.44, 138.02, 135.01, 133.69, 130.39,126.92, 123.77, 122.88, 
115.74, 114.57, 15.43, 15.03.  




Synthesis of BDN-2: A solution of BDN-1 (20 mg, 0.064 mmol) and DIEA 
(12 µL, 0.096 mmol) in CH2Cl2 (6 mL) was stirred under N2 atmosphere at 0 
ºC. Acetyl chloride (6 µL, 0.077 mmol) in CH2Cl2 (1 mL) was added dropwise 
and the resulting mixture was stirred at 0 ºC for 1 h. After removal of the 
CH2Cl2, the residue was purified by silica gel chromatography (CH2Cl2–
MeOH, 95: 5) to give BDN-2 as a yellow solid (18 mg, 80%). 
1
H NMR (300 MHz, CDCl3): δ 7.70 (s, 1H), 7.69 (d, J=8.7 Hz, 2H), 7.34 (d, 
J=8.5 Hz, 2H), 7.30 (s, 1H), 6.45 (s, 1H), 6.41 (s, 1H), 6.17 (s, 1H), 2.66 (s, 
3H), 2.26 (s, 3H), 1.63 (s, 3H); 
13
C NMR (75.5 MHz, CDCl3): 161.94, 160.00, 
146.85, 139.20, 138.58, 134.71, 129.66, 129.46, 126.95, 123.21, 119.19, 
116.01, 24.65, 15.23, 15.11.  






    Synthesis of BDN-3: To a solution of BDN-1 (115 mg, 0.37 mmol) in 70 
mL of dry tetrahydrofuran (THF) was added cyanuric chloride (101 mg, 0.55 
mmol). The reaction mixture was stirred for 1 h at 0 ºC. After removal of the 
THF, the residue was purified by silica gel chromatography (hexane–EtOAc, 
4 : 1) to give BDN-3 as a yellow solid (152 mg, 90%). 
1
H NMR (300 MHz, CDCl3): δ 7.81 (s, 1H), 7.73 (d, J=8.5 Hz, 2H), 7.70 (s, 
1H), 7.40 (d, J=8.5 Hz, 2H), 6.41 (s, 1H), 6.38 (s, 1H), 6.15 (s, 1H), 2.63 (s, 
3H), 1.60 (s, 3H); 
13
C NMR (75.5 MHz, CDCl3): 171.47, 170.44, 164.02, 
162.37, 146.68, 142.13, 138.89, 137.22, 134.56, 133.51, 130.92, 129.95, 
126.91, 123.41, 120.48, 116.20, 29.65, 15.24.  




Synthesis of BDN-4: A solution of BDN-3 (25 mg, 0.054 mmol) and DIEA 
(10 µL, 0.081 mmol) in THF (6 mL) was stirred under N2 atmosphere at rt. 1-
Butanamine (8 µL, 0.081 mmol) was added and the resulting mixture was 
stirred at rt for 2 h. After removal of the THF, the residue was purified by 
silica gel chromatography (CH2Cl2–MeOH, 95: 5) to give BDN-4 as a yellow 




H NMR (300 MHz, CDCl3): δ 7.80 (d, J=8.5 Hz, 2H,), 7.72 (s, 1H), 7.38 (d, 
J=8.5 Hz, 2H), 6.49 (s, 1H), 6.42 (s, 1H), 6.18 (s, 1H), 3.57-3.47 (m, 2H), 2.67 
(s, 3H), 1.66 (m, 5H), 1.49-1.41(dd, 2H), 1.03-0.97 (m, 3H); 
13
C NMR (75.5 
MHz, CDCl3): 163.84, 161.98, 146.72, 142.86, 139.14, 138.67, 134.73, 133.62, 
129.66, 129.22, 126.96, 123.25, 119.78, 116.06, 41.15, 31.19, 20.00, 15.27, 
15.13, 13.69.  




    Synthesis of BDN-5: Compound BDN-5 was synthesized as for BDN-4 
and obtained as a yellow solid (61%). 
1
H NMR (300 MHz, CDCl3): δ 7.80 (d, J=8.5Hz, 2H), 7.74 (s, 1H), 7.41-7.24 
(m, 7H), 6.50 (s, 1H), 6.43 (s, 1H), 6.18 (s, 1H), 3.85-3.76 (m, 2H), 2.99 (t, 
J=7.0Hz, 2H), 2.68 (s, 3H), 1.66(s, 3H); 
13
C NMR (75.5 MHz, CDCl3): 169.31, 
163.81, 162.03, 146.73, 139.06, 138.70, 138.07, 134.73, 129.71, 129.34, 
128.81, 128.73, 128.65, 126.98, 126.95, 126.83, 123.26, 119.88, 119.80, 
116.11, 42.61, 35.43, 15.28, 15.14.  
HRMS m/z (C28H25BClF2N7) calculated: 543.1921, found: 542.1876 (M-H)
-
. 







    
1
H NMR (500 MHz, CDCl3-MeOD): δ 8.26 (s, 1H), 8.10 (d, J=7.2 Hz, 1H), 
7.73 (d, J=7.6 Hz, 1H), 7.62 (s, 1H), 7.61 (d, J=12.3 Hz, 2H), 7.45 (s, 1H), 
7.41-7.36 (m, 2H), 7.32 (s, 1H), 7.25 (s, 1H), 6.87 (s, 1H), 6.48 (s, 1H), 4.50 (s, 
2H), 3.39 (s, 2H), 2.52 (s, 3H), 1.41(s, 2H), 1.24(s, 3H); 
13
C NMR (125 MHz, 
CDCl3-MeOD): 159.16, 144.20, 142.85, 142.84, 140.95, 140.10, 135.94, 
135.12, 133.31, 126.49, 125.94, 125.63, 123.14, 122.44, 121.80, 120.83, 
120.20, 120.15, 119.32, 115.37, 114.44, 108.67, 108.58, 40.53, 37.29, 26.45, 
15.75, 13.26.  





H NMR (500 MHz, CDCl3): δ 8.14 (t, J=7.8 Hz, 2H), 7.80-7.58 (m, 10H), 
7.52-7.40 (m, 2H), 7.33-7.29 (m, 2H), 7.06 (s, 1H), 6.79 (d, J=16.9 Hz, 1H), 
6.51-6.39 (m, 3H), 6.13 (d, J=25.4 Hz, 1H), 3.97 (d, J=7.0 Hz, 3H), 3.90 (s, 
1H), 3.76 (s, 1H), 3.32 (dd, J=14.2, 7.4 Hz, 2H), 2.65-2.52 (m, 6H), 1.60 (d, 
J=20.1 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 166.92, 166.90, 162.19, 156.74, 
146.71, 144.85, 144.73, 144.17, 140.78, 140.69, 139.30, 138.74, 138.65, 
138.44, 136.47, 136.35, 135.18, 134.62, 134.55, 134.47, 133.56, 130.18, 
129.75, 129.51, 129.25, 128.70, 127.26, 127.10, 127.05, 126.77, 126.66, 
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124.11, 123.94, 123.36, 120.28, 119.92, 119.79, 119.07, 118.87, 116.40, 
116.13, 52.16, 43.10, 42.59, 16.69, 16.53, 15.31.  






H NMR (500 MHz, CDCl3): δ 7.74-7.70 (m, 3H), 7.67-7.64 (m, 2H), 7.59 (s, 
1H), 7.42 (dd, J=39.8, 8.9 Hz, 1H), 7.32-7.31 (m, 2H), 7.25 (d, J=3.8 Hz, 1H), 
7.02 (s, 1H), 6.81 (d, J=18.8 Hz, 1H), 6.70 (dd, J=27.4, 8.9 Hz, 1H), 6.48-6.39 
(m, 3H), 6.14 (d, J=10.8 Hz, 1H), 3.98-3.88 (m, 10H), 3.77 (dd, J=13.5, 6.5 
Hz, 1H), 3.31 (dd, J=14.2, 7.3 Hz, 2H), 2.64-2.51 (m, 6H), 1.61 (d, J=13.3 Hz, 
3H); 
13
C NMR (125 MHz, CDCl3): 165.08, 163.37, 162.11, 158.56, 158.36, 
155.52, 155.49, 152.85, 146.74, 144.35, 143.71, 142.67, 142.27, 138.64, 
137.04, 135.41, 135.11, 134.91, 134.62, 134.15, 133.54, 129.71, 129.67, 
126.97, 123.33, 122.84, 122.70, 120.24, 117.32, 116.10, 115.76, 107.87, 61.57, 
60.89, 56.09, 43.08, 42.64, 16.64, 16.52, 15.30. 









H NMR (500 MHz, CDCl3): δ 7.87 (d, J=29.2 Hz, 1H),7.80-7.64 (m, 7H), 
7.50 (d, J=16.1 Hz, 1H), 7.35 (d, J=8.2 Hz, 1H), 7.32 (d, J=8.3 Hz, 1H), 7.27 
(d, J=3.7 Hz, 1H), 7.20-7.13 (m, 2H), 7.05 (s, 1H), 6.81 (s, 1H), 6.51-6.37 (m, 
3H), 6.11 (d, J=48.0 Hz, 1H), 3.96 (d, J=8.6 Hz, 3H), 3.90 (d, J=6.6 Hz, 1H), 
3.80 (dd, J=12.6, 6.2 Hz, 1H), 3.32 (dd, J=14.9, 7.8 Hz, 2H), 2.65-2.52 (m, 
6H), 1.60 (d, J=32.8 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 162.13, 158.90, 
158.88, 146.73, 144.16, 140.55, 140.39, 138.74, 138.63, 138.59, 137.64, 
135.61, 134.34, 134.32, 133.60, 131.35, 131.23, 130.18, 130.14, 130.03, 
129.78, 129.73, 129.15, 128.83, 127.57, 124.52, 124.38, 123.37, 123.34, 
123.31, 120.18, 120.13, 120.10, 119.96, 119.47, 116.13, 116.09, 116.05, 
106.13, 55.40, 43.29, 31.90, 16.75, 16.61, 15.33.  






H NMR (500 MHz, CDCl3): δ 7.85 (d, J=23.8 Hz, 1H), 7.73-7.46 (m, 7H), 
7.37-7.30 (m, 3H), 7.20 (d, J=3.9 Hz, 1H), 7.13 (dd, J=10.0, 3.1 Hz, 1H), 6.81 
(d, J=9.1 Hz, 1H), 6.54 (dd, J=10.2, 3.0 Hz, 1H), 6.46-6.38 (m, 3H), 6.12 (d, 
63 
 
J=34.9 Hz, 1H), 4.13-4.07 (m, 2H), 3.91 (s, 1H), 3.80 (s, 1H), 3.31 (dd, 
J=16.0, 8.1 Hz, 2H), 3.65-2.51 (m, 6H), 1.91-1.86 (m, 2H), 1.60 (d, J=27.8 Hz, 
3H), 0.96 (q, J=7.5 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 162.75, 162.17, 
158.78, 146.75, 144.26, 143.11, 138.81, 138.64, 137.33, 136.48, 135.54, 
135.43, 134.63, 134.00, 133.58, 130.02, 129.77, 129.72, 129.15, 128.98, 
127.43, 127.33, 127.00, 126.88, 123.37, 122.62, 121.32, 120.55, 120.25, 
120.12, 116.16, 116.12, 115.57, 115.50, 110.10, 102.25, 102.22, 48.25, 43.09, 
31.92, 23.60, 22.67, 16.59, 14.09, 11.46. 






H NMR (500 MHz, CDCl3): δ 7.71-7.29 (m, 12H), 7.11 (dd, J=29.4, 2.9 Hz, 
1H), 6.94 (s, 1H), 6.71 (d, J=6.2 Hz, 1H), 6.50-6.39 (m, 3H), 6.12 (d, J=34.1 
Hz, 1H), 3.88 (s, 1H), 3.80 (d, J=28.1 Hz, 3H), 3.68 (s, 1H), 3.22 (s, 2H), 2.62 
(d, J=29.3 Hz, 3H), 2.47 (d, J=17.6 Hz, 3H), 1.61 (d, J=21.5 Hz, 3H); 
13
C 
NMR (125 MHz, CDCl3): 165.90, 163.95, 162.00, 158.31, 146.74, 144.16, 
142.86, 142.60, 142.34, 138.94, 138.86, 138.63, 138.50, 138.39, 136.95, 
134.70, 134.62, 134.13, 133.58, 131.45, 131.41, 130.49, 129.73, 129.62, 
129.35, 126.94, 126.81, 123.37, 123.28, 122.20, 121.19, 120.15, 120.03, 
119.91, 116.04, 115.56, 101.61, 43.00, 32.98, 31.87, 22.65, 16.64, 16.51. 








H NMR (500 MHz, CDCl3): δ 8.27 (d, J=25.7 Hz, 1H), 8.15 (dd, J=11.8, 7.8 
Hz, 1H), 7.77-7.65 (m, 5H), 7.59-7.40 (m, 4H), 7.35-7.30 (m, 3H), 7.21 (s, 
1H), 6.97 (s, 1H), 6.76 (d, J=32.1 Hz, 1H), 6.48-6.37 (m, 3H), 6.11 (d, J=45.8 
Hz, 1H), 4.42-4.32 (m, 2H), 3.91 (s, 1H), 3.73 (s, 1H), 3.27 (dd, J=13.5, 6.8 
Hz, 2H), 2.62 (d, J=23.7 Hz, 3H), 2.50 (s, 3H), 1.60 (d, J=27.3 Hz, 3H), 1.30-
1.27 (m, 3H); 
13
C NMR (125 MHz, CDCl3): 163.27, 162.16, 158.49, 146.72, 
144.16, 142.35, 141.21, 140.45, 138.74, 138.59, 136.41, 135.45, 134.64, 
134.18, 134.04, 133.56, 129.74, 129.70, 126.97, 126.83, 126.30, 126.01, 
125.96, 123.53, 123.50, 123.33, 122.87, 121.12, 120.74, 120.19, 119.74, 
116.13, 116.06, 115.56, 115.47, 115.35, 115.09, 109.03, 109.00, 108.89, 
108.86, 60.37, 43.00, 37.77, 29.67, 16.72, 16.53, 15.31, 13.83. 
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Chapter 3 Discovery of a Turn-on FRET-based BODIPY 




















Biological thiols such as cysteine (Cys), homo-cysteine (Hcy), and 
glutathione (GSH) play important roles in a number of biological processes in 
living organisms.
1
 Cys is precursor to the antioxidant GSH, and their abnormal 
levels are closely related to human aging and various diseases.
2
 While Hcy is a 
risk factor for Alzheimer’s disease and cardiovascular diseases, total plasma 
Hcy concentrations have been proven to link to birth defects and cognitive 
impairment at the elderly stage.
3
 In view of the importance of thiols, the 
design of analytical methodologies for the detection of biomolecular thiols in 
biological and environmental samples has consistently attracted a great deal of 





 as well as 
electrospray ionization-mass spectrometry
6
 have been used to detect thiols. 
However, these methods are not convenient for use, since they often involve 
the expensive instrumentation and can be technically demanding in their 
handling.  
On the contrary, fluorescent molecular probes are more attractive, due to 
their high sensitivity and easy visibility. Also, fluorescent molecular probes 
offer the possibility of quantitative optical detection of biothiols and broad 
bioimaging applications, such as detecting the carcinoma region of liver tissue 
based on the differences of glutathione level.
7
 Till now, a number of diverse 
sensing mechanisms have been employed for thiol detection, including 
thiol−halogen nucleophilic substitution,8 Michael addition,9 –CHO attached 
fluorophore,
10
 and de-protection of 2,4-dinitrobenzenesulfonyl (DNBS)-
protected fluorophores.
11
 Most of these published probes show good 
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selectivity and sensitivity in detecting certain biothiols by simple 
spectroscopic techniques, which monitor optical responses caused by different 
concentrations of biothiols. However, most of them were designed based on a 
single fluorophore as the fluorescence signaling profile, which may limit their 
applications, due to the fluorescence detection errors caused by relatively 
small Stokes shifts. Some FRET-based probes, constructed with dyes that have 
high extinction coefficients and high quantum yields as donors, have also been 
explored for thiols detection. Unfortunately, instances of fluorescence leaks 
from the donor have been inevitable, as a result of either low energy transfer 
efficiencies or environmental changes.
12
           
Hence, newly improved FRET probes with better photophysical properties, 
which can efficiently eliminate the interference from background fluorescence 
and scattered light, are worthwhile to design. Several criteria must be satisfied 
for the FRET probe: 1) absorbance of light at a high extinction coefficient but 
no fluorescence emission from donor part to ensure that there is no 
background influence; 2) large pseudo-Stokes shifts and emission shifts to 
avoid serious self-quenching and fluorescence detection errors caused by 
excitation backscattering effects;
13
 3) high efficient FRET energy transfer. 
Here, we designed and synthesized a turn-on FRET-based molecular probe 1 
containing a 2,4-dinitrobenzenesulfonyl (DNBS) group on its acceptor, acting 
as the reaction site for biothiols. In addition, the application of probe 1 for 






3.2 Results and Discussion 
3.2.1 Design and Synthesis of the Probe 1 
Here, we designed a reactive FRET probe 1 having long emission 
wavelength and large pseudo-Stokes shifts characteristics. BDN skeleton was 
chosen as the donor because of its high extinction coefficient and low quantum 
efficiency.
14
 The red emitting styryl BDM153 was chosen as acceptor part of 
the FRET pair of probe 1, which is expected to be a good quantum yield 
BODIPY dye with emission at 580 nm. This elegant choice of donor and 
acceptor, when successfully incorporated into a triazine- moiety results in a 
large Stokes-shifts dye, the precursor of probe 1 which has moderate quantum 
yield with minimum emission leakage from donor part. This precursor of 
probe 1, BNM153, consists of hydroxyl group at the end of BNM acceptor, 
which is reasoned to be a high quantum yield dye. Upon obtaining the large 
Stokes-shifts, FRET based-precursor, the strong electron-deficient 2,4-
dinitrobenzenesulfonyl group (DNBS), was introduced at the end of probe 1, 
hoping that it would give rise to a fluorogenic thiol reactive probe 1. Here the 
fluorogenic characteristic or in other word the reduction of fluorescence 
intensity is caused by the intramolecular photoinduced electron transfer (PeT) 
process from the excited fluorophore to the strong electron-acceptor DNBS. 
Based on previous knowledge, it is evident that after the addition of Cys or 
Hcy to probe 1, reaction would occur to cleave DNBS quencher from the 
probe 1 and thereby emission would restore. The major advantage of this 
current thiol probe over the existing FRET probes would be the minimum 
emission leakage from the donor site. In general, upon binding to the analyte, 
emission leakage from the donor site is quite inevitable for the regular FRET 
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probe and thereby it limits the possibility of usage of probe as multicolour 
imaging agent. Therefore, this is the first report of a turn on red-emitting 
FRET based biothiol probe where there is no emission leakage from the donor 
site of the probe. 
Scheme 3.1 indicates the synthesis of probe 1. At first, BDN-1 was reacted 
with the cyanuric chloride linker to obtain an intermediate BDN-3. Then, this 
key intermediate was reacted with acceptor BDM153 to give a FRET 
construct BNM153. A DNBS group was then incorporated to BNM153 in the 
presence of Et3N to get the target probe 1. Since the DNBS unit is known to be 
a potent electron acceptor which produces a dark excited state, the 
incorporation of this unit into the fluorescent molecule (BNM153) would 
consequently quench the emission to give probe 1, a non-fluorescent thiol 
reactive dye. Subsequent cleavage of the DNBS group will then restore the 
emission of the fluorophore BNM153 in the presence of thiols. The structures 




C NMR and HRMS analysis. 
Scheme 3.1 Synthesis of the FRET thiol probe 1 
 
Reagents and conditions: (a) Cyanuric chloride, DIEA, THF, 0 ºC, 1h, 90%; (b) 
DIEA, THF, rt, 2h, 72%; (c) 2,4-Dinitrobenzenesulfonyl chloride, Et3N, DCM, 








Figure 3.1 The absorbance and emission spectra of probe 1 and the relative 






3.2.2 Spectroscopic Properties of Compounds 
The absorbance and fluorescence spectra of probe 1, the precursor BNM153, 
BDN-3 and BDM153 were investigated. The absorption spectra of BNM153 
displayed the characteristic absorption signal of BDN-3 at around 494 nm and 
the typical absorption signal of BDM153 at around 561 nm, respectively 
(Figure 3.1a). Compared with the unconjugated BDN-3 and BDM153, the 
shape of BNM153 absorption spectra did not show obvious change, which 
reveals that the electronic interactions between the donor and the acceptor are 
very weak. Compared with the precursor BNM153, absorption of probe 1 
shows a blue shift, due to the protection of the strong electron-acceptor DNBS. 
The emission spectra of probe 1 and its precursor BNM153 are shown in 
Figure 3.1b. Upon excitation of probe 1 at the donor absorption band (470 nm), 
only the characteristic emission band of the acceptor at around 561 nm was 
observed, while the emission of BDN-3 was not observed. This indicates that 
the energy transfer is efficient from donor to acceptor. For BNM153, the 
maximum emission wavelength was shifted to 580 nm. It is worth noting that 
the quantum yield of BNM153 is much larger than probe 1, which is almost 
non-fluorescent because of the PeT process. The maximum wavelengths of 
absorbance, fluorescence emission, quantum yield, and Stokes shifts as 








Table 3.1 Photophysical data of BDN-3, BDM153, precursor BNM153 and 





 Logεmax λem(nm) Φ
c
 Δλd 
BDN-3 492 4.65 – – 510 <0.001 18 
BDM153 – – 560 4.76 580 0.56 20 
BNM153 494 4.66 561 4.76 580 0.16 86 
Probe 1 494 4.66 551 4.83 561 0.01 67 
a
The maximal absorption of donor part; 
b
The maximal absorption of acceptor 
part; 
c
Fluorescence quantum yields were determined using rhodamine B 




Pseudo-Stokes shifts of the BNM153 and 
probe 1 and the Stokes shifts of the BDN-3 and BDM153. 
 
3.2.3 Selective Detection of Cys and Hcy 
The fluorescence response of probe 1 towards Cys was investigated. The 
pH-independent spectra shows that probe 1 can work in a wide physiological 
pH range (Figure 3.2). All the tests were taken 1 h after the addition of Cys, to 
ensure that the reaction reached equilibrium. Probe 1 alone is almost non-
fluorescent, as a result of the quenching effect of the protecting group DNBS. 
In the presence of Cys, however, the electron-withdrawing DNBS moiety is 
cleaved and the fluorescence intensity is dramatically enhanced by 12-fold at 
580 nm. Also, a remarkable red shift of the maximum emission (19 nm) 
between probe 1 and the corresponding cleavage BNM153 and a large 
pseudo-Stokes shift were observed. After cleavage, the precursor BNM153 
displays an intense absorption at 494 nm and emission at 580 nm, giving a 
pseudo-Stokes shifts of up to 86 nm. In addition, the emission colour changed 
from non-fluorescent to bright orange, which corresponds to probe 1 and 
BNM153 after the addition of Cys (Figure 3.3). Also, emission spectra of 
probe 1 show that this is no emission leakage from donor part before and after 
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addition of Cys, clearly demonstrating its advantage over other FRET dyes in 
their applications. 
 
Figure 3.2 pH-dependency of the emission of the probe 1 and BNM153, (10 
μM, MeOH–H2O, 4 : 1, v/v), λex=470 nm, λem=580 nm. Values are represented 
as means and error bars as standard deviations (n = 3), Measurements were 
taken at rt. 
 
 
Figure 3.3 Fluorescence emission spectra (λex = 470 nm) of probe 1 (10 μM) 
before and after addition of L-cysteine (3 mM, MeOH–H2O, 4 : 1, v/v). Inset: 
Pictures of probe 1 (10 μM) before and after adding L-cysteine (3 mM) under 




Figure 3.4 (a) Fluorescence response of probe 1 (10 μM) upon incubation 
with serial dilutions of Cys (0-4 mM) (λex = 490 nm); (b) A linear relationship 
of the fluorescence intensity vs the concentration of Cys (0-300 μM) Values 




Figure 3.5 Plot of the emission intensity at 580 nm as a function of Cys 
concentration. Values are represented as means and error bars as standard 
deviations (n = 3), Measurements were taken at rt. Kd = 0.37 mM (one-site 
specific binding model). 
 
Under optimal conditions, we evaluated the capability of the proposed 
method for quantitative detection of Cys. The fluorescence responses of probe 
1 with different concentrations of Cys (0-4 mM) are shown in Figure 3.4. The 
results show that the fluorescence of probe 1 increases with gradual addition 
of Cys (0-4 mM). A linear increment, with respect to the concentration of Cys 
within the 0 to 0.3 mM range, is also observed. The calculated Kd value for 
Cys is 0.37 mM (Figure 3.5). 
The sensing kinetics of Cys, Hcy and GSH by probe 1 was also 
investigated. As shown in Figure 3.6, the recognition of Cys and Hcy by probe 
1 almost complete within 60 min, whereas probe 1 does not show any 
observed response towards GSH. Reaction rate constants for the recognition of 
Cys and Hcy were determined to be 0.027 min
-1
 and 0.016 min
-1
, respectively 
(Figure 3.7). The results obtained in this study are consistent with the reported 






Figure 3.6 The sensing kinetics of probe 1 (10 μM) toward Cys, Hcy and 
GSH (3 mM). λex=490 nm, λem=580 nm. Values are represented as means and 







Figure 3.7 The reaction rate constants for recognition of Cys (a) and Hcy (b). 
 
In order to examine the selectivity of probe 1, the fluorescence change of 
probe 1 in the presence of different amino acids and biological thiols, such as 
GSH and Hcy, was examined by monitoring the changes in emission spectral 
intensities at 580 nm. The results of the fluorescence changes are summarized 
in Figure 3.8. Probe 1 shows good selectivity for Cys and Hcy over other 
amino acids. At the same time, probe 1 also displays very weak response 
towards GSH, which is probably due to the bulkiness of this analyte in the 
solvent system.
11e, 12a





Figure 3.8 Fluorescence responses of probe 1 (10 μM) to different analytes (3 
mM). Values are represented as means and error bars as standard deviations 
( n = 3). Measurements were taken at rt. 
 
3.2.4 Rationalization of the Sensing Mechanism of Thiol Probe  
The selectivity of probe 1 is dependent on its sensing mechanism. Although 
the mechanism of detecting Cys using similarly designed dyes has been 
studied by NMR and HRMS, no systematic study regarding the change of 
reaction in aqueous media has been reported to date.
11f, 16
 To obtain more 
detailed insights into the mechanism, interaction between probe 1 and Cys was 
monitored by HPLC-MS. Results from HPLC-MS monitor test show that the 
signal corresponding to probe 1 at 8.3 min became smaller, whereas a new 
peak corresponding to BNM153 at 8 min appeared and got bigger over time 
(Figure 3.9). This result was further confirmed by mass spectra analysis. The 
signal at 8.3 min shows characteristic mass information for probe 1, while the 
new peak at 8.0 min shows mass information for BNM153 (Figure 3.10). 
Further characterization shows that another new peak which appeared at 4.9 
min was proven to be a by-product (Figure 3.11). Taken together, the results 
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have successfully demonstrated that probe 1 when in response to Cys forms 




Figure 3.9 (a) Proposed sensing mechanism; (b) HPLC-MS spectral changes 
for probe 1 upon addition of Cys (from 0 min to 90 min, UV detection: 560 






Figure 3.10 HPLC-MS characterization of probe 1 upon addition of Cys (1 h). 
a) Chromatograms (descending order) at 350 nm, 500 nm, 560 nm and MS-
TIC; b) left, right: ESI-negative MS spectra at 8.3 min and ESI-negative MS 




Figure 3.11 HPLC-MS characterization of probe 1 upon addition of Cys. ESI-
positive and ESI-negative MS spectra at 4.9 min for by-product. 
 
Meanwhile, density functional theory (DFT) calculations were carried out 
to elucidate the mechanism of fluorescence enhancement when BNM153 
formation was observed after the addition of Cys to probe 1. The excited state 
related calculations were carried out with the time-dependent DFT (TDDFT), 
based on the optimized ground state geometry. From the calculated data, both 
HOMO and LUMO of BNM153 are localized on the π-conjugated acceptor 
part, and the HOMO-1 and LUMO+1 are localized on the donor BODIPY part 
(Figure 3.12 and Figure 3.13). Also, from the calculated energy, two main 
allowed electronic transition were observed for BNM153, which are H-1 
→L+1, 402 nm, f=0.6936 and H →L, 461 nm, f=0.6895 (Table 3.2). These 
calculation results indicated two main absorption bands of BNM153. The 
calculated oscillator strength (f) for the HOMO to LUMO transition is 1.1342, 




At the same time, the HOMO of probe 1 is localized from the BODIPY part 
of the acceptor onto the phenylethelene linker (C=C), whereas the LUMO of 
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probe 1 is localized on DNBS moiety. The HOMO to LUMO transition is 
composed of a full electron-transfer process from acceptor BODIPY to the 
electron-withdrawing DNBS moiety. The calculated oscillator strength (f) for 
this transition is only 0.004. This means that the direct HOMO to LUMO 
transition is forbidden, thus LUMO to HOMO is a non-radioactive 
transition.
11e, 17
 These predictions are in full agreement with the experimental 
results and clearly demonstrate the reasons for the photoproperties of probe 1 
and the precursor BNM153. Furthermore, the calculated red shift from probe 1 
to BNM153 (6 nm) matches well with the experimental data (9 nm). This 
concordant calculated data provides strong support for the proposed 







Figure 3.12 The frontier molecular orbitals (MOs) of BNM153 and probe 1. 
(a) the HOMO of BNM153, (b) the LUMO of BNM153, (c) the HOMO of 
probe 1 and (d) the LUMO of probe 1. The energy levels of the MOs are 
shown (eV). Calculations are based on ground state geometry by DFT at the 








Table 3.2 Selected parameters for the vertical excitation (UV-vis absorptions) 
of the compounds. Electronic excitation energies (eV) and oscillator strengths 
(f), configurations of the low-lying excited status of the probe 1 and BNM153. 














2.6887 eV  
(461.14 nm) 
1.1342 H →L 0.68946 
3.0837 eV  
(402.06 nm) 
0.4788 H-1 →L+1 0.69358 
Probe 1 
2.7202 eV  
(455.79 nm) 
1.0094 H →L+1 0.69348 
3.0783 eV  
(402.76 nm) 
0.4734 H-1 →L+2 0.68706 
3.5597 eV  
(348.29 nm) 
0.004 H →L 0.60272 
a
Only selected excited states were considered. The numbers in parentheses are 




H stands for HOMO 
and L stands for LUMO. Only the main configurations are presented. 
d
Coefficient of the wavefunction for each excitations. The CI coefficients are 
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Figure. 3.13 The frontier molecular orbitals (MOs) of BNM153 (a) and probe 
1 (b). The energy levels of the MOs are shown (eV). Calculations are based on 





3.2.5 Application of Probe 1 in Fluorescent Imaging of Cellular Thiols 
Considering the excellent sensing performance of probe 1 towards Cys and 
Hcy, we decided to employ probe 1 for the fluorescence imaging of cellular 
thiols (Figure 3.14). After incubating HeLa cells with probe 1 at 37 ºC for 30 
min, an obvious fluorescence was observed inside the cells. To validate the 
finding that this fluorescence turn-on was specific due to the cellular thiols, a 
control experiment was performed, where HeLa cells were first incubated with 
N-methylmaleimide (NMM) at 37 ºC for 30 min to remove cellular thiols prior 
to incubation with probe 1. The results show that when NMM was used, 
almost no fluorescence was observed inside the cells, suggesting that 
fluorescence signal observed is most likely due to the reaction of probe 1 with 
intracellular thiol species.  
To eliminate possible interference by GSH during intracellular Cys 
detection, HeLa cells were treated with L-buthionine sulfoximine (BSO), prior 
to imaging with probe 1. Unlike NMM which does not differentiate between 
Cys, Hcy or GSH, but lowers concentration of cellular thiols in general, BSO 
selectively inhibits γ–glutamylcysteine synthetase.18 As such, it is expected 
that addition of BSO precludes replenishment of GSH from Cys, hence, 
lowering the effective concentration of GSH within the cells under the 
conditions of oxidative stress. In fact, the fluorescence intensity of probe 1 
was decreased with BSO-H2O2 pre-treatment and recovered by the addition of 
L-Cys (Figure 3.15 and Figure 3.16). On this note, we thus believe that the 
fluorescence signal from the cells is associated with changes in intracellular 
Cys concentration rather than with GSH. Moreover, considering the much 
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lower intracellular concentration of Hcy, probe 1 can be used for monitoring 
changes of the cellular Cys concentration. 
 
Figure 3.14 Fluorescent microscopic images of HeLa cells. (a-c) Images of 
cells incubated with probe 1 (3 μM) for 30 min at 37 ºC. (d-f) Images of cells 
pre-treated with N-methylmaleimide (1 mM) for 30 min and then incubated 
with probe 1 (3 μM) for 30 min at 37 ºC; (a) and (d) represent the 
corresponding phase contrast images of (b) and (e), respectively; (c) and (f) 
represent the corresponding merged images of (a, b) and (d, e), respectively. 
Images were taken with a 40× objective. Scale bar represents 50 µm. 
 
 
Figure 3.15 Fluorescent microscopic images of HeLa cells. (e) Cells were 
incubated with probe (3 μM) for 30 min; (f) and (g) Cells were pre-treated 
with 1 mM BSO or 1 mM BSO and 0.1 mM hydrogen peroxide for 1-2 h 
before incubation with probe 1 (3 μM) for 30 min; (h) BSO and hydrogen 
peroxide-treated cells were then treated with L-cysteine (far right) to increase 
cellular cysteine levels before incubation with probe (3 μM) for 30 min; (a, b, 
c, d) represent the corresponding phase contrast images of (e, f, g, h), 





Figure 3.16 Fluorescent intensity measurements of HeLa cells. Cells were 
pre-treated with 1 mM L-buthionine sulfoximine (BSO) or 1 mM BSO and 0.1 
mM H2O2 for 1 h. Cells from latter incubation were further treated with 1 mM 
L-cysteine (L-cys) for 1 h or left untreated before incubation with probe (3 μM) 
for 30 min. As control, cells were incubated with probe 1 only. Fluorescence 
intensities were displayed as averages of measurements from three sites. *p < 
0.005.   
 
3.3 conclusion 
In this chapter, we explored the rationalization of the sensing mechanism of 
the thiol probe with HPLC-MS and DFT/TDDFT calculations. The selectivity 
of the probe is dependent on the sensing mechanism. Although the mechanism 
of detecting cysteine using the similar designed dyes has been studied by 
NMR and HRMS, no systematic study regarding the change of reaction in 
aqueous media has been reported to date.
11f
 To obtain more detailed insight 
into the mechanism, the interaction between the probe and cysteine was 
monitored using the HPLC-MS method. Meanwhile, density functional theory 
(DFT) calculations were carried out to elucidate the mechanism of 
fluorescence enhancement that BNM153 formation was observed after adding 
cysteine to the probe. The results from calculations clearly demonstrated the 
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reasons for the photoproperties of the probe and the precursor BNM153. This 
concordant calculated data provides strong supports for the proposed 
mechanism for the cysteine probe. These results from the spectra and the 
Gaussian calculation suggest that the rational design of fluorescent molecular 
probes can be used for designing new fluorescent probes. Furthermore, the 
bioimaging showed the probe can easily penetrate cell membranes to perform 
fluorescence imaging detection for thiol species in living cells. These results 
indicated that the probe is a good candidate for biothiol detection process in 
living cells imaging.  
Further research is needed to explore real applications for the cysteine 
probe, such as quantitative detection of cysteine in human blood plasma. The 
quantitative estimation of Cys and Hcy in human blood plasma is crucial 
because they play significant roles in various physiological processes. This is 
particularly important for understanding the role of thiols in the pathogenesis 
of cardiovascular diseases and gives important clues for the view point of 
diagnostic and clinical applications. 
3.4 Experimental Section 
3.4.1 Reagents and Solvents 
The chemicals, including aldehydes and solvents, were purchased from 
Sigma Aldrich, Acros and Alfa Aesar. All the chemicals were directly used 
without further purification. Normal phase column chromatography 
purification was carried out using MERCK silica Gel 60 (Particle size: 230-
400 mesh, 0.040-0.063 mm). 
3.4.2 Measurements and Analysis 
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HPLC-MS was taken on an Agilent-1200 with a DAD detector and a single 
quadrupole mass spectrometer (6130 series). The analytical method, unless 
indicated, is A: H2O (0.1% HCOOH), B: CH3CN (0.1% HCOOH), gradient 
from 10 to 90% B in 10 minutes; C18 (2) Luna column (4.6 x 50 mm2, 3.5 μm 
particle size). 
Spectroscopic and quantum yield data were measured on a SpectraMax M2 





C-NMR spectra were recorded on Bruker ACF300 (300 
MHz) or AMX500 (500 MHz) spectrometers, and chemical shifts are 
expressed in parts per million (ppm) and coupling constants are reported as a J 
value in Hertz (Hz).  
3.4.3 Quantum Yield Measurements 
Quantum yields for all the fluorescent compounds were measured by 
dividing the integrated emission area of their fluorescent spectrum against the 
area of Rhodamine B in EtOH excited at 490 nm (Φrho-B = 0.7).
15
 Quantum 
yields were then calculated using equation (1), where F represents the 
integrated emission area of fluorescent spectrum, η represents the refractive 
index of the solvent, and Abs represents absorbance at excitation wavelength 
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3.4.4 DFT Calculations 
All calculations have been performed with the Gaussian09 code. Full 
geometry optimizations and electronic structure calculations were performed 
with density functional theory (DFT) at B3LYP/6-31G(d) level. The excited 
state related calculations were carried out with the time-dependent DFT 
(TDDFT), based on the optimized ground state geometry.
19
 
3.4.5 Cell Culture and Imaging Experiments 
HeLa cells were cultured in clear bottom, 96-well plate and maintained in 
an incubator at 37 °C with 5 % CO2, 24-36 hours prior to imaging experiments. 
Cells were grown in Dulbecco’s Modified Eagle Medium (Sigma) with 10 % 
newborn calf serum, as well as 5 mM L-glutamine and 5 mg/mL gentamicin. 
Probe stock solution in DMSO (1 mM) was diluted to 100 μM with PBS 
before being added to cell culture wells to reach the final concentration of 3 
μM. After 30 minutes incubation at 37 °C, cells were washed with PBS buffer 
twice prior to imaging. Cells were also treated with 1 mM N-methylmaleimide 
in PBS at 37 °C for 30 minutes and subsequently washed twice with PBS 
buffer, prior to incubation with probe as per described. Separately, as control 
experiment, cells were pre-treated with 1 mM L-buthionine sulfoximine (BSO) 
or 1 mM BSO in the presence of 0.1 mM hydrogen peroxide for 1 h. The latter 
was further treated with 1 mM L-cysteine for 1 h or left untreated before 
incubation with probe. Live cells imaging was done with an inverted 
fluorescence microscope Ti (Nikon), equipped with an Ex 480nm/40, long-





3.4.6 Synthesis  




Synthesis of BDN-3: To a solution of BDN-1 (115 mg, 0.37 mmol) in 70 
mL of dry tetrahydrofuran (THF) was added cyanuric chloride (101 mg, 0.55 
mmol). The reaction mixture was stirred for 1 h at 0 ºC. After removal of the 
THF, the residue was purified by silica gel chromatography (hexane–EtOAc, 4: 
1) to give BDN-3 as a yellow solid (152 mg, 90%). 
1
H NMR (300 MHz, CDCl3): δ 7.81 (s, 1H), 7.73 (d, J=8.5 Hz, 2H), 7.70 (s, 
1H), 7.40 (d, J=8.5 Hz, 2H), 6.41 (s, 1H), 6.38 (s, 1H), 6.15 (s, 1H), 2.63 (s, 
3H), 1.60 (s, 3H); 
13
C NMR (75.5 MHz, CDCl3): 171.47, 170.44, 164.02, 
162.37, 146.68, 142.13, 138.89, 137.22, 134.56, 133.51, 130.92, 129.95, 
126.91, 123.41, 120.48, 116.20, 29.65, 15.24.  
HRMS m/z (C20H15BCl2F2N6) calculated (M-H)
- 




Synthesis of BDM153: Compound 2 (50 mg, 103 μmol) and 4-
hydroxybenzaldehyde (25.2 mg, 206 μmol) were dissolved in acetonitrile (5 
mL), with pyrrolidine (5.2 μL, 618 μmol) and 6 equiv. of AcOH (3.5 μL, 618 
μmol). The mixture was heated to 85 oC and keep for 5 min. After removal of 
the solvent, the residue was purified by silica gel chromatography (eluents: 
CH2Cl2–MeOH, 98: 2 to 90: 10) to give BDM153 as a purple solid (21.7 mg, 
57%).   
1
H NMR (500 MHz, CDCl3): δ 7.41 (s, 1H), 7.32 (d, J=8.6 Hz, 2H), 7.26 (dd, 
J=34.7, 16.3 Hz, 3H), 7.11 (d, J=3.8 Hz, 1H), 6.69 (s, 1H), 6.68 (d, J=8.5 Hz, 
2H), 6.31 (dd, J=3.9, 2.1 Hz, 1H), 3.25-3.21 (m, 2H), 3.07 (t, J=7.0 Hz, 2H), 
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3.04-3.00 (m, 2H); 
13
C NMR (125 MHz, CDCl3):159.32, 159.19, 144.21, 
141.47, 136.46, 135.46, 135.14, 133.37, 129.74, 127.21, 122.03, 120.12, 
115.71, 115.60, 114.69, 44.98, 23.80, 15.70.  
HRMS m/z (C20H20BF2N3O) calculated (M+Na)
+ 




Synthesis of BNM153: BDN-3 (20 mg, 54 μmol), BDM153 (25 mg, 54 
μmol) and DIEA (14 μL, 108 μmol) were dissolved in THF (10 mL) and 
stirred at room temperature for 2 h. After evaporation of the solvent, the crude 
product was purified by silica gel chromatography (eluents: CH2Cl2 to 
CH2Cl2–MeOH (95: 5)) to afford the corresponding BNM153 as red solid 
(30.7 mg, 72%). 
1
H NMR (500 MHz, CDCl3): δ 8.21 (d, J=11.6 Hz, 1H), 7.88 (d, J=8.3 Hz, 
1H), 7.72 (d, J=8.2 Hz, 1H), 7.66 (s, 1H), 7.58 (d, J=10.1 Hz, 1H), 7.55 (d, 
J=8.4 Hz, 1H), 7.49 (d, J=8.6 Hz, 1H), 7.44-7.40 (m, 2H), 7.32 (d, J=8.2 Hz, 
1H), 7.19 (s, 1H), 6.97-6.89 (m, 3H), 6.51-6.44 (m, 3H), 6.27 (d, J=47.5 Hz, 
1H), 3.83 (dd, J=13.5, 6.8 Hz, 1H), 3.70 (dd, J=14.8, 7.1 Hz, 1H), 3.32 (dd, 
J=13.7, 6.7 Hz, 2H), 2.63-2.52 (m, 6H), 1.62 (d, J=41.6 Hz, 3H); 
13
C NMR 
(125 MHz, CDCl3): 166.14, 164.40, 162.58, 159.10, 147.71, 145.81, 143.61, 
143.45, 141.08, 140.72, 140.51, 140.42, 140.12, 139.81, 137.85, 137.77, 
136.40, 136.17, 133.63, 129.72, 129.64, 129.59, 128.48, 127.91, 126.65, 
126.54, 123.67, 123.57, 123.37, 120.26, 119.91, 119.75, 116.05, 116.02, 
114.95, 42.16, 29.80, 15.96, 15.80, 14.34. 
HRMS m/z (C40H34B2ClF4N9O) calculated (M-H)
- 






Synthesis of Probe 1: BNM153 (30 mg, 38 μmol) and Et3N (16 μL, 114 
μmol) was dissolved in 10 mL of dry CH2Cl2. The mixture was stirred at 0 °C 
for 15 min under N2 atmosphere. A solution of 2,4-dinitrobenzenesulfonyl 
chloride (20.3 mg, 76 μmol) in 5 mL CH2Cl2 was added dropwise. The 
reaction mixture was stirred for 2 h at rt. After evaporation of the solvent, the 
crude product was purified by silica gel chromatography (eluents: CH2Cl2 to 
CH2Cl2–MeOH (95: 5)) to afford the corresponding probe 1 as red solid (23 
mg, 59%).  
1
H NMR (500 MHz, CDCl3): δ 8.66 (s, 1H), 8.48 (d, J=8.6 Hz, 1H), 8.14 (dd, 
J=8.6, 4.9 Hz, 1H), 7.72 (d, J=8.4 Hz, 1H), 7.63-7.48 (m, 7H), 7.33 (d, J=3.6 
Hz, 1H), 7.27-7.15 (m, 4H), 6.48-6.34 (m, 3H), 6.10 (d, J=21.9 Hz, 1H), 3.80 
(s, 1H), 3.68 (s, 1H), 3.26 (dd, J=15.0, 7.5 Hz, 2H), 2.58-2.43 (m, 6H), 1.55 (d, 
J=28.0 Hz, 3H); 
13
C NMR (125 MHz, CDCl3): 165.28, 162.12, 161.97, 155.68, 
155.58, 150.90, 149.01, 148.82, 146.82, 139.09, 138.93, 138.75, 138.36, 
138.25, 136.64, 136.56, 135.91, 135.80, 134.59, 133.91, 133.88, 133.47, 
133.10, 129.52, 129.44, 129.20, 126.84, 126.50, 126.45, 124.56, 123.35, 
123.23, 122.36, 122.32, 120.29, 120.11, 120.01, 119.90, 119.50, 116.64, 
116.56, 115.95, 42.44, 30.72, 16.42, 14.93.  
HRMS m/z (C46H36B2ClF4N11O7S) calculated  (M-H)
- 
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Protein misfolding diseases represent a group of disorders that have protein 
aggregation and plaque formation in common.
1
 Alzheimer’s disease (AD) is 
one of the most studied protein misfolding diseases in which amyloid β-
peptide (Aβ) aggregates forming extracellular neuritic plaques in the brain. 
AD affects well over 35 million worldwide and this number is expected to 
grow dramatically as the population ages.
2
  Amyloidogenic proteins and 
peptides can adopt a number of distinct assembly states and a key issue is 
which of these assembly states are more closely associated with pathogenesis. 
Fibrillization of Aβ resulting in plaque deposition has long been regarded as 
the cause of neurodegeneration in AD. However, recent data suggest that 
oligomeric soluble Aβ is principally responsible for the pathogenesis of AD 
and its levels are more important in the disease progression.
3
 The concept of 
Aβ intermediate involvement in the development of AD has been used to 
explain why amyloid pathology, defined by Aβ plaque load, is only poorly 
correlated with clinical AD presentation, effectively suggesting that amyloid 
plaque is a relatively non-toxic aggregated form of Aβ. Hence, there is an 
urgent need for the development of detection methods that are able to identify 
a variety of morphologically distinct Aβ peptides. 
Due to its proposed role in the pathophysiology of AD and the requirement 
of inhibitor of the neurotoxic oligomers, it is urgent to develop a convenient 
method to detect the neurotoxic oligomers. However, the detection of 
oligomers can be challenging, given their transient and unstable nature. In fact, 
a plethora of terms have been coined to account for their diversity, for instance, 
Aβ peptide forms structures including paranuclei, globulomers, Aβ *56 and 
105 
 
Aβ -derived diffusible ligands.4 Although there are a number of fibril-specific 
dyes, like Congo Red (CR)
5
 or Thioflavin T (ThT),
6
 which bind to mature 
amyloid fibrils, oligomer-specific dyes are rare. Thus, specific sensors for 
neurotoxic oligomers, which can recognize the toxic oligomers of Aβ over 
monomers and mature Aβ fibrils, are urgently needed. Currently, there have 
been numerous efforts to develop effective oligomer detection methods such 
as oligomer-specific antibody fragment,
7
 oligomer-specific peptide-FlAsh 
system,
8
 peptide-based fluorescent protein
9
 and also ELISA method.
10
 
However, these biological detection methods often involve expensive 
instrumentation or long testing time, which make them not convenient for use 
or inappropriate for rapid detection. Fluorescent molecular probes provide 
high sensitivity and easy visibility, which offer a convenient and straight-
forward approach for the detection of Aβ oligomers. One of the reported 
oligomer-specific fluorescence sensor shows the capability of distinguishing 
soluble oligomers from ordered conformation oligomers, but fell short of 
discriminating oligomers from fibrillar Aβ.11 As typical amyloid ligands were 
shown to interact less well with pre-fibrillar species, there is a need for small 
molecule amyloid ligands that identify a broader subset of proteinaceous 
aggregated species and variety of morphologically distinct protein aggregates.  
Here, we describe a novel fluorescent chemical probe that preferentially 
recognizes Aβ oligomeric assemblies over monomers and fibrils, and displays 
an increase in fluorescence with oligomer binding. The probe also 
demonstrates a dynamic oligomer-sensing ability during Aβ peptide 




4.2 Results and Discussion 
4.2.1 Conformational Specificity of BDO-1 and MK-H4 
Firstly, a screening platform known as the diversity oriented fluorescence 
library approach (DOFLA), which employs fluorescent small molecule 
libraries was established in combination with high-content image 
acquisition.
12
 5 candidate dyes were selected out of 3500 compounds based on 
the fluorescence intensity, when screened against positive 7PA2 cells, which 
has been reported in the literature to be enriched in Aβ oligomers3c and 
negative untransfected CHO cells, from which the 7PA2 cells were propagated 




Figure 4.1 5 selected oligomer sensors based on cell-based high throughput 
screening. The hit compounds which stained 7PA2 cell more brightly than 
CHO cells were selected based on the intensity data and manual screening of 





    We then sought to further narrow these candidates by a more direct 
approach, using different conformations of synthetic Aβ peptide: monomer, 
oligomer and fibrils. Since the proposed role of Aβ oligomers in the 
pathophysiology of AD, synthetic Aβ oligomers have been used as tools for 
the development of therapeutics and biomarkers.  
We confirmed the conformations of different Aβ peptide by dot blot assays 
and the results showed that the oligomer preparation responded most strongly 
when probed with the anti-oligomer antibody (A11), which has been reported 
to specifically recognize a generic epitope common to pre-fibrillar oligomers 
but not fibrils, monomers or natively folded precursor proteins.
13
 These 
oligomers are called ‘pre-fibrillar’ because they kinetically precede fibril 
formation and disappear after fibrils have formed. Blotting a replicate 
membrane with anti-Aβ1-16 (6E10) antibody, which does not discriminate 
different conformations of Aβ, showed similar amount of Aβ in all the 3 
preparations, confirming the oligomer specificity of A11 and different 
aggregation stages of our samples (Figure 4.2).  
 
Figure 4.2 Dot blots of Aβ monomers, oligomers and fibrils probed by 
oligomer-specific A11 and 6E10 antibodies. 
 
Each peptide preparation was treated with the fluorescence dye and 
reference compound Thioflavin T (ThT), which is routinely used to indicate 
the presence of β-sheet amyloidogenic structures. As expected, increasing 
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ThT fluorescence response is observed in the order of freshly prepared Aβ 
monomers, followed by oligomeric and fibrillar preparations of Aβ (Figure 
4.3a). The best two oligomer fluorescence turn-on probes were identified to be 
BDD-I-G3 (named BDO-1) and MK-H4 (Figure 4.3).  
 
 
Figure 4.3 Conformational specificity of BDO-1 and MK-H4. (a) Chemical 
structure of commercial ThT and fluorescence emission spectra (λex = 440 nm) 
of ThT (5 μM) before and after incubated with monomers, oligomers and 
fibrils (20 µM); (b) Chemical structure of BDO-1 and fluorescence emission 
spectra (λex = 530 nm) of BDO-1 (5 μM) before and after incubated with 
monomers, oligomers and fibrils (20 µM); (c) Chemical structure of MK-H4 
and fluorescence emission spectra (λex = 470 nm) of MK-H4 (5 μM) before 




With BDO-1 and MK-H4, the highest fluorescence enhancement is 
observed upon incubation with Aβ oligomers, indicating a preference for these 
intermediary conformations of Aβ aggregation over monomers or fibrils 
(Figure 4.3b and Figure 4.3c). To quantify the affinity for oligomers, we 
measured the apparent binding constant (Kd) of BDO-1 and MK-H4 by 
conducting a saturation assay (Figure 4.4). The fluorescent intensity of BDO-1 
and MK-H4 increased in a dose-dependent manner and was saturated at a 
higher concentration. Transformation of the saturation binding data indicated 
affinity of BDO-1 and MK-H4 for oligomers at Kd value of 0.50 µM and 0.48 
µM (Figure 4.4). 
 
Figure 4.4 (a) and (d) the fluorescence intensity of BDO-1 and MK-H4 in the 
absence of Aβ oligomers; (b) and (e) the fluorescence intensity of BDO-1 and 
MK-H4 in the presence of Aβ oligomers; (c) and (f) Plot of the fluorescence 
intensity as a function of the concentration of BDO-1 and MK-H4 in the 
presence of Aβ oligomers (20 μM) in PBS. 
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4.2.2 BDO-1 and MK-H4 Detect Oligomers on-fibril Pathway  
Next, we investigated the oligomer-sensing ability of these probes over the 
course of Aβ fibril formation. To do this, we subjected Aβ peptide to fibril 
forming conditions, and at each selected time point, a small aliquot was 
removed and added to dyes for fluorescence measurement. Concurrently, Aβ 
fibril formation was monitored with ThT, which reaches a maximum 
fluorescence after about 1-day and plateaus for the remaining incubation 
period (Figure 4.5a). Measurements with BDO-1 and MK-H4 observed a 
gradual increase in fluorescence, which reaches maximum fluorescence 
intensity at about day-1 incubation, followed by a decrease in signal over the 
remaining incubation period (Figure 4.5a). Fluorescence measurement of the 
probe alone in the same manner reveals no change in its signal intensity (data 
not shown). We postulate that the observed changes in fluorescence signal is 
an indication of BDO-1 and MK-H4 detection on-fibril pathway especially for 
oligomeric species of Aβ, whereby the signal increases as monomers 
aggregate into oligomers but decreases as more Aβ assemble into fibrils. 
To elucidate the species or the changes in protein conformations that our 
probe recognizing, we performed biophysical characterizations of the sample 
during the fibril formation over time. Particular attention was paid towards 
day-1 species, where the probes have been observed to yield maximum 
fluorescence enhancement. Dot blots over the course of fibril formation 
showed that A11 recognizes earlier species in the incubation, most intense at 
3-5 h, as compared to our probes, which recognizes the later (day-1) species 
(Figure 4.5b). Pelleting assay showed that at day-1, quite similar to day-0, 
majority of Aβ are still in solution and have not aggregated into large 
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sedimenting materials. This implies that the aggregated species which 
enhanced the fluorescence of BDO-1 and MK-H4 are soluble, which is in 
stark contrast to the decrease in the fraction of soluble protein after 2-days 
incubation (Figure 4.5c). At the same time, transmission electron microscopic 
(TEM) images taken at the end of the 4-days incubation confirmed the 
presence of Aβ fibrils. In contract, TEM images captured either immediately 
after fibril formation has been initiated (day-0) or after 1-day incubation did 
not yet show any signs of fibrils (Figure 4.5d). 
 
Figure 4.5 Biophysical characterization of oligomer-specific response. (a) 
Time-dependent fibril formation of Aβ was monitored by ThT, whereas 
BDO-1 and MK-H4 detect on-fibril pathway oligomers (dye: 5 µM, Aβ: 20 
µM); (b) Kinetics of oligomer-specific immunoreactivity during 
fibrillogenesis, as probed by oligomer-specific A11 and 6E10 antibodies; (c) 
CD spectra for Aβ freshly initiated to form fibrils, 1-day and 4-days after 
kinetic time course has been initiated; (d) Transmission electron microscopy 
(TEM) images of Aβ at day-0, day-1 and day-4 of fibrillogenesis. 
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    The secondary structure of Aβ analyzed by circular dichroism (CD) 
spectroscopy at selected time points indicated that Aβ is random coil when 
freshly initiated to form fibrils, which is consistent with reports in the 
literature,
14
 while day-1 species is observed to possess β-sheet content similar 
to fibrils at day-4 (Figure 4.6). Taken together, the presence of β-sheet 
structure alone does not suffice to explain the binding specificity of our probe. 
 
Figure 4.6 Pelleting assay of Aβ at day-0, day-1 and day-4 of fibrillogenesis. 
 
Whatever assembly state or conformational change oligomer sensors may 
recognize exists in soluble, pre-fibrillar Aβ aggregates. It is believed that 
aggregated Aβ peptides which have not attained the final mature form of an 
amyloid fibril display exposed hydrophobic patches. In fact, 4,4-bis-1-phenyl-
amino-8-naphthalene sulfonate (bis-ANS) was shown to bind oligomeric 
intermediates,
15
 which has been widely used in the protein folding field for 
many decades as a marker for surface exposed hydrophobic patches and 
molten-globule-like characteristics.
16
 We postulate that as Aβ peptide 
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underwent structural rearrangements during the course of fibril formation, our 
probes get buried within the increasing number of hydrophobic pockets 
formed. As most BODIPY dyes tend to form aggregates in polar solutions due 
to their relatively hydrophobic nature,
17
 we hypothesize that our probes 
behave similarly, disaggregating in a more hydrophobic environment which 
translates into an enhancement in fluorescence signal.   
4.2.3 Structure Activity Relationship Analysis 
With the intention of investigating more deeply into the binding event, 
several derivatives of the original probes were synthesized, in which 
modifications were made to the side chains on the left or right of BDO-1 and 
MK-H4 (Figure 4.7a and Figure 4.8a).  
The derivatives were tested against monomers, oligomers and fibrils of Aβ, 
as described earlier, and ratio differences of the compound signal when 
reacted with oligomers were plotted against signal observed for either 
monomers or fibrils (Figure 4.7b and Figure 4.8b). For BDO-1 derivatives, the 
most noticeable trend is the increased ratio differences of the derivatives’ 
responses towards oligomers as compared to monomers, while there are only 
very modest changes in sensing oligomers against fibrils. It appears that the 
left side of the structure is important for oligomer sensing, where the 3 
derivatives which had their left part altered gave less fold-change response 
than the other derivatives with modifications on the right side. Then we kept 
same on the left side and synthesized several derivatives with modifications on 
the right side. With the exception for BDO-5, all BDO derivatives with 
modifications on the right side had improvements in sensing oligomers against 
monomers, but slight or no improvements in sensing oligomers against fibrils. 
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Based on this observation, we shortlisted 5 derivatives and investigated their 
oligomer-sensing ability over the course of fibril formation, as described 
earlier. The derivatives displayed similar trends as the original compound, 
BDO-1, but with varying degree of fluorescence fold-change (Figure 4.7c). 
Structural-activity analysis showed that BDO-8 gave the best enhanced 
response. With further structural modification for future application in mind, 
we introduced fluorine to the BDO-8 structure to get BDO-10, and found that 
the modified derivative too responded well towards intermediate during the 
course of fibril formation. The similar study was made to MK-H4 derivatives. 
From the in vitro test, we found that the compounds with cyclopropane or 
cyclohexane on the left side and cyclohexylmethanamine or 
phenylmethanamine on the right side show improved response both towards 
oligomers as compared to monomers and fibrils (Figure 4.8b). Based on this 
observation, 5 MK-H4 derivatives were chose and investigated their 
oligomer-sensing ability over the course of fibril formation, as described 
earlier. Similar trends were got as the original compound, MK-H4, but with 












Figure 4.7 (a) Chemical modifications of BDO-1 derivatives for structural-
activity relationship study; (b) Normalized fluorescence ratio of BDO-1 and 
derivatives in the presence of oligomers, as compared to when in the presence 
of monomers or fibrils; (c) The ability of BDO-1 derivatives to detect 












Figure 4.8 (a) Chemical modifications of MK-H4 derivatives for structural-
activity relationship study; (b) Normalized fluorescence ratio of MK-H4 and 
derivatives in the presence of oligomers, as compared to when in the presence 
of monomers or fibrils; (c) The ability of MK-H4 derivatives to detect 








4.2.4 In vitro Staining of Oligomer Sensors and Their Derivatives 
To investigate the oligomer detection ability of oligomer sensors and its 
derivatives to detect oligomers in biological tissue, a set of brain tissue 
imaging experiments are carried out. A triple transgenic (Tg) knock-in mouse 
(APPsw/P301L tau/ PSENM146) was used as our model, which has been 
reported to develop both plaque and tangle pathology in AD-relevant brain 
regions.
18
 Immunofluorescence analysis of the mouse brain with anti-Aβ 
(6E10) antibody showed that extracellular Aβ deposition, co-stained by 
Thioflavin S (ThS), is evident. In addition, 6E10 also identified sites of Aβ 
intracellular accumulation (Figure 4.9).  
 
Figure 4.9 Amyloid plaques and Aβ oligomers deposition in AD brain. 
Floating sections from AD and wild-type mouse brain were immunostained 
with 6E10 antibody for Aβ (red) and counterstained with ThS for amyloid 
plaques (green). Examples of extracellular Aβ deposition, co-stained by ThS 
are highlighted by dashed circles. Arrowheads annotate examples of Aβ 





Using the anti-oligomer antibody (A11), we observed that A11 stains the 
peripheral of ThS-reactive area, leaving the core unstained. While ‘cored’ 
plaques are stained by ThS and CR, diffuse plaques are negative,
19
 hence it is 
generally accepted that diffuse amyloid plaques are “non-fibrillar” based on a 
lack of binding fibril-specific dyes. In addition, there were also regions stained 
by A11 which are independent of obvious ThS staining. This is especially 
prominent when brain sections from AD mice of different ages were analyzed 
(Figure 4.10). As expected, 22-months old AD mice being the oldest had more 
amyloid plaques, as shown by ThS staining, than its 15-months old 
counterpart, while the youngest 8-months old mice were devoid of any 
amyloid deposition at this stage. Besides observing A11 staining surrounding 
ThS signals, there were also many small focal or punctuate deposits in 
proximity. 
Initial staining of BDO-1 and MK-H4 showed that BDO-1 and its 
derivatives stain in the plaques of tissue sections while MK-H4 does not stain 
(data not shown). Then we focus on the in vitro staining using BDO-1 and its 
derivatives. In vitro staining of BDO-1 and 4 of its selected derivatives on 
cryosections of 3x Tg-AD mouse showed that oxygen on the right part of the 
chemical structure seems to be crucial, as substitution with an amide group 






Figure 4.10 Pre-fibrillar, oligomers of Aβ in AD brains of various ages, 22 
months, 15 months and 8 months, were visualized with the A11 antibody (red) 
and counterstained with ThS for amyloid plaques (green). Dashed circles 
highlight examples of A11 staining surrounding ThS signal, while examples of 
small, punctuate deposits of A11 not directly associated with ThS staining are 




Figure 4.11 Fluorescence images of 3xTg AD mouse brain tissue. 
Cryosections were stained by BDO-1 and its derivatives, and then 





Co-incubation with either BDO-1 or BDO-10 showed that both dyes stain 
in peripheral marginal areas which has a significant overlap of areas stained 
with oligomer-specific antibody A11 (Figure 4.12). Also observed from the 
tissue staining was that both BDO-1 and BDO-10 displayed more intense 
staining in the core region which are not labeled by A11, synonymous with 
ThS stained areas. Further studies with BDO-10 staining of brain sections 
from mice of different ages showed that the dye could detect oligomers in 22-
months and 15-months, but not in 8-months old mice, consistent with A11 
labelling (Figure 4.13). Even so, it can be observed that BDO-10 has not 
labeled all A11-stained areas, while some staining was more prominent, others 
were almost negligible. It has been suggested that insoluble amyloid plaques 
may represent a reservoir that releases toxic soluble oligomers.
3a
 We postulate 
that the tissue staining pattern is a reflection of this phenomena, where our 
probe labeled-soluble Aβ intermediates are associated with in plaque cores, as 
well as with the periphery of plaques. Further support for this hypothesis is 
provided by the observation of a halo of enlarged, abnormal neuronal 
processes surrounding amyloid plaques, suggesting that the source of 
synaptoxicity resides within the plaque and can diffuse to distant locations.
20
 
Moreover, considering the fact that the kinetic data shows our probe to be 
labelling later assembly states of Aβ, while A11 recognizes earlier pre-fibrillar, 
Aβ oligomers, it may explain why our probe labeling is more intense within 
the core which lacks A11 labeling and is usually associated with the periphery 








Figure 4.12 Fluorescence images of 3xTg AD mouse brain tissue. Sections 
from AD mouse brain were immunostained with oligomer-specific A11 
antibody (red) and counterstained with Thioflavin S (green) or our oligomer 
probes (yellow). Scale bar, 100 μm.   
 
    
 
 
Figure 4.13 Fluorescence images of 3xTg AD mouse brain tissue. Sections 
from mouse brain were immunostained with oligomer-specific A11 antibody 





Aggregation of amyloid β-peptide (Aβ) is implicated in the pathology of 
Alzheimer’s disease (AD), with the soluble, Aβ oligomeric species thought to 
be the critical pathological species. Identification and characterization of 
intermediate species formed during the aggregation process is crucial to the 
understanding of the mechanisms by which oligomeric species mediate 
neuronal toxicity and following disease progression. Probing these species 
proved to be extremely challenging, as evident by the lack of reliable sensors, 
due to their heterogeneous and transient nature. We describe here oligomer-
specific fluorescent chemical probes, BDO-1 and MK-H4, developed through 
the use of the diversity-oriented fluorescent library approach (DOFLA) and 
high-content, imaging-based screening. Considering all the data described 
above, the fluorescence sensors we developed could be used for detection of 
A oligomers, discriminating them from the monomeric and fibrillar states of 
A. We anticipate that further development of these probes will be applicable 
to early diagnostics and therapeutics of AD.  
 
4.4 Experimental Section 
4.4.1 Reagents and Solvents 
The chemicals, including aldehydes and solvents, were purchased from 
Sigma Aldrich, Acros and Alfa Aesar. All the chemicals were directly used 
without further purification. Normal phase column chromatography 
purification was carried out using MERCK silica Gel 60 (Particle size: 230-
400 mesh, 0.040-0.063 mm). 
4.4.2 Measurements and Analysis 
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HPLC-MS was taken on an Agilent-1200 with a DAD detector and a single 
quadrupole mass spectrometer (6130 series). The analytical method, unless 
indicated, is A: H2O (0.1% HCOOH), B: CH3CN (0.1% HCOOH), gradient 
from 10 to 90% B in 10 minutes; C18 (2) Luna column (4.6 x 50 mm2, 3.5 μm 
particle size). 
Spectroscopic and quantum yield data were measured on a SpectraMax M2 





C-NMR spectra were recorded on Bruker ACF300 (300 
MHz) or AMX500 (500 MHz) spectrometers, and chemical shifts are 
expressed in parts per million (ppm) and coupling constants are reported as a J 
value in Hertz (Hz).  
4.4.3 Quantum Yield Measurements 
Quantum yields for all the fluorescent compounds were measured by 
dividing the integrated emission area of their fluorescent spectrum against the 
area of Rhodamine B in EtOH excited at 490 nm (Φrho-B = 0.7). Quantum 
yields were then calculated using equation (1), where F represents the 
integrated emission area of fluorescent spectrum, η represents the refractive 
index of the solvent, and Abs represents absorbance at excitation wavelength 
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4.4.4 DOFL High Throughput/Content Screening 
    DOFL compounds were diluted from 1mM DMSO stock solutions with the 
culture medium to make final concentration of 0.5 µM or 1.0 µM. The two 
different types of cells, CHO cells and 7PA2 cells, are plated by side on 384-
well plates and incubated with the DOFL compounds for 2 h at 37°C. The 
fluorescence cell images of two regions per well were acquired using 
ImageXpress Micro™cellular imaging system (Molecular Device) with 
10×objective lens and the intensity was analyzed by MetaXpress® image 
processing software (Molecular Device). The hit compounds which stained 
7PA2 cells more brightly than CHO cells were selected based on the intensity 
data and manual screening of the raw images. 
4.4.5 Peptide Preparation 
    Synthetic Aβ1-40 was purchased from American Peptide in lyophilized form. 
Dry peptide was dissolved in 1,1,1,3,3,3-hexafluoro-2-isopropanol (HFIP) and 
incubated at 25°C for 1 h to remove any preformed aggregates. It was 
aliquoted into small aliquots and dried using a speed-vac. The dry peptide was 
stored at -20°C until required, where each aliquot was then dissolved in 5 M 
GuHCl 10 mM Tris
.
Cl pH 8 to 1 mM peptide solution. After sonication in a 
sonicating water bath for 15 mins, the solution is diluted with phosphate 
buffered saline (PBS), pH 7.4 and stored on ice until use. This freshly 
prepared sample is referred to as monomer. To form fibrils, the sample is 
incubated for 24 h at 37°C with 5 s shaking at every 7 min interval. Pre-
formed oligomers were prepared by Aβ1-40 peptide solubilized in borate 
buffered saline (50 mM BBS/PBS) and reacted with 5 mM glutaraldehyde 





 The solution was neutralized with Tris buffer then 
dialyzed verus deionized distilled water overnight and lyophilized. Prior to 
fluorescence assay, it is resolubilized in deionized distilled water and diluted 
in PBS. Western blot performed on the sample with anti-Aβ 4G8/6E10 as 
primary antibody, revealed major band of about 80 kDa and higher with no 
monomer. By electron microscopy, the sample makes spheres of 10-20 nm. 
Characterization of this sample preparation has been reported elsewhere.  
4.4.6 Time-dependent Fibril Formation  
    Thioflavin T (ThT) is routinely used to indicate the presence of β-sheet 
amyloidogenic structures. For monitoring of fibril formation over time, 40 μM 
peptide solution of Aβ1-40 was prepared as above and incubated at 37°C with 5 
s shaking at every 7 min interval. Fluorescence readings were taken at various 
time point intervals by mixing 30 μL aliquot of peptide solution to 10 μM of 
dye. ThT signal was monitored at 480 nm by 440 nm excitation, whereas 
BDO-1 and its derivatives was excited at 530 nm and its emission detected at 
585 nm, MK-H4 and its derivatives was excited at 470 nm and its emission 
detected at 555 nm. Aβ1-40 was also co-incubated with dye to study any effects 
the dye may have on fibril formation. Fluorescence was measured using 
SpectraMax M2 spectrophotometer (Molecular Devices, Sunnyvale, CA).  
4.4.7 Dot Blot Analysis 
    3 μL of 40 μM Aβ1-40 sample are spotted onto nitrocellulose membrane 
(Bio-Rad) at selected time points. The membranes are blocked by 10 % (w/v) 
fat-free milk in 50 mM Tris 150 mM NaCl, pH 7.4 and 0.05 % (v/v) Tween-20 
(TBST buffer) for 1 h at room temperature, followed by incubation with anti-
oligomer polyclonal A11 antibody (1:1000 dilution), anti-amyloid fiber OC 
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polyclonal antibody (1:1000 dilution) or Aβ1–16 (6E10) monoclonal antibody 
(1:1000 dilution, SIG-39300; Covance) in 5 % (w/v) fat-free milk and TBST 
buffer overnight at 4 °C. The membranes were washed 3 times in TBST 
before incubation with anti-rabbit or anti-mouse antibody (1:5000 dilution) in 
5 % (w/v) fat-free milk and TBST buffer at room temperature for 1 h. 
4.4.8 Pelleting Assay 
    Aβ1-40 samples were incubated at 37 °C. At selected time points, aliquots of 
150 μL were removed and subjected to centrifugation at 100,000 rpm (TL-100 
rotor, Beckman) for 20 min at 4 °C. Under these centrifugation conditions, 
monomeric Aβ does not sediment significantly. The concentration of 
monomeric Aβ in the supernatant after centrifugation was monitored using 
fluorescence measurements based on the reaction of fluorescamine with 
primary amine groups. The supernatants (45 μL) were added to a microtitre 
plate along with 15 μL of 1 mg/mL fluorescamine in DMSO. Samples were 
incubated at room temperature for 5 min and fluorescence intensities were 
measured using SpectraMax M2 (Molecular Devices, Sunnyvale, CA) with 
excitation and emission filters of 355 and 460 nm, respectively. 
4.4.9 Transmission Electron Microscopy  
At selected time points, Aβ1-40 sample incubated at 37 °C was removed and 
applied to freshly glow-discharged carbon-coated copper grids. The grids were 
then stained with several drops of 2 % potassium phosphotungstate, pH 6.8, 
and examined using an FEI Tecnai 12 transmission electron microscope 
operating at 120 kV. Images were obtained using an Olympus SiS 




4.4.10 CD Spectroscopy 
    CD measurements were made using an Aviv model 62 DS CD spectrometer 
(Aviv Associates Inc., Lakewood, NJ) at 25 °C with a 1-mm path length 
quartz cuvette, a spectral bandwidth of 1 nm, a signal averaging time of 1 s, 
and a data interval of 0.5 nm. The spectra presented are the averages of five 
measurements and corrected using a reference solution lacking Aβ.  
4.4.11 Biological Tissue Preparation 
    8-23 months old triple transgenic mice (APPsw/P301L tau/ PSENM146) 
were sacrificed for tissue harvesting. The animals were either perfused with 
4 % (w/v) paraformaldehyde (PFA), or the brain tissue was rapidly frozen and 
stored at -80 °C immediately after extraction. Free-floating sections were 
prepared from the PFA-perfused brain using vibratome (Leica) and 40 μm 
slices were stored in anti-freeze solution at -20 °C until required. Separately, 
10 μm sections of rapidly frozen brain were prepared using a cryostat and 
picked up on coated slides and stored in a -20 °C freezer.  
4.4.12 Immunofluorescence and Compounds Staining  
For Aβ immunohistochemistry, the sections were stained free-floating with 
a 1:400 dilution of primary anti-Aβ antibody (6E10) (Covance) or anti-
oligomer antibody (A11) (Invitrogen), followed by a goat anti-mouse or goat 
anti-rabbit secondary antibody conjugated with Alexa647 fluorophore 
(Invitrogen). Incubation times were overnight at 4 °C for the primary antibody 
and 1 h at room temperature for the secondary antibody. Sections were then 
treated with 5 μM compound for 1 h at room temperature, rinsed and mounted 
on slides. Separately, the cryosections was stained with 0.05 % ThS in 50 % 
(v/v) ethanol for 5-8 minutes to establish the presence and location of amyloid 
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plaques within the AD mouse brain tissue. Consecutive sections were treated 
with 5 μM compound for 1 h at room temperature. Imaging was done with an 
inverted fluorescence microscope Ti (Nikon). TRITC and Cy5 filters were 
used for fluorescence image acquisition. 
4.4.13 Synthesis 
Scheme 4.1 Synthetic scheme of BDO-1 and its derivatives 
 
 
Reagents and conditions: (a) pyrrolidine, acetic acid, ACN, 90°C, 5 min; (b) 
pyrridine, HATU, DMF, rt, 12 h; (c) pyrrolidine, acetic acid, ACN, 90°C, 5 
min. 
 
    Compound 1 and 2 were synthesized following previous reports.
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    General procedure for BDO-SM synthesis: 
    To an ice cold solution of compound 2 (0.07 mmol) in dry DMF was added 
pyrridine (0.34 mmol), followed by HATU (0.08 mmol) and stirred for 5 min. 
To the reaction mixture, corresponding alcohol/amine (0.34 mmol) was added 
and stirred overnight under room temperature. The reaction mixture was 
diluted with DCM (50 mL) and washed with water three times to remove the 
DMF. After removal of the DMF, the DCM part was dried over anhydrous 
Na2SO4, evaporated of the DCM to yield the crude compound. The crude 
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compound was finally purified by silica gel chromatography in 7:3 hexane and 
EA mixture. 
    General procedure for BDO-1 and its derivatives synthesis 
    Compound 1 or BDO-SM (20 mg, 47 µmol) and aldehyde (94 µmol, 2 
equiv) were dissolved in acetonitrile (3 mL), with 6 equiv. of pyrrolidine (23.5 
µL, 282 µmol) and 6 equiv. of AcOH (16.1 µL, 282 µmol). The condensation 
reaction was performed by heating to 90 °C for 5 min. The reaction mixture 
was cooled down to room and concentrated under vacuum, and purified by 
short silica column.  
BDO-5-SM 
1
H NMR (500 MHz, CDCl3) δ = 7.08 (s, 1H), 6.87 (d, J=4.0, 1H), 6.29 (d, 
J=4.0, 1H), 6.11 (s, 1H), 5.76 (s, 1H), 3.26 (t, J=7.5, 2H), 3.15 (dd, J=13.1, 
6.7, 2H), 2.63 (t, J=7.5, 2H), 2.56 (s, 3H), 2.25 (s, 3H), 1.43 (dd, J=14.5, 7.3, 
2H), 0.84 (t, J=7.4, 3H); 
13
C NMR (126 MHz, CDCl3): 171.78, 160.15, 157.42, 
143.84, 135.08, 133.39, 128.30, 123.76, 120.39, 117.57, 41.27, 36.00, 24.98, 
22.66, 14.89, 11.28, 11.22. 





H NMR (500 MHz, CDCl3) δ = 7.47-7.36 (m, 6H), 7.05 (d, J=3.9, 1H), 6.47 
(d, J=4.0, 1H), 6.30 (s, 1H), 6.24 (s, 1H), 4.58 (d, J=5.6, 2H), 3.49 (t, J=7.4, 
2H), 2.87 (t, J=7.5, 2H), 2.72 (s, 3H), 2.44 (s, 3H); 
13
C NMR (126 MHz, 
CDCl3): 171.66, 160.28, 157.14, 143.88, 138.11, 135.11, 133.37, 128.51, 
128.20, 127.66, 127.25, 123.75, 120.42, 117.54, 43.55, 35.95, 24.85, 14.88, 
11.27. 







H NMR (500 MHz, CDCl3) δ = 7.38-7.31 (m, 6H), δ = 7.07 (s, 1H), 6.85 (d, 
J=4.0, 1H), 6.23 (d, J=4.0, 1H), 6.11 (s, 1H), 5.14 (s, 2H), 3.32 (t, J=7.5, 2H), 
2.82 (t, J=7.6, 2H), 2.56 (s, 3H), 2.24 (s, 3H); 
13
C NMR (126 MHz, CDCl3): 
172.32, 160.43, 157.00, 143.81, 135.91, 135.21, 133.27, 128.49, 128.21, 
128.14, 128.00, 123.78, 120.42, 116.68, 66.35, 33.42, 23.91, 14.92, 11.26. 





H NMR (500 MHz, CDCl3) δ = 7.07 (s, 1H), 6.87 (d, J=3.9, 1H), 6.26 (d, 
J=3.9, 1H), 6.10 (s, 1H), 4.15 (q, J=7.2, 2H), 3.29 (t, J=7.6, 2H), 2.75 (t, J=7.6, 
2H), 2.56 (s, 3H), 2.24 (s, 3H), 1.25 (t, J=7.2, 3H); 
13
C NMR (126 MHz, 
CDCl3): 172.50, 160.34, 157.28, 143.75, 135.17, 133.28, 128.03, 123.77, 
120.37, 116.71, 60.53, 33.44, 23.95, 14.91, 14.19, 11.26. 





H NMR (500 MHz, CDCl3) δ = 7.07 (s, 1H), 6.87 (d, J=3.9, 1H), 6.27 (d, 
J=4.0, 1H), 6.10 (s, 1H), 4.05 (t, J=6.8, 2H), 3.29 (t, J=7.6, 2H), 2.76 (t, J=7.6, 
2H), 2.56 (s, 3H), 2.24 (s, 3H), 1.64 (dd, J=14.3, 7.1, 2H), 0.92 (t, J=7.4, 3H); 
13
C NMR (126 MHz, CDCl3): 172.59, 160.32, 157.30, 143.75, 135.16, 133.29, 
128.04, 123.77, 120.36, 116.68, 66.18, 33.40, 23.96, 21.94, 14.91, 11.26, 
10.34. 





H NMR (500 MHz, CDCl3) δ = 7.70 (s, 2H), 7.28 (dd, J=7.6, 1.0, 1H), 7.02 
(s, 1H), 6.82 (m, 4H), 6.28 (d, J=3.9, 1H), 4.78 (s, 2H), 4.20 – 4.04 (m, 2H), 
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3.39 (t, J=7.5, 2H), 2.96 (t, J=7.5, 2H), 2.25 (s, 3H), 1.45 (t, J=7.0, 3H); 
13
C 
NMR (126 MHz, CDCl3): 171.05, 157.99, 155.12, 145.96, 144.73, 143.09, 
136.88, 133.60, 133.52, 126.81, 122.40, 121.88, 119.73, 119.43, 118.84, 
116.97, 116.29, 112.13, 94.89, 74.02, 64.72, 33.03, 23.68, 14.81, 11.30. 





H NMR (500 MHz, CDCl3) δ = 7.69 (s, 2H), 7.67 (d, J=7.5, 1H), 7.19 (t, 
J=7.6, 1H), 7.05 (s, 1H), 6.96 (t, J=7.4, 1H), 6.86 (d, J=3.9, 1H), 6.79 (s, 1H), 
6.77 (d, J=4.3, 1H), 6.30 (d, J=3.9, 1H), 4.78 (d, J=5.5, 2H), 3.39 (t, J=7.5, 
2H), 2.96 (t, J=7.5, 2H), 2.28 (s, 3H). 





H NMR (500 MHz, CDCl3) δ = 7.60 (s, 1H), 7.56 (s, 1H), 7.29 (s, 1H), 7.12 
(d, J=8.5, 2H), 7.09 (s, 1H), 6.90 (d, J=3.9, 1H), 6.84 (d, J=8.1, 1H), 6.73 (s, 
1H), 6.33 (d, J=3.9, 1H), 4.79 (d, J=5.7, 2H), 3.39 (t, J=7.6, 2H), 2.97 (t, 
J=7.6, 2H), 2.30 (s, 3H). 





H NMR (500 MHz, CDCl3) δ = 9.84 (s, 1H), 7.79 (d, J=8.4, 2H), 7.47 (d, 
J=8.2, 2H), 7.03 (s, 1H), 6.96 (d, J=8.4, 2H), 6.85 (d, J=8.6, 2H), 6.30 (d, 
J=3.7, 1H), 4.77 (s, 2H), 3.39 (t, J=7.4, 2H), 2.97 (t, J=7.5, 2H), 2.28 (s, 3H). 





H NMR (500 MHz, CDCl3) δ = 7.71 (s, 1H), 7.26 (s, 1H), 7.06 (s, 1H), 6.91 – 
6.78 (m, 4H), 6.31 (d, J=4.0, 1H), 5.93 (s, 1H), 5.71 (s, 1H), 5.34 (s, 2H), 4.14 
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(dd, J=13.9, 6.9, 2H), 3.31 (t, J=7.6, 2H), 3.17 (t, J=7.6, 2H), 2.71 (t, J=7.6, 
2H), 2.30 (s, 3H), 1.47 (t, J=7.0, 3H), 0.88 (t, J=7.0, 3H). 





H NMR (500 MHz, CDCl3) δ = 7.69 (d, J=8.5, 1H), 7.30 – 7.23 (m, 4H), 7.18 
(d, J=7.1, 2H), 7.04 (s, 1H), 6.83 (m, 4H), 6.30 (d, J=3.9, 1H), 5.34 (m, 2H), 
4.41 (d, J=5.5, 2H), 4.14 (dd, J=14.0, 7.0, 2H), 3.34 (t, J=7.3, 2H), 2.74 (t, 
J=7.5, 2H), 2.30 (s, 3H), 1.46 (t, J=7.0, 3H). 





H NMR (500 MHz, CDCl3) δ = 7.71 (s, 1H), 7.36 – 7.27 (m, 6H), 7.03 (s, 
1H), 6.87 – 6.77 (m, 4H), 6.24 (d, J=4.0, 1H), 5.35 (t, J=6.8, 1H), 5.16 (s, 2H), 
4.13 (q, J=6.9, 2H), 3.36 (t, J=7.6, 2H), 2.84 (t, J=7.6, 2H), 2.29 (s, 3H), 1.46 
(t, J=7.0, 3H). 





H NMR (500 MHz, CDCl3) δ = 7.71 (s, 1H), 7.29 (d, J=7.6, 1H), 7.04 (s, 1H), 
6.88 – 6.78 (m, 4H), 6.28 (d, J=3.9, 1H), 5.37 – 5.32 (m, 1H), 4.15 (td, J=14.1, 
7.0, 4H), 3.33 (t, J=7.6, 2H), 2.78 (t, J=7.6, 2H), 2.29 (s, 3H), 1.46 (t, J=7.0, 
3H), 0.88 (t, J=6.9, 3H). 





H NMR (500 MHz, CDCl3) δ = 7.71 (s, 1H), 7.29 (d, J=7.6, 1H), 7.04 (s, 1H), 
6.89 – 6.78 (m, 4H), 6.28 (d, J=3.9, 1H), 5.35 (d, J=5.7, 1H), 4.14 (dd, J=13.9, 
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6.9, 2H), 4.07 (dd, J=11.5, 4.8, 2H), 3.34 (t, J=7.6, 2H), 2.79 (t, J=7.6, 2H), 
2.29 (s, 3H), 2.25 – 2.20 (m, 2H), 1.46 (t, J=7.0, 3H), 0.93 (t, J=7.4, 3H). 





H NMR (500 MHz, CDCl3) δ = 7.71 (s, 1H), 7.29 (d, J=7.6, 1H), 7.05 (s, 1H), 
6.87 – 6.80 (m, 4H), 6.28 (d, J=3.9, 1H), 5.35 (s, 1H), 4.67 – 4.55 (m, 2H), 
4.42 – 4.30 (m, 2H), 4.14 (q, J=7.0, 2H), 3.35 (t, J=7.5, 2H), 2.85 (t, J=7.6, 
2H), 2.29 (s, 3H), 1.46 (t, J=7.0, 3H). 




Scheme 4.2 Synthetic scheme of MK-H4 and its derivatives 
 
Reagent and conditions: (a) CTC-PS resin, DIEA, CH2Cl2/DMF, rt, 24 h;(b) 
NaN3, DMF, rt, 30 min; (c) DMF: R1NH2 (4:1), rt, 1 h; (d) R2-C≡CH, CuI, 
ascorbic acid, rt, 30 min; (e) 0.5% TFA in CH2Cl2, 3x10 min. 
 
Compound MK-SM were synthesized following previous reports.
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General procedure for the preparation of the  MK compounds.  
2-Chlorotrityl chloride resin (220 mg, 0.275 mmol) was swollen in DCM for 
15 min. The mixture of MK-SM (30 mg, 0.085 mmol) and DIEA (200 µL, 
1.15 mmol) in DMF (2 mL) was added to the resin suspension and shaken at rt 
for 24 h. After reaction, the resin was capped with MeOH (0.4 mL, 1.8 mL/g 
resin) and DIEA (100 µL) for another 12 h. The resin was filtered, washed 
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with DMF (4x10 mL) and DCM (4x10 mL) and dried. The loaded resin was 
resuspended in DMF and a suspension of NaN3 (50 mg, 0.77 mmol) in DMF 
(3.0 mL) was added and the reaction mixture was shaken at rt for 30 min. 
After washing with DMF (4x10 mL), a solution of DMF–amine (4: 1) (4.0 mL) 
was added and the reaction shaken for 45 min. The alkyne (0.854 mmol), CuI 
(65 mg, 0.34 mmol) and ascorbic acid (60 mg, 34mmol) were subsequently 
added and the reaction mixture shaken for another 30 min. The resin was 
filtered, washed with DMF (4x10 mL) and DCM (4x10 mL) following which 
cleavage was performed with 0.5% TFA in DCM (3x15 mL, 10 min each). 
The organic extracts were recovered and concentrated in vacuo. The residue 
was purified by column (DCM to DCM–MeOH (98: 2) to afford the 
corresponding MK compounds as an orange solid. 
MK-H4 
1
H NMR (500 MHz, CD3CN) δ = 8.27 (s, 1H), 8.07 (d, J=6.9, 1H), 7.69 (d, 
J=8.5, 1H), 7.51 (d, J=8.2, 1H), 7.35 (d, J=8.2, 2H), 7.14 (s, 1H), 6.97 – 6.89 
(m, 3H), 6.84 (d, J=8.0, 1H), 6.55 – 6.41 (m, 3H), 4.67 (d, J=7.1, 2H), 3.26 (s, 
1H), 1.84 – 1.76 (m, 8H). 





H NMR (500 MHz, CD3CN) δ = 7.98 (s, 1H), 7.34 (dd, J=8.2, 5.5, 2H), 7.27 
(d, J=8.3, 2H), 7.10 (dd, J=11.8, 5.7, 3H), 6.74 (d, J=8.4, 2H), 6.47 (dd, 
J=22.8, 3.7, 2H), 6.43 (d, J=5.1, 1H), 4.60 (d, J=6.6, 2H), 4.52 (s, 1H), 2.02 
(ddd, J=13.3, 8.7, 5.0, 1H), 1.02 – 0.95 (m, 2H), 0.89 – 0.82 (m, 2H). 







H NMR (500 MHz, CD3CN) δ = 8.01 (s, 1H), 7.37 – 7.32 (m, 2H), 7.28 (d, 
J=8.4, 2H), 7.14 – 7.08 (m, 3H), 6.75 (d, J=8.3, 2H), 6.48 (d, J=18.3, 2H), 
6.43 (d, J=5.1, 1H), 4.61 (d, J=6.5, 2H), 4.53 (s, 1H), 3.23 (dd, J=15.3, 7.6, 
1H), 0.89 – 0.80 (m, 8H). 





H NMR (500 MHz, CD3CN) δ = 7.99 (s, 1H), 7.34 (dd, J=8.4, 5.6, 2H), 7.28 
(d, J=8.5, 2H), 7.11 (dd, J=11.3, 6.3, 3H), 6.75 (d, J=8.5, 2H), 6.48 (dd, 
J=22.0, 3.7, 2H), 6.43 (d, J=5.1, 1H), 4.61 (d, J=6.6, 2H), 4.53 (s, 1H), 2.80 (s, 
1H), 2.08 (d, J=11.0, 2H), 1.83-1.81 (m, 2H), 1.73 (d, J=12.8, 2H), 1.55 – 1.40 
(m, 4H). 





H NMR (500 MHz, CD3CN) δ = 8.01 (s, 1H), 7.34 (dd, J=8.3, 5.4, 2H), 7.28 
(d, J=8.5, 2H), 7.10 (dd, J=12.2, 5.1, 3H), 6.75 (d, J=8.5, 2H), 6.49 (dd, 
J=19.9, 3.8, 2H), 6.43 (d, J=5.1, 1H), 4.61 (d, J=6.5, 2H), 4.53 (s, 1H), 2.75 (d, 
J=7.3, 2H), 2.26 – 2.18 (m, 2H), 2.01 (s, 1H), 1.80 (d, J=7.1, 2H), 1.66 (s, 2H), 
1.56 (dd, J=7.1, 4.6, 2H). 





H NMR (500 MHz, CD3CN) δ = 7.98 (s, 1H), 7.40 – 7.24 (m, 7H), 7.08 (d, 
J=5.0, 1H), 6.75 (d, J=8.3, 2H), 6.46 (dd, J=18.1, 3.6, 2H), 6.42 (d, J=5.0, 1H), 
4.62 (d, J=6.7, 2H), 2.02 (ddd, J=13.3, 8.4, 5.0, 1H), 0.98 (dt, J=6.0, 4.0, 2H), 
0.85 (dt, J=6.5, 4.2, 2H). 







H NMR (500 MHz, CD3CN) δ = 8.01 (s, 1H), 7.38 – 7.27 (m, 7H), 7.09 (d, 
J=5.1, 1H), 6.74 (d, J=8.4, 2H), 6.48 (dd, J=18.9, 3.7, 2H), 6.42 (d, J=5.1, 
1H) , 4.63 (d, J=6.7, 2H), 4.52 (s, 1H), 3.23 (dd, J=15.3, 7.6, 1H), 1.81-1.69 
(m, 8H). 





H NMR (500 MHz, CD3CN) δ = 8.00 (s, 1H), 7.38-7.27 (m, 7H), 7.10 (d, 
J=5.1, 1H), 6.74 (d, J=8.4, 2H), 6.48 (dd, J=20.0, 3.7, 2H), 6.43 (d, J=5.1, 1H), 
4.64 (d, J=6.7, 2H), 4.52 (s, 1H), 2.80 (s, 1H), 2.11 – 2.05 (m, 2H), 2.02 (d, 
J=5.8, 2H), 1.82 (d, J=10.1, 2H), 1.55 – 1.41 (m, 4H). 





H NMR (500 MHz, CD3CN) δ = 8.02 (s, 1H), 7.38-7.27 (m, 7H), 7.10 (d, 
J=5.1, 1H), 6.74 (d, J=8.3, 2H), 6.48 (dd, J=17.6, 3.7, 3H), 6.43 (d, J=5.1, 1H), 
4.64 (d, J=6.7, 2H), 4.52 (s, 1H), 2.75 (d, J=7.4, 2H), 2.27 – 2.18 (m, 2H), 
2.00 (s, 1H), 1.79 (dd, J=12.0, 7.0, 2H), 1.65 (t, J=12.7, 2H), 1.56 (dd, J=7.2, 
4.6, 2H). 





H NMR (500 MHz, CD3CN) δ = 7.96 (s, 1H), 7.28 (d, J=8.3, 2H), 7.12 (d, 
J=5.1, 1H), 6.81 (s, 1H), 6.77 (d, J=8.4, 2H), 6.51 (d, J=5.2, 1H), 6.44 (dd, 
J=10.8, 3.7, 2H), 3.26 (t, J=6.9, 2H), 2.02 (ddd, J=13.3, 8.4, 5.0, 1H), 1.71 (d, 
J=10.5, 4H), 1.65 (d, J=11.9, 1H), 1.31-1.14 (m, 6H), 1.02 – 0.94 (m, 2H), 
0.88 – 0.82 (m, 2H). 
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H NMR (500 MHz, CD3CN) δ = 7.98 (s, 1H), 7.28 (d, J=8.4, 2H), 7.12 (d, 
J=5.1, 1H), 6.79 (s, 1H), 6.75 (d, J=8.5, 2H), 6.50 (d, J=5.1, 1H), 6.44 (dd, 
J=12.2, 3.7, 2H), 4.51 (s, 1H), 3.26 (t, J=6.8, 2H), 2.12-2.09 (m, 2H), 2.02 (d, 
J=5.9, 1H), 1.84 – 1.56 (m, 7H), 1.31 – 1.15 (m, 6H), 0.99 – 0.78 (m, 4H). 




 1H NMR (500 MHz, CD3CN) δ = 7.97 (s, 1H), 7.28 (d, J=8.3, 2H), 7.13 (d, 
J=5.1, 1H), 6.79 (s, 1H), 6.75 (d, J=8.3, 2H), 6.51 (d, J=5.1, 1H), 6.44 (dd, 
J=9.4, 3.7, 2H), 4.50 (s, 1H), 3.26 (t, J=6.8, 2H), 2.79 (s, 1H), 2.08 (d, J=5.0, 
2H), 2.02 (d, J=6.0, 1H), 1.73-1.64 (m, 4H), 1.55 – 1.41 (m, 6H), 0.99-0.84 (m, 
8H). 
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Chapter 5 Synthesis of Zwitterionic NIR Library and Its 



















NIR dye is widely used in the field of bioimaging. Cyanine dye is one of 
the commercially available near-infrared fluorescent dyes and attract more 
attention in the field of bioimaging.
1
 There are several advantages of NIR dye 
over other small molecules are that NIR fluorescence can deeply penetrate into 
tissue with reduction of auto-fluorescence and lower light scattering which are 
almost shown in visible light emission. Therefore, NIR dyes have been shown 





 fluorescence tag in DNA sequencing.
4
 
Currently, a large number of NIR fluorescent small molecules have been 
developed and used for clinical detection and diagnosis of cancer.
5
 However, 
most of them still show some limitations such as exhibiting high uptake in the 
liver, contaminating the gastrointestinal (GI) tract or limited modification 
part.
6
 An ideal NIR fluorescence probe need to have the following 
characteristics: 1) superior chemical and photophysical properties; 2) function 
in the NIR spectral range, with high molar absorption coefficient and quantum 
yield for intense fluorescence and 3) good solubility and sufficient chemical 
and photostability in aqueous media. Recently, Choi’s group reported the 
synthesis and in vivo fate of zwitterionic near-infrared fluorophores, ZW800-1, 
which is rapidly cleared by the kidneys, and exhibit low background binding 
to normal tissues and organs.
7
 Also, ZW800-1 provides a single carboxylic 
acid at the end of molecule for the covalent conjugation to targeting ligands 
through a stable amide bond. Based on their discussion, the reason for quick 
body excretion is because of its neutral surface charge, which can distribute 
over the entire surface of the molecule to completely shield the underlying 
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hydrophobicity. This design gives light to further development of NIR dye 
with diversity in structures and superior chemical and photophysical properties.  
Here, we describe the synthesis of zwitterionic near-infrared library, 
CyZW, which shows broad chemical diversity and high photostability. An 
elastin fibers probe CyZW-599 was selected through tissue-based screening 
against rat aortas tissue. The probe also shows ex vivo imaging of aorta 
sections and outer ear sections. 
5.2 Results and Discussion 
5.2.1 Library Design, Characterization and Photostability Studies 
In order to get more water soluble dyes for applications, I designed the 
CyZW library based on the famous zwitterionic near-infrared fluorophore, 
ZW800-1. ZW800-1 shows much better in vivo properties than other NIR 
dyes, like no serum protein binding, rapid renal clearance, and ultralow 
nonspecific tissue uptake
7
. The only problem is the limited choice of structure 
diversities for different potential use. To overcome this problem, we designed 
a new family of zwitterionic near-infrared dyes based on the key structure of 
ZW800-1. First, we improved the synthesis of the key intermediate of the 
chloro dye by changing the middle reagent.
8
 Using this method, we can make 
the key intermediate more efficiently and can get abundant amount of product 
without frustrating purification step (details see experiment part). Second, a 
broad range of structural diversities were introduced to a series of primary 
amines by reacting with tert-butyl 2-bromoacetate to get amine linkers quite 
efficiently. Then the key intermediate ZW800-1 was coupled with the 
diversity amine building blocks by using standard coupling protocol.
9
 The 
final step of de-protection of acid linker at the end to get final products yield 
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80-members of CyZW library (Scheme 5.1 and Chart 5.1). All the final 
CyZW compounds were purified by Prep HPLC. It is noteworthy that all the 
CyZW compounds also provide a single carboxylic acid at the end of the 
structure. The acid linker will be useful for further applications such as 
conjugated with various reporter or affinity tags for bio-conjugation depending 
on the biological study requirements. 






Reagents and conditions: a: ACN, DIEA, rt, 2 h, b: MeOH, rt,1 h; c: Toluene, 
130 ˚C, overnight; d: Benene/BuOH, reflux, overnight; e: DMSO, 65 ˚C, 
macrowave 1 h; f: DMSO: DMF (1: 4), HATU, rt, 3 h; g: 20 % TFA in DCM, 
















5.2.2 Spectral Properties of CyZW Library 
Both the absorbance and fluorescence spectra were measured in DMSO. 
All the CyZW compounds share the same core structure and all of them show 
the similar spectral properties. CyZW compounds show the maximum 
absorption wavelengths around 790 nm and emission around 805 nm in 
DMSO (example shown in Figure 5.1). Also, the zwitterionic near-infrared 




 and much 
higher quantum yield (average quantum yield 0.39) than normal near-infrared 
dyes. All the discussed data were summarized in Table 5.1. 
 
Figure 5.1 Absorption and Emission spectra of a representative CyZW library 
compounds (CyZW-599, 10 µM in DMSO, λex= 740 nm).  
 
Table 5.1 Spectroscopic properties and purity table for CyZW library: 
absorbance maximum (λabs), fluorescent emission maximum (λem), quantum 















A2 CyZW-32 1118.54 1119.0 787 803 0.39 98 
A3 CyZW-55 1182.67 1183.8 786 802 0.26 99 
A4 CyZW-77 1118.54 1119.0 786 801 0.42 99 
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A5 CyZW-80 1126.49 1126.8 789 804 0.36 97 
A6 CyZW-92 1084.56 1185.4 788 804 0.36 98 
A7 CyZW-100 1194.58 1195.4 789 800 0.23 98 
A8 CyZW-101 1104.53 1105.2 788 807 0.33 99 
A9 CyZW-102 1134.54 1135.0 787 804 0.34 98 
A10 CyZW-103 1134.54 1135.0 787 802 0.45 97 
A11 CyZW-105 1097.56 1098.2 786 805 0.47 95 
B2 CyZW-131 1132.56 1133.2 787 804 0.40 99 
B3 CyZW-153 1122.52 1123.0 787 803 0.56 96 
B4 CyZW-165 1072.52 1173.0 787 802 0.41 98 
B5 CyZW-177 1058.51 1058.8 788 802 0.43 98 
B6 CyZW-181 1150.53 1151.2 788 805 0.39 96 
B7 CyZW-184 1164.55 1165.0 789 804 0.39 98 
B8 CyZW-185 1070.54 1071.2 787 804 0.42 98 
B9 CyZW-193 1170.63 1171.0 788 805 0.41 99 
B10 CyZW-201 1132.56 1132.8 789 806 0.43 97 
B11 CyZW-218 1108.5 1109.2 787 803 0.38 96 
C2 CyZW-220 1108.5 1109.2 788 802 0.35 98 
C3 CyZW-221 1124.47 1125.4 788 805 0.35 99 
C4 CyZW-230 1112.59 1113.2 789 802 0.34 96 
C5 CyZW-262 1150.53 1151.0 786 804 0.39 98 
C6 CyZW-267 1125.47 1126.2 789 807 0.34 99 
C7 CyZW-273 1134.54 1135.2 789 807 0.40 97 
C8 CyZW-274 1100.56 1101.0 785 806 0.39 97 
C9 CyZW-275 1132.56 1132.8 790 802 0.44 99 
C10 CyZW-277 1098.58 1099.2 788 805 0.36 97 
C11 CyZW-329 1168.42 1170.0 789 802 0.33 98 
D2 CyZW-335 1118.54 1119.0 788 805 0.36 99 
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D3 CyZW-341 1168.42 1169.8 787 802 0.34 95 
D4 CyZW-351 1126.49 1127.2 787 804 0.38 99 
D5 CyZW-356 1180.55 1181.0 790 803 0.45 96 
D6 CyZW-358 1150.53 1151.4 787 804 0.38 97 
D7 CyZW-359 1149.51 1149.8 788 805 0.38 99 
D8 CyZW-361 1135.5 1136.0 788 805 0.35 94 
D9 CyZW-364 1124.47 1125.4 790 807 0.37 95 
D10 CyZW-373 1056.53 1057.0 788 803 0.40 98 
D11 CyZW-374 1090.51 1090.8 787 804 0.37 97 
E2 CyZW-375 1108.5 1108.8 787 807 0.35 99 
E3 CyZW-377 1056.53 1057.2 786 803 0.41 96 
E4 CyZW-381 1120.52 1121.0 787 803 0.40 97 
E5 CyZW-382 1096.56 1096.8 788 802 0.40 95 
E6 CyZW-384 1112.59 1113.0 789 802 0.44 99 
E7 CyZW-387 1120.52 1121.0 787 803 0.35 99 
E8 CyZW-389 1122.52 1123.0 786 799 0.45 95 
E9 CyZW-395 1134.54 1135.2 789 803 0.39 97 
E10 CyZW-396 1104.53 1105.0 790 803 0.43 98 
E11 CyZW-398 1104.53 1104.8 787 803 0.38 96 
F2 CyZW-399 1126.49 1127.0 786 803 0.40 97 
F3 CyZW-401 1091.51 1092.2 787 801 0.38 97 
F4 CyZW-403 1124.47 1125.4 787 806 0.35 99 
F5 CyZW-405 1122.52 1123.0 788 804 0.39 97 
F6 CyZW-407 1140.62 1141.6 788 804 0.33 97 
F7 CyZW-412 1126.49 1127.0 787 801 0.42 95 
F8 CyZW-413 1091.51 1092.2 787 801 0.40 96 
F9 CyZW-414 1139.6 1139.8 788 805 0.34 97 
F10 CyZW-419 1070.54 1071.0 788 802 0.40 97 
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F11 CyZW-425 1070.54 1071.0 787 802 0.41 99 
G2 CyZW-442 1070.54 1070.8 787 804 0.38 98 
G3 CyZW-449 1126.49 1127.0 786 803 0.43 97 
G4 CyZW-477 1122.52 1122.8 788 804 0.40 99 
G5 CyZW-478 1118.54 1119.0 786 802 0.41 97 
G6 CyZW-480 1138.49 1139.6 787 803 0.43 99 
G7 CyZW-487 1056.53 1057.0 789 803 0.37 97 
G8 CyZW-531 1158.44 1159.8 788 802 0.40 96 
G9 CyZW-548 1180.56 1181.0 789 806 0.37 98 
G10 CyZW-554 1126.61 1127.2 786 805 0.47 99 
G11 CyZW-565 1158.44 1160.0 788 803 0.35 96 
H2 CyZW-572 1182.44 1183.6 787 803 0.50 99 
H3 CyZW-574 1070.54 1071.0 787 805 0.27 96 
H4 CyZW-577 1168.65 1169.2 787 803 0.43 97 
H5 CyZW-599 1180.56 1181.0 787 805 0.39 99 
H6 CyZW-608 1142.47 1143.0 787 805 0.38 97 
H7 CyZW-618 1110.58 1111.0 787 803 0.36 93 
H8 CyZW-631 1168.49 1168.8 786 805 0.36 99 
H9 CyZW-656 1250.73 1251.2 789 804 0.35 97 
H10 CyZW-677 1138.49 1139.0 788 803 0.40 97 
H11 CyZW-686 1172.45 1174.0 787 805 0.32 96 
  All absorbance and fluorescence excitation and emission data were recorded 
by SpectraMax M2 spectrophotometer (Molecular Devices) (10 μM 
compounds in DMSO (100 μL) for λabs, 10 μM compounds in DMSO (100 μL) 
for λem in 96-well polypropylene plates (λem=740 nm). Mass was calculated as 
(M+), and found in ESI-MS (M+H); Purity data was calculated on the basis of 






5.2.3 Photostability Evaluation 
Photostability is one of most important properties in NIR dyes.
8, 10
 To 
evaluate the photostability of CyZW in comparison with ICG, which is used 
in medicine as an indicator substance in cardiac, circulatory, hepatic and 
ophthalmic conditions,
11
 The relative of fluorescence intensity (F/F0) of the 
compounds in PBS was measured under strong light condition after 2h (UV 
Blak-Ray® B-100AP high intensity mercury lamp, 100W, 365 nm). It clearly 
shows that CyZW compounds exhibit much better photostability than ICG 
(Figure 5.2). From the screening result, the average intensity decrease after 2 h 
due to decomposition was around 30% and 13 selected CyZW compounds 
showed less than 20% decrease, while under the same condition, ICG showed 
more than 85% decrease (Figure 5.3). It clearly shows that CyZW compounds 
exhibit much better photostability than ICG. 
 
Figure 5.2 Photostability evaluation: Fraction of fluorescent intensities (2 h) 
vs. fluorescent intensities (0 h), in a time-course fluorescence measurement 
using 10 µM (1% DMSO) solutions in PBS buffer (x, y show plate code, z 




Figure 5.3 Photostability assessments under strong UV irradiation in each 10 
min interval for 2 h of selected CyZW compounds and ICG in 10 µM (1% 
DMSO) solutions in PBS buffer (pH 7.4). The bar graphs exhibit fluorescence 
intensity after 2 h. 
 
5.2.4 Elastin Sensor Development  
5.2.4.1 Elastin 
Elastin fibers provide mechanical strength to almost all animal tissues. 
These mechanically flexible networks of fibers were assembled by elastin, 
which was secreted by cells.
12
 Interaction between cells and extracellular 
matrix fibers play a most important role in embryogenesis, tissue remodeling 
and regeneration.
13
 Imaging elastin fibers in live tissue can provide better 
understanding about the structures and role of elastin fibers in biological 
processes.  
Due to their important roles in the tissues and their small size, the imaging 
of elastin fibers is always difficult to acquire. To facilitate such study, a 
method of imaging with simple and rapid detection, less disturbance to issue 
should be developed. The imaging of elastin fibers in frozen tissues has been 
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developed by several microscopy techniques, but the imaging elastin fibers in 
live tissues in freshly excised tissues are still limited. The methods used in 
imaging elastin fibers in freshly excised tissues, such as immunofluorescence 
and autofluorescence, show some obvious drawbacks like varies of specificity 
of fluorescent signals and strength between tissues which make it difficult to 
obtain high quality images.
14
 Endofluorescence of elastin have been reported 
by several cases, and among most of them, the fluorescence emission has been 
highly influenced by the scattering of surrounding tissues, which makes it 
shows low efficiency in comparison with dye staining. NIR fluorescent small 
molecules would exhibit improved in vitro and in vivo fluorescence imaging 
due to their deep tissue penetration as well as lower auto-fluorescence 
background advantages. 
5.2.4.2 In Vitro Fluorescent Staining of Aorta Sections 
Aorta contains a characteristic architecture of elastic lamellae in the vessel 
wall. Medial lamellar unit of the wall of aorta is constructed with elastin which 
arranged in concentric lamellae and smooth muscle cells lies between those 
lamellae.
15
 This makes the aorta tissue a good model for elastin imaging. In 
order to discover new utilization of a classic dye that appears to be specific to 
elastic fibers, we first performed tissue-based screening using CyZW 
compounds against frozen slices of rat aortas. Frozen section of aortas were 
incubated with CyZW library compounds for 1 h. Fluorescence microscopic 
images showed that CyZW-599 treated aorta section stained in elastin part 
even after washing several times. Based on fluorescence intensity analyzed 
using image analysis software and visual confirmation, CyZW-599 was 
selected for further validation.  
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To confirm the staining of CyZW-599 for elastin lamellae in the aortas, 
fluorescent staining with CyZW-599 was carried out using aorta sections from 
C57BL/6 mouse (Figure 5.4). Aorta has a characteristic architecture of elastic 
fibers in the vessel wall, in tunica media. There was a clear overlap between 
the CyZW-599 stained elastin and endofluorescence elastin fibers in the 
image. These observations can make the conclusion that CyZW-599 exhibits 
good affinity to elastin. Another thing, when comparing the Hoechst nuclear 
staining and CyZW staining, we found that CyZW-599 cannot stain the 




Figure 5.4 Comparison between endofluorescence and CyZW-599 staining of 
elastin lamellae of a frozen section of aorta. (a) Fluorescence image of elastin 
lamellae using CyZW-599 (10 µM); (b) the endofluorescence imaging of 
elastin lamellae using FITC channel; (c) Fluorescence image of a frozen 




5.2.4.3 Ex Vivo Imaging of Aorta and Outer Ear Sections from Normal 
Mice 
To evaluate the potential of CyZW-599 in aorta tissue, we carried out 
experiments ex vivo using a 10 weeks-old C57BL/6 mouse with one non-
injected mouse as control. The mice were then sacrificed after one hour tail 
injection. The result showed that there is a clear staining with elastin when 
injected with CyZW-599 and the staining patterns in the aorta tissue sections 
were consistent with that observed in in vitro staining even after several times 
washing with PBS (Figure 5.5). On the other hand, there is no signal detected 
from NIR channel when no compound injected (Figure 5.6). Considering all 
the data available, we can make the conclusion that CyZW-599 specifically 
stains the elastic.  
Binding of CyZW-599 to elastin was further confirmed by staining outer 
ear. We tested the CyZW-599 in outer ear tissue section using a 10 weeks-old 
C57BL/6 mouse. The mice were then sacrificed after one hour tail injection. 
Elastic cartilage is a type of cartilage present in the outer ear. It contains 
elastic fiber networks and collagen fibers. The fluorescence imagings were 
taken after one hour injection and the results showed that CyZW-599 clearly 
stains elastin cartilage. After washing with PBS, the signal detected from 
elastin cartilage shows high target binding with low background binding to 
normal tissues and organs. Similarly like aorta tissue imaging, there is no 






Figure 5.5 Ex vivo fluorescence observation of aorta sections from a 10 
weeks-old C57BL/6 mouse. (a-c) A section of aorta (a-CyZW-599 staining 
from NIR channel, b- endofluorescence imaging from FITC channel, c-the 
CyZW-599 and endofluorescence images overlaid). Images were taken with a 
4× objective; (d-f) A section of aorta (d-CyZW-599 staining from NIR 
channel, e- endofluorescence imaging from FITC channel, f- the CyZW-599 
and endofluorescence images overlaid). Images were taken with a 20× 
objective; (g-i) A section of aorta after wash with PBS. Images were taken 
with a 20× objective. 
Figure 5.6 Ex vivo fluorescence observation of aorta sections from a 10 
weeks-old C57BL/6 mouse. (a-c) A section of aorta (a-imaging from NIR 
channel, b- endofluorescence imaging from FITC channel, c- Merged images 
of a and b. Images were taken with a 4× objective; (d-f) d-imaging from NIR 
channel, e- endofluorescence imaging from FITC channel, f- Merged images 




Figure 5.7 Ex vivo fluorescence observation of outer ear sections from a 10 
weeks-old C57BL/6 mouse. (a-c) A section of outer ear (a-CyZW-599 staining 
from NIR channel, b- endofluorescence imaging from FITC channel, c-the 
CyZW-599 and endofluorescence images overlaid). Images were taken with a 
4× objective; (d-f) A section of outer ear (d-CyZW-599 staining from NIR 
channel, e- endofluorescence imaging from FITC channel, f- the CyZW-599 
and endofluorescence images overlaid). Images were taken with a 20× 
objective; (g-i) A section of outer ear after wash with PBS. Images were taken 
with a 20× objective. 
 
Figure 5.8 Ex vivo fluorescence observation of outer ear sections from a 10 
weeks-old C57BL/6 mouse. (a-c) A section of outer ear (a-imaging from NIR 
channel, b- endofluorescence imaging from FITC channel, c- Merged images 
of a and b. Images were taken with a 4× objective; (d-f) d-imaging from NIR 
channel, e- endofluorescence imaging from FITC channel, f- Merged images 




In this chapter, we constructed the zwitterionic library, CyZW, using the 
famous zwitterionic near-infrared dye, ZW800-1. Each of the CyZW 
compound from the library was synthesized with zwitterionic charges and 
single carboxylic acid at the end for the covalent conjugation to target ligands 
through a stable amide bond. The photostability tested by high intensity 
mercury lamp showed that CyZW compounds consist of much better 
photostability compared to the most used ICG dye. Because of their 
hydrophobic nature, we applied these NIR dye for elastic fibers screening. 
From the frozen slices of rat aortas screening, we chose the best staining dye 
CyZW-599 as our target dye for elastin. Furthermore, ex vivo imaging of aorta 
sections and outer ear sections from a 10 weeks-old C57BL/6 mouse shows 
that CyZW-599 can clearly stain elastic fibers, while those without compound 
injection showed no such staining. This type of clear imaging can help us to 
understand the function of elastin in embryogenesis, tissue remodeling and 
regeneration. 
5.4 Experimental Section 
5.4.1 Reagents and Solvents 
The chemicals, including amines and solvents, were purchased from Sigma 
Aldrich, Acros and Alfa Aesar. All the chemicals were directly used without 
further purification. Normal phase column chromatography purification was 
carried out using MERCK silica Gel 60 (Particle size: 230-400 mesh, 0.040-
0.063 mm). 
5.4.2 Measurements and Analysis 
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HPLC-MS was taken on an Agilent-1200 with a DAD detector and a single 
quadrupole mass spectrometer (6130 series). The analytical method, unless 
indicated, is A: H2O (0.1% HCOOH), B: CH3CN (0.1% HCOOH), gradient 
from 10 to 90% B in 10 min; C18 (2) Luna column (4.6 x 50 mm2, 3.5 μm 
particle size). 
 Spectroscopic and quantum yield data were measured on a SpectraMax M2 
spectrophotometer (Molecular Devices). Data analysis was performed using 




C-NMR spectra were recorded on Bruker ACF300 (300 
MHz) and AMX500 (500 MHz) spectrometers, and chemical shifts are 
expressed in parts per million (ppm) and coupling constants are reported as a J 
value in Hertz (Hz). Characterization details (NMR) are contained in the 
Supporting Information. 
5.4.3 Quantum Yield Measurements 
Quantum yields for all the fluorescent compounds were measured by 
dividing the integrated emission area of their fluorescent spectrum against the 
area of ICG in DMSO excited at 740 nm (ΦICG = 0.14). Quantum yields were 
then calculated using equation (1), where F represents the integrated emission 
area of fluorescent spectrum, η represents the refractive index of the solvent, 
and Abs represents absorbance at excitation wavelength selected for standards 
and samples. Emission was integrated from 760 nm to 850 nm. 
sample sample reference
sample reference
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5.4.4 Photostability Experiment  
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Procedure: 1 nmol CyZW in 96-well black plate was added 1 µL DMSO 
and followed by 99 µL PBS buffer (pH 7.4). The final concentrations of 
compounds were 10 µM. Fluorescence intensity measurements were carried 
out in each 10 min interval for a total period of 2 h (λex= 760 nm, λem= 800 
nm).   
5.4.5 In Vitro Fluorescent Staining of Aorta Sections 
Mouse obtained from the Biological Resource Centre (Biomedical Sciences 
Institutes). After the mouse was sacrificed, the aorta (without fat removal) was 
removed and sliced into serial sections 10μm thick. Each slide was incubated 
with a 10% DMSO solution of CyZW compounds (10 μM). Finally, the 
sections were washed with PBS and examine using fluorescence microscope 
Ti (Nikon). NIR and FITC filters were used for fluorescence image acquisition. 
5.4.6 Ex Vivo Imaging of Aorta and Outer Ear Sections from Normal Mice 
Mouse obtained from the Biological Resource Centre (Biomedical Sciences 
Institutes). 10 weeks-old C57BL/6 mice were injected with 200 μL of 1 mM 
CyZW-599 (10% DMSO in PBS). Non-compound injected mice were used as 
controls. The animals were sacrificed after 1 h and the harvested organs, 
including aorta and outer ear were rapidly frozen and stored at -80 °C 
immediately after extraction. 10 μm sections of rapidly frozen aorta and outer 
ear were prepared using a cryostat and picked up on coated slides and 
observed with an inverted fluorescence microscope Ti (Nikon). NIR and FITC 
filters were used for fluorescence image acquisition. Separately, non-
compound injected cryosections were stained with 10 µM CyZW-599 (10 % 
DMSO in PBS) for 20 min, washed with PBS and mounted with anti-fade 






5.4.7 Synthesis  
 
To a chilled solution of dimethylformamide (20 mL, 273 mmol) in 20 mL 
DCM under N2 atmosphere, 20 mL of POCl3 (17.5 mL, 115 mmol) in DCM 
were added dropwise under an ice bath. After 30 min, cyclohexanone was 
added (5 g, 50 mmol), and the resulting mixture was refluxed with vigorous 
stirring for 3 h at 80 
o
C. After reaction, the mixture was poured into ice-cold 
water, and kept overnight to obtain product as a yellow solid. The solid was 
washed with H2O and dried under high vacuum, which was used in the next 
step without further purification. 
 
A mixture of reagent (4.8 g, 0.02 mol), potassium hydroxide (1.3 g, 0.02 
mol), methanol (5 mL) and 2-propanol (5 mL) was stirred and heated to reflux 
for 30 min. Then the reaction mixture turned yellow and 2,3,3-
trimethylindolenium-5-sulfonic potassium salt began to precipitate 
quantitatively as yellow solid after the reaction mixture cooled to room 
temperature. The solid was washed with ether and dried under high vacuum, 
which was used in the next step without further purification. 
1
H NMR (500 MHz, DMSO-d6): δ 7.64 (d, J=1.1 Hz, 1H), 7.56 (dd, J=7.9, 1.5 





) calculated: 238.05, found: (M+2H) 240.00. 
 
A mixture of 2,3,3-trimethyl-3H-indole-5-sulfonic acid (1.0 g, 3.6 mmol) 
and (3 - bromopropyl) trimethyl ammonium bromide (1.1 g, 4.3 mmol) in 
toluene (6 mL) was heated at 130 ˚C for 3 days under a nitrogen atmosphere. 
The mixture was cooled to room temperature and the solvent was decanted. 
The crude product was crystallized from methanol and MTBE to afford pink 
crystals, which was used in the next step without further purification. 
1
H NMR (500 MHz, DMSO-d6): δ 8.03 (s, 1H), 8.02 (d, J=8.1 Hz, 1H), 7.69 
(d, J=8.0 Hz, 1H), 4.52 (t, J=7.2 Hz, 2H), 3.65 (t, J=7.2 Hz, 2H), 3.14 (s, 9H), 
2.93 (s, 2H), 2.37 (s, 3H), 1.56 (s, 6H). 
ESI-MS m/z (C17H27N2O3S
+
) calculated: 339.17, found: (M+) 338.8. 
 
 
A mixture of bromide salt (1.1 g, 3.24 mmol) and middle part reagent (0.5 
g, 2.86 mmol) in BuOH-benzene (7:3) was refluxed at 130 ˚C for 10 h under 
N2 atmosphere. Afterwards, the mixture was cooled to room temperature and 
poured into hexane. The mixture was kept for 2 days to obtain product as a 





3-(4-hydroxyphenyl) propionic acid (1.66 g, 10 mmol) and sodium 
hydroxide (0.88 g, 20 mmol) was dissolved in water and the mixture was 
stirred at room temperature for 2 h. After reaction, dry the solvent by 
lyophilization. The pale yellow solid was used for the next step without further 
purification. 
 
The synthesis of key intermediate was followed the reference.
7
 Briefly 
speaking, the chloro dye (110 mg, 0.1 mmol) and 2 equiv. of linker (42 mg) 
were dispersed in DMSO under nitrogen atmosphere. The mixture was heated 
under microwave conditions for 30 min under the irradiation at 65 ˚C. The 
crude product was washed with MTBE 3 times and precipitated with methanol 
and MTBE (1:4) to yield CyZW acid as a dark green solid. The product was 
used for the next step without further purification. 
 
The BOC blocked diversity building block were prepared from tert-butyl 2-
bromoacetate to which was added the different primary amine. For each 
reaction, tert-butyl 2-bromoacetate was dissolved in acetonitrile. 1 equiv. of 
each amine and 1 equiv. of DIEA were then added to the mixture. The reaction 
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mixture was stirred for 2 h at room temperature. After completion of the 
reaction, the solvent was concentrated in vacuo. The residue was purified by 
column chromatography on silica gel (DCM: MeOH =95:5) to afford the 
amine linker. 
General procedure for synthesis of CyZW library 
 
To synthesize CyZW library, each of amine linker (3 equiv.) was mixed 
with CyZW acid (1 equiv.), HATU (3 equiv.) and DIEA (3 equiv.) in the 
solvent (DMSO: DMF=1: 4). The mixture was stirred for 3 h at room 
temperature. After reaction, collect the solid after adding enough ether to the 
reaction mixture. Then the dark solid was suspended in 20 % TFA in DCM 
and stirred for 3 h at 60 ˚C. After evaporation of the solvent, the crude product 
was purified by Prep-HPLC to afford the corresponding CyZW library 












HPLC-MS characterization of CyZW-599. 
ESI-MS m/z (C67H82N5O10S2
+
) calculated: 1180.5, found: 1181.0. 
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    Amyloid-β (Aβ) deposits are a pathological hallmark of Alzheimer’s 
disease (AD). Their formation arises from the aggregation of peptides Aβ40 
and Aβ42, which are generated from   amyloid peptide precursor (APP) by 
cleavage with β- and γ-secretases.1 Currently, memory and behavioral tests are 
widely used for late-stage AD diagnosis;
 
however, early detection at the 
asymptomatic syndrome stage still presents a challenge. Molecular imaging, a 
detection technique with sensitivity at the molecular level, represents a 
promising approach to face this challenge.
1b
 Prior studies have shown that the 
essential criteria for successful agents include: having a relatively small 
molecular size, being neutral and lipophilic for good blood–brain barrier (BBB) 
penetration, and showing specific plaque labeling in vivo.
2
 To date, several 
interesting approaches for developing amyloid aggregates specific ligands 
have been reported. Thioflavin T (ThT)
3
 and Congo Red (CR)
4 
are the two 
most successful dyes that have been used for in vitro staining of β -amyloid 
plaques for decades. Beside these, ThT derivatives without charged moieties 
include the PIB and BTA series, the IMPY and TZDM series were also 
developed (Figure 6.1). 
 




    The synthesis of DOFL needs quite efficient synthesis approach and 
relatively easily purification to acquire a large number of dyes. Most of the 
traditional library was constructed in solution phase chemistry using one 
single core scaffold with different building block. Although several libraries 
have already been published, the problems like fussy purification and typical 
low recovery yields were still not solved. Solid phase synthesis was first 
introduced to peptide synthesis by Bruce Merrifield in 1963.
5
 Later the solid 
phase methodologies was introduced to the combinational chemistry and the 
challenges showed in solution phase synthesis were overcame efficiently.
6
 In 
the process of the solid phase synthesis, the key reagent scaffold is attached to 
an insoluble materials using high efficient and high yield reaction. Then this 
solid support reagent can be used to combinational synthesis. The purification 
step can be replaced by washing the resin with a variety of solvent, which can 
help to circumvent the technical difficulties related with the solubility and 
purification. One of the major advantage of solid phase synthesis is that we 
can developed a library containing a huge number of fluorescent molecules in 
a short time.  
Here, we designed the solid phase route to secure a pure benzimidazole 
(BID) library in high efficiency by minimizing the crucial purification step. 
We chose to investigate a novel series of benzimidazole derivatives, 







6.2 Results and Discussion 
6.2.1 Library Design, Characterization and Photostability Studies 
    In order to develop more useful amyloid specific imaging agents, we chose 
to investigate a novel series of benzimidazole derivatives. According to the 
literatures, nearly all known compounds showing good binding affinity to Aβ 
aggregates share simply and unique structure feature: all of the active 
compounds contain either an N-methylamino or N, N-dimethylaminophenyl 
group on one end of the molecule.
7
 Thus, we designed the BID and 
BIDAC/BIDCA libraries. For the main structure, we introduced N-
methylaminophenyl group on one end of the molecule as good binding 
structure part, fluorine as the future radiolabeled part and different amines as 
diversity part. The structures of the BID, BIDAC/BIDCA libraries are shown 
in Figure 6.2. 
 
Figure 6.2. The structures of the BID, BIDAC/BIDCA libraries. 
 
    The introduction of the diversified structures has been reported by our 
group. The bromine in bromopropyl amine (loaded in chlorotrityl resin) has 
been replaced by various primary amines, in order to generate solid supported 
diversified secondary amines, which can be coupled with different acids 
attached with fluorophores or small molecules. 
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    The synthetic routes of the BID acid are illustrated in Scheme 6.1. The 
hydroxy group in compound 1, which was obtained by using condensation of 
o-phenylamine and aldehyde, was replaced by a better leaving group (OTs). 
Then the leaving group was replaced by flourine, the element who will be 
changed to radiolabel part. The addition of the acid linker can be coupled with 
different amines. 
As shown in the Scheme 6.1, first, 3-bromopopropylamine has been loaded 
to the chlorotrityl resin. Then, a broad range of structural diversity has been 
achieved when the varieties of primary amines were employed to displace 
bromine from bromopopropylamine with aid of simple nucleophilic reaction.  
Here, the nucleophilic displacement has led the wide structurally diversified 
products of solid supported secondary amines. The amines are then coupled 
with BID core structure by using standard acid-amine coupling protocol. The 
final step cleavage from the solid support has been in turn generated the BID 
library. 
     All the compounds in the library have been characterized by HPLC-MS 
and 80 relatively pure compounds (average purity is more than 90%, measured 
at 254 nm (Table 6.1) have been assembled for further study. Library 
consisted blue emission compounds (excitation at 320 nm and emission at 














Reagent and conditions: 1: DIEA, THF, rt, 12 h; 2: DIEA, RNH2, NMP, 
70 °C; a: DMF/water 1:4, 90 °C, 2 h, 67%; b: Tosyl chloride, DMAP, Et3N, 4 
h, 70%; c: Bu4NF, THF, reflux, 3 h, 87%; d: NaH, DMF, 0 °C; Methyl 
bromoacetate, 2 h, rt., 47%; e: NaOH, ethanol, 2 h, 76%; f: HATU, DIEA, rt, 





Figure 6.3 Absorption and emission spectra of representative BID, BIDAC 





    After successfully synthesizing the BID library, the affinity tags were 
introduced to the BID compounds for developing another set of bioimaging 
probes (BIDCA compounds) that could facilitate the identification of the 
target proteins from the biological systems. Firstly, active ester resin were 
prepared by treating the nitrophenol resin with chloroacetyl chloride (for CA 
version) and acetyl chloride (for AC version). The BIDCA compounds were 
afforded by treating corresponding active ester resin and BID compounds in 
presence of catalytic amount of NaHCO3 solution.  Similarly, BIDAC 
compounds have been achieved.  BIDAC compounds are another useful set of 
bioimaging probes.  
    The reaction completed within 2h and the products have been obtained with 
an average purity above 90% for each library. These compounds have similar 
excitation and emission like BID compounds. The synthetic route for BIDCA 
and BIDAC is given in Scheme 6.2. 
 
Scheme 6.2 Synthesis scheme of BIDAC/BIDCA libraries. 
 
 
Reagent and condition: a: DIC, HOBt, DMF; b: RCOCl, DIEA, DCM: c: 








Table 6.1 Spectroscopic properties and purity table for BID library: 
absorbance maximum (λabs), fluorescent emission maximum (λem), extinction 















BID-28 579.4 580.4 317 396 0.422 98 
BID-49 517.2 518.2 320 395 0.567 95 
BID-77 501.3 502.4 319 396 0.500 95 
BID-80 509.2 510.2 320 396 0.605 98 
BID-92 467.3 468.2 319 399 0.410 97 
BID-100 577.3 578.4 318 397 0.494 98 
BID-101 487.3 488.2 319 397 0.571 98 
BID-103 517.3 518.2 319 397 0.504 95 
BID-124 533.3 534.2 320 398 0.645 94 
BID-131 515.3 516.4 318 397 0.547 96 
BID-135 541.2 543.2 319 397 0.593 94 
BID-153 505.2 506.2 318 396 0.497 96 
BID-167 469.3 470.4 318 395 0.555 92 
BID-177 441.3 442.2 320 398 0.598 90 
BID-180 451.3 452.4 320 397 0.623 91 
BID-181 533.3 534.2 320 398 0.612 93 
BID-184 547.3 548.4 320 397 0.576 94 
BID-193 553.4 554.4 319 396 0.403 96 
BID-201 515.3 516.4 319 398 0.552 97 
BID-218 491.2 492.2 318 397 0.543 97 
BID-220 491.2 492.2 321 397 0.476 95 
BID-221 507.2 508.2 320 395 0.509 98 
BID-230 495.3 496.4 321 396 0.501 94 
BID-240 549.3 550.2 318 398 0.412 90 
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BID-262 533.3 534.2 320 396 0.422 91 
BID-266 547.3 548.2 321 397 0.444 90 
BID-267 508.2 509.2 318 397 0.204 93 
BID-273 517.3 518.4 318 397 0.561 97 
BID-274 483.3 484.4 318 396 0.386 92 
BID-275 515.3 516.4 319 397 0.461 97 
BID-277 481.3 482.4 318 396 0.427 95 
BID-319 533.3 534.4 319 397 0.432 92 
BID-329 552.2 553.2 319 398 0.436 92 
BID-330 541.2 542.2 319 397 0.420 96 
BID-335 501.3 502.2 319 396 0.527 96 
BID-341 551.1 552.2 320 396 0.469 96 
BID-356 563.3 564.2 321 398 0.471 95 
BID-358 533.3 534.4 318 397 0.431 94 
BID-359 532.2 533.2 317 399 0.146 93 
BID-361 518.2 519.2 318 397 0.113 95 
BID-364 507.2 508.2 318 397 0.580 93 
BID-373 439.3 440.4 319 398 0.506 93 
BID-374 473.3 474.2 320 398 0.587 94 
BID-375 491.2 492.2 320 397 0.871 90 
BID-381 503.3 504.2 319 397 0.601 97 
BID-382 479.3 480.4 319 398 0.422 95 
BID-386 487.3 488.4 320 395 0.401 97 
BID-387 503.3 504.4 322 397 0.490 96 
BID-388 503.3 504.4 319 396 0.499 87 
BID-389 505.3 506.4 318 398 0.535 96 
BID-395 517.3 518.2 319 398 0.624 94 
BID-396 487.3 488.2 319 398 0.509 98 
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BID-398 487.3 488.4 319 398 0.430 97 
BID-399 509.2 510.2 320 396 0.568 96 
BID-403 507.2 508.2 320 398 0.532 97 
BID-405 505.3 506.2 320 396 0.478 98 
BID-407 523.4 524.4 319 396 0.559 97 
BID-412 509.2 510.2 319 398 0.600 98 
BID-419 453.3 454.4 320 397 0.357 94 
BID-425 453.3 454.2 319 398 0.403 92 
BID-429 479.3 480.4 318 399 0.679 92 
BID-439 467.3 468.4 318 396 0.358 97 
BID-441 479.3 480.2 319 398 0.456 92 
BID-442 453.3 454.4 320 399 0.553 94 
BID-443 479.3 480.4 320 395 0.403 94 
BID-446 463.2 464.2 319 398 0.524 98 
BID-449 509.2 510.2 320 397 0.589 94 
BID-457 509.2 510.2 318 396 0.620 95 
BID-477 505.3 506.2 319 398 0.398 96 
BID-480 521.2 522.2 319 399 0.552 95 
BID-531 541.2 542.2 319 397 0.445 96 
BID-548 563.3 564.4 318 398 0.496 95 
BID-565 541.2 542.2 320 396 0.427 91 
BID-572 565.2 567.2 320 398 0.562 97 
BID-574 453.3 454.4 319 397 0.521 97 
BID-608 525.2 526.2 319 397 0.398 94 
BID-656 633.5 634.4 318 397 0.455 86 
BID-661 540.3 541.4 320 396 0.499 90 
BID-677 521.4 522.2 319 398 0.564 96 
BID-686 555.2 556.2 318 396 0.430 95 
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Table 6.2 Spectroscopic properties and purity table for BIDAC library: 
absorbance maximum (λabs), fluorescent emission maximum (λem), extinction 















BIDAC-28 621.4 622.4 317 396 0.511 95 
BIDAC-49 559.2 560.2 318 399 0.723 96 
BIDAC-77 543.3 544.4 318 399 0.585 96 
BIDAC-80 551.2 552.4 318 399 0.680 99 
BIDAC-92 509.3 510.4 318 396 0.528 98 
BIDAC-100 619.3 620.4 318 396 0.580 98 
BIDAC-101 529.3 530.4 317 399 0.657 97 
BIDAC-103 559.3 560.4 318 397 0.598 98 
BIDAC-124 575.3 576.4 317 397 0.727 96 
BIDAC-131 557.3 558.4 318 398 0.591 95 
BIDAC-135 583.2 584.2 318 398 0.601 94 
BIDAC-153 547.2 548.4 318 397 0.562 94 
BIDAC-167 511.3 512.4 318 402 0.551 95 
BIDAC-177 483.3 484.4 318 398 0.685 90 
BIDAC-180 493.3 494.4 318 396 0.685 95 
BIDAC-181 575.3 576.4 318 398 0.649 96 
BIDAC-184 589.3 590.4 318 396 0.605 95 
BIDAC-193 595.4 596.4 319 398 0.469 98 
BIDAC-201 557.3 558.4 318 399 0.590 97 
BIDAC-218 533.2 534.2 318 397 0.550 94 
BIDAC-220 533.2 534.2 318 398 0.564 98 
BIDAC-221 549.2 550.2 318 397 0.614 96 
BIDAC-230 537.3 538.4 318 398 0.550 98 
BIDAC-240 591.3 592.4 318 396 0.576 98 
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BIDAC-262 575.3 576.4 319 397 0.535 97 
BIDAC-266 589.3 590.4 319 397 0.552 95 
BIDAC-267 550.2 551.2 318 397 0.203 96 
BIDAC-273 559.3 560.4 318 396 0.606 97 
BIDAC-274 525.3 526.4 318 398 0.488 95 
BIDAC-275 557.3 558.2 318 398 0.537 96 
BIDAC-277 523.3 524.4 318 398 0.510 98 
BIDAC-319 575.3 576.4 320 396 0.564 97 
BIDAC-329 595.2 596.2 318 399 0.524 98 
BIDAC-330 583.2 584.2 319 397 0.545 98 
BIDAC-335 543.3 544.4 319 396 0.594 99 
BIDAC-341 593.1 594.2 318 399 0.563 98 
BIDAC-356 605.3 606.4 320 398 0.596 97 
BIDAC-358 575.3 576.4 319 397 0.535 96 
BIDAC-359 574.2 575.2 298 402 0.158 85 
BIDAC-361 560.2 561.2 313 401 0.132 94 
BIDAC-364 549.2 550.2 318 396 0.601 96 
BIDAC-373 481.3 482.4 318 401 0.564 98 
BIDAC-374 515.3 516.4 318 397 0.607 98 
BIDAC-375 533.2 534.2 317 397 0.918 95 
BIDAC-381 545.3 546.4 319 396 0.626 95 
BIDAC-382 521.3 522.4 318 396 0.514 96 
BIDAC-386 529.3 530.4 318 398 0.509 97 
BIDAC-387 545.3 546.4 318 398 0.571 97 
BIDAC-388 545.3 546.2 318 399 0.553 95 
BIDAC-389 547.3 548.4 319 396 0.626 95 
BIDAC-395 559.3 560.4 317 399 0.644 97 
BIDAC-396 529.3 530.4 318 397 0.515 98 
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BIDAC-398 529.3 530.4 319 397 0.507 98 
BIDAC-399 551.2 552.2 318 400 0.615 97 
BIDAC-403 549.2 550.2 319 398 0.551 97 
BIDAC-405 547.3 548.4 318 397 0.524 98 
BIDAC-407 565.4 566.4 318 398 0.577 96 
BIDAC-412 551.2 552.2 318 398 0.677 97 
BIDAC-419 495.3 496.4 318 397 0.464 85 
BIDAC-425 495.3 496.4 317 396 0.479 94 
BIDAC-429 521.3 522.4 316 397 0.746 92 
BIDAC-439 509.3 510.4 318 397 0.457 96 
BIDAC-441 521.3 522.4 319 397 0.508 98 
BIDAC-442 495.3 496.4 318 399 0.621 97 
BIDAC-443 521.3 522.4 318 396 0.501 97 
BIDAC-446 505.2 506.2 318 395 0.601 95 
BIDAC-449 551.2 552.2 319 397 0.635 98 
BIDAC-457 551.2 552.2 318 398 0.653 98 
BIDAC-477 547.3 548.4 318 396 0.504 99 
BIDAC-480 563.2 564.2 318 398 0.590 97 
BIDAC-531 583.2 584.2 316 396 0.515 98 
BIDAC-548 605.3 606.4 318 402 0.668 98 
BIDAC-565 583.2 584.2 318 399 0.512 97 
BIDAC-572 607.2 608.2 318 398 0.607 96 
BIDAC-574 495.3 496.4 315 399 0.597 97 
BIDAC-608 567.2 568.2 318 396 0.461 99 
BIDAC-656 675.5 676.4 318 397 0.545 97 
BIDAC-661 582.3 583.4 318 396 0.590 94 
BIDAC-677 563.4 564.2 318 396 0.620 95 
BIDAC-686 597.2 598.2 317 398 0.528 96 
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Table 3. Spectroscopic properties and purity table for BIDCA library: 
absorbance maximum (λabs), fluorescent emission maximum (λem), extinction 














BIDCA-28 655.4 656.4 319 397 0.363 97 
BIDCA-49 593.2 594.2 317 398 0.532 98 
BIDCA-77 577.3 578.2 318 399 0.442 95 
BIDCA-80 585.2 586.2 319 398 0.603 97 
BIDCA-92 543.3 544.2 318 396 0.375 95 
BIDCA-100 653.3 654.2 318 396 0.463 96 
BIDCA-101 563.3 564.2 320 397 0.518 95 
BIDCA-103 593.3 594.2 319 397 0.457 94 
BIDCA-124 609.3 610.2 318 397 0.640 95 
BIDCA-131 591.3 592.4 318 397 0.486 96 
BIDCA-135 617.2 618.2 318 397 0.563 98 
BIDCA-153 581.2 582.2 320 398 0.508 97 
BIDCA-167 545.3 546.2 319 398 0.505 96 
BIDCA-177 517.3 518.2 320 398 0.633 97 
BIDCA-180 527.3 528.2 319 398 0.643 97 
BIDCA-181 609.3 610.2 319 398 0.630 97 
BIDCA-184 623.3 624.4 318 397 0.546 97 
BIDCA-193 629.4 630.4 319 397 0.406 97 
BIDCA-201 591.3 592.2 319 397 0.513 96 
BIDCA-218 567.2 568.2 318 398 0.555 95 
BIDCA-220 567.2 568.2 319 397 0.387 92 
BIDCA-221 583.2 584.2 319 397 0.539 94 
BIDCA-230 571.3 572.4 320 398 0.478 94 
BIDCA-240 625.3 626.2 319 397 0.488 93 
BIDCA-262 609.3 610.2 321 398 0.469 95 
BIDCA-266 623.3 624.2 320 396 0.478 92 
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BIDCA-267 584.2 585.2 320 398 0.174 97 
BIDCA-273 593.3 594.2 319 398 0.558 98 
BIDCA-274 559.3 560.4 319 399 0.420 96 
BIDCA-275 591.3 592.2 319 397 0.431 97 
BIDCA-277 557.3 558.4 318 397 0.393 95 
BIDCA-319 609.3 610.2 320 397 0.439 95 
BIDCA-329 627.1 628.2 319 398 0.434 94 
BIDCA-330 617.2 618.2 319 397 0.423 94 
BIDCA-335 577.3 578.2 320 397 0.505 98 
BIDCA-341 627.1 628.2 322 396 0.468 97 
BIDCA-356 639.3 640.2 321 397 0.485 98 
BIDCA-358 609.3 610.2 318 397 0.470 94 
BIDCA-359 608.2 609.2 313 401 0.148 85 
BIDCA-361 594.2 595.2 314 398 0.120 94 
BIDCA-364 583.2 584.2 319 397 0.482 97 
BIDCA-373 515.3 516.2 321 398 0.576 97 
BIDCA-374 549.3 550.2 321 398 0.511 97 
BIDCA-375 567.2 568.2 321 397 0.929 90 
BIDCA-381 579.3 580.2 320 398 0.530 97 
BIDCA-382 555.3 556.2 320 398 0.471 97 
BIDCA-386 563.3 564.2 319 395 0.419 95 
BIDCA-387 579.3 580.2 320 397 0.499 97 
BIDCA-388 579.3 580.2 318 398 0.477 95 
BIDCA-389 581.3 582.2 318 396 0.495 98 
BIDCA-395 593.3 594.2 318 397 0.554 97 
BIDCA-396 563.3 564.2 319 398 0.452 98 
BIDCA-398 563.3 564.2 319 397 0.379 96 
BIDCA-399 585.2 586.2 321 396 0.631 98 
BIDCA-403 583.2 584.2 320 396 0.456 98 
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BIDCA-405 581.3 582.2 320 397 0.421 98 
BIDCA-407 599.4 600.4 319 397 0.540 95 
BIDCA-412 585.2 586.2 319 395 0.573 97 
BIDCA-419 529.3 530.2 319 398 0.347 95 
BIDCA-425 529.3 530.2 318 398 0.406 95 
BIDCA-429 555.3 556.2 318 397 0.594 97 
BIDCA-439 543.3 544.4 319 397 0.397 95 
BIDCA-441 555.3 556.4 319 396 0.435 95 
BIDCA-442 529.3 530.2 318 396 0.528 96 
BIDCA-443 555.3 556.4 319 397 0.389 96 
BIDCA-446 539.2 540.2 321 397 0.385 96 
BIDCA-449 585.2 586.2 320 397 0.582 98 
BIDCA-457 585.2 586.2 319 397 0.551 97 
BIDCA-477 581.3 582.2 318 398 0.379 97 
BIDCA-480 597.2 598.2 319 398 0.485 95 
BIDCA-531 617.2 618.2 319 397 0.372 96 
BIDCA-548 639.3 640.4 320 397 0.425 94 
BIDCA-565 617.2 619.2 319 398 0.406 96 
BIDCA-572 641.2 642.2 318 397 0.478 95 
BIDCA-574 529.3 530.2 319 396 0.369 93 
BIDCA-608 601.2 602.2 318 397 0.336 95 
BIDCA-656 709.5 710.4 319 399 0.437 96 
BIDCA-661 616.3 617.2 321 398 0.364 85 
BIDCA-677 597.4 598.2 319 398 0.421 92 
BIDCA-686 631.2 634.2 319 395 0.351 92 
All absorbance and fluorescence excitation and emission data were recorded 
by a Synergy 4, Biotek Inc. fluorescent plate reader (100 μM compounds in 
DMSO (100 μL) for λabs, 100 μM compounds in DMSO (100 μL) for λem in 
96-well polypropylene plates for λem (λex= 320 nm). Mass was calculated as 
(M), and found in ESI-MS (M+H), Purity data was calculated on the basis of 





    I have successfully synthesized a BID library using solid phase method. 
Also, I have successfully modified them with chloroacteyl and acetyl versions 
(BIDCA and BIDAC). These sets of library could be used in bioimaging 
applications. 
6.4 Experimental Section 
6.4.1 Material and Methods 
The chemicals, including amines and solvents, were purchased from Sigma 
Aldrich, Acros and Alfa Aesar. All the chemicals were directly used without 
further purification. Normal phase column chromatography purification was 
carried out using MERCK silica Gel 60 (Particle size: 230-400 mesh, 0.040-
0.063 mm). 2-chlorotrityl alcohol resin (1.37mmol/g) was purchased from 
BeadTech Inc., Korea.  
6.4.2 Measurements and Analysis 
HPLC-MS was taken on an Agilent-1200 with a DAD detector and a single 
quadrupole mass spectrometer (6130 series). The analytical method, unless 
indicated, is A: H2O (0.1% HCOOH), B: CH3CN (0.1% HCOOH), gradient 
from 10 to 90% B in 10 minutes; C18 (2) Luna column (4.6 × 50 mm2, 3.5 μm 
particle size). 
Spectroscopic and quantum yield data were measured on a SpectraMax M2 




C-NMR spectra were 
recorded on Bruker ACF300 (300 MHz) or AMX500 (500 MHz) 
spectrometers, and chemical shifts are expressed in parts per million (ppm) 
and coupling constants are reported as a J value in Hertz (Hz).  
6.4.3 Quantum Yield Measurements 
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Quantum yields were calculated by measuring the integrated emission area 
of the fluorescent Spectrum and comparing that value to the area measured for 
coumarin 1 in DMSO when excited at 370 nm (Φcoumarin1 = 0.49). Quantum 
yields for the BID, BIDAC and BIDCA then calculated using eq 1, where F 
represents the area of fluorescent emission, n is reflective index of the solvent, 
and Abs is absorbance at excitation wavelength selected for standards and 
samples. Emission was integrated between 360 to 500 nm. 
 
6.4.4 Synthesis 
Preparation of 2-chlorotrityl chloride from 2-chlorotrityl alcohol resin 
Thionyl chloride (1.2 mL, 16.48 mmol, 3 eq) and 2-Chlorotrityl alcohol 
resin (4 g, 1.37 mmol/g, 5.48 mmol, 1 eq) were suspended in 40 mL of 
anhydrous DCM. The mixture was shaken for 12 h at room temperature. After 
reaction, the solvent was removed and the filtered resin was washed 
thoroughly with DMF (3×40 mL) and DCM (3×40 mL). Then the resin was 
dried in vacuum for 4 h. 
General procedure for loading of solid supported 3-bromopropylamine 
3-bromopropylamine (3.5 g, 15.75 mmol, 5 eq) and (6 mL, 32.5 mmol, 10 
eq) DIEA were dissolved in THF (5 mL/g). The resulting solution was then 
added to 2-chlorotrityl chloride resin (2.5 g, 3.25 mmol, 1 eq, 1.3 mmol/g) 
suspended in dichloromethane (10 mL/g). The mixture was shaken for 12 h at 
room temperature and the resin was filtered and washed with DMF (5×40 mL), 
methanol (5×40 mL), and dichloromethane (10×40 mL). The resin was then 
shaken with 20% MeOH in DMF for 2 h for the capping of excess 2-
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chlorotrityl chloride resin. The final resin was washed with DMF (5×40 mL), 
methanol (5×40 mL), and dichloromethane (5×40 mL) and then was dried 
using high vacuum for 4 h. 
General procedure for synthesis of solid supported secondary amines 
For each reaction, solid supported 3-bromopropylamine (100 mg, 0.1 
mmol, 1 eq, 1 mmol/g) was suspended in 4 mL of N-Methylpyrrolidone 
(NMP). 7 eq of each amine (0.7 mmol) and 14 eq of DIEA (1.4 mmol) were 
then added to the mixture. The reaction mixture was shaken for 12 h at 70 °C 
in the heat block and the resin was filtered and washed with DMF (5×5 mL), 
methanol (5×5 mL), and dichloromethane (5×5 mL). The solid supported 
secondary amine resins were dried and used for next step reactions. 
Synthesis of active ester p-nitrophenol resin 
To an amino polystyrene resin (1 g, 1.2 mmol) in DMF (15 mL) were 
added 4-hydroxy-3-nitrobenzoic acid (1 g, 5.5 mmol), HOBt (1 g, 7.4 mmol), 
and DIC (1 mL, 6.4 mmol). After overnight shaking, the resin was filtered and 
washed with DMF (5×20 mL), DCM (5×20 mL), and methanol (5×20 mL). To 
remove any undesirable side product, DMF (5 mL) and piperidine (0.5 mL) 
were added to the resin and allowed to shake for another 1.5 h. The resin was 
filtered and washed with DMF (5×20 mL). The resulting piperidine salt was 
removed via the addition of a 10% HCl solution (in DMF, 20 mL) and was 
allowed to shake for 1.5 h. The resin was then filtered; washed with DMF 
(5×20 mL), DCM (5×20 mL), and methanol (5×20 mL); and dried by nitrogen 
gas flow. This nitrophenol resin is subsequently treated with chloroacetyl 
chloride or acetyl chloride at room temperature with continuous shaking to 
obtain the active ester resin. 
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General procedure for synthesis of BID library 
To synthesize BID library, each of (solid supported secondary amine) 
resin 1 (50 mg, 0.035 mmol, 1.0 eq, 0.7 mmol/g) was suspended in 3 mL of 
DMF in a 10 mL syringe then (22 mg, 0.07 mmol, 1.0 eq) BID acid, (30 mg, 
0.77 mmol, 2.2 eq) HATU and (30 μL, 0.168 mmol, 4.8 eq) DIEA were added. 
At a time 20 individual reaction mixtures were placed on orbital shaker for 24 
h at room temperature and after complete the reaction the resin was filtered 
through 10 mL cartridge washed with DMF (5×5 mL), methanol (5×5 mL), 
and DCM (5×5 mL). 
The resin was dried under high vacuum to afford solid supported 
compounds resin 2 and then the subsequently the dried resin of 50 mg was 
treated with 1 % TFA in DCM (5 mL) for 1 h. The solution was drained to the 
20 mL vial and then organic layer was washed with the saturated NaHCO3 
solution, and then the organic layer was separated and dried using Speed 
Vacuum to afford the BID library products. Each of BID compound was solid 
and primarily characterized by LC-MS.  
2-((4-(1H-benzo[d]imidazol-2-yl)phenyl)(methyl)amino)ethanol (1): The 
stirred mixture of o-phenylenediamine (1.513 g, 14.0 mmol) and aldehyde (2.5 
g, 14.0 mmol) in water: DMF(4:1) was heated at 90 °C for 2 h. After 
completion of the reaction, the mixture was cooled to room temperature, the 
solvent was concentrated in vacuo, and the residue was extracted with diethyl 
ether. The organic layer was dried over anhydrous Na2SO4. The crude was 
purified by column chromatography on silica gel (EtOAc: MeOH=99:1) to 




H NMR (300 MHz, CDCl3+MeOD): 2.72 (s, 3H), 2.98 (m, 1H), 3.20 (t, J 
=6.2 Hz, 2H), 3.41 (t, J=6.2 Hz, 2H), 6.47 (d, J =9.1 Hz, 2H), 6.85 (dd, J =3.1 
Hz, 2H), 7.18 (dd, J =3.1 Hz, 2H), 7.56 (d, J =9.0 Hz, 2H). 
13
C NMR (75.5 MHz, CDCl3): 37.9, 53.6, 58.4, 111.1, 113.4, 115.5, 121.7, 
127.3, 137.8, 150.4, 152.4. 




methylbenzenesulfonate (2): To a solution of 1 (5 g, 18.7 mmol), DMAP and 
Et3N (5.7 mg, 56.1 mmol) in DCM (1.2 L) was added Tosyl chloride (4.3g, 
22.5mmol) at 0
 
ºC and continue stirring for 1 h. After warmed to rt, the 
resulting reaction mixture was stirred at rt for 3 h. After reaction, the reaction 
mixture was washed with 2N HCl, saturated NaHCO3, and brine and dried 
over Na2SO4. After remove the solvent, the residue was purified by flash 
column chromatography on silica gel (DCM: MeOH= 98:2) to afford 2 as a 
gray solid (5.5 g, 13.0 mmol, 69.8 % yield); 
 
1
H NMR (300 MHz, CDCl3): 2.36 (s, 3H), 2.86 (s, 3H), 3.59 (t, J =5.7 Hz, 
2H), 4.15 (t, J=5.7 Hz, 2H), 6.48 (d, J =4.5 Hz, 2H), 7.18-7.25 (m, 4H), 7.58-
7.61 (m, 2H), 7.69 (d, J =8.3 Hz, 2H), 7.93 (d, J =8.9 Hz, 2H); 
13
C NMR (75.5 
MHz, CDCl3): 21.6, 29.7, 38.9, 50.8, 66.9, 111.7, 114.5, 116.8, 122.6, 127.7, 
128.1, 129.8, 132.5, 138.3, 145.1, 149.6, 152.1. 
ESI-MS m/z: C23H23N3O3S, calculated: 421.15, found: 422.2 (M+H)
+
. 
4-(1H-benzo[d]imidazol-2-yl)-N-(2-fluoroethyl)-N-methylaniline (3). To a 
solution of 2 (4.5 g, 10.7 mmol) in 500 mL of dry tetrahydrofuran (THF) was 
added anhydrous TBAF (21.35 mL, 1 M in THF). The reaction mixture was 
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refluxed for 3 h. After removal of the THF, the residue was purified by silica 
gel chromatography to give 3 as a gray solid (2.5 g, 9.28 mmol, 86.7 % yield);  
1
H NMR (500 MHz, CDCl3): 3.03 (s, 3H), 3.64 (t, J =5.0 Hz, 1H), 3.68 (t, J 
=5.0 Hz, 1H), 4.55(t, J =5.1 Hz, 1H), 4.64 (t, J =5.1 Hz, 1H), 6.67 (d, J =8.7 
Hz, 2H), 7.20 (dd, J =3.1 Hz, 2H), 7.57 (dd, J =3.0 Hz, 2H), 7.93 (d, J =8.8 Hz, 
2H); 
13
C NMR (75.5 MHz, CDCl3): 29.7, 39.0, 52.3, 81.0, 82.3, 111.9, 114.4, 
122.4, 128.0, 150.2, 152.2. 
ESI-MS m/z: C16H16FN3, calculated: 269.13, found: 270.2 (M+H)
+
. 
Methyl 2-(2-(4-((2-fluoroethyl) (methyl) amino) phenyl)-1H-benzo[d] 
imidazol-1-yl) acetate (4). To a mixture of compound 3 (2.5 g, 9.28 mmol) in 
dimethylformide (50 mL) was added sodium hydride (60%, 18.56 mmol) at 0 
ºC and stirred for 40 min Methyl bromoacetate (2.84 mg, 18.56 mmol) was 
added at 0 ºC. The temperature of the reaction mixture was then allowed to 
warm to room temperature and stirred for 3h. After completion of the reaction, 
water was slowly added to reaction mixture and extracted with ethyl acetate. 
The organic layer was washed with water, brine and dried over anhydrous 
Na2SO4 and concentrated under vacuum. The residue was purified by flash 
column chromatography on silica gel (EtOAc: Hexane= 1:1) to afford 4 as a 
light yellow solid (1.5 g, 4.40 mmol, 47.4 % yield);  
1
H NMR (300 MHz, CDCl3): 3.10 (s, 3H), 3.68 (t, J =5.1 Hz, 1H), 3.76 (t, J 
=5.1 Hz, 1H), 3.82 (s, 3H), 4.56 (t, J =5.1 Hz, 1H), 4.72 (t, J =5.1Hz, 1H), 
4.93 (s, 2H), 6.81 (d, J =9.0 Hz, 2H), 7.29 (t, J =3.1 Hz, 2H), 7.33 (t, J =3.0 
Hz, 1H), 7.61 (d, J =8.9 Hz, 2H), 7.84 (dd, J =3.0 Hz, 2H); 
13
C NMR (75.5 
MHz, CDCl3): 38.9, 46.4, 52.7, 80.9, 82.2, 109.1, 111.8, 116.9, 119.5, 122.5, 
122.6, 130.3, 136.0, 142.9, 149.8, 154.5, 168.5. 
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yl)acetic acid (5): To the solution of  4 (1.5 g) in the mixed solvent (ethanol: 
water=4:1) was added 4M NaOH to adjust the pH to 14. The mixture was 
stirred for 2 h at rt. After completion of the reaction, the solvent was 
concentrated in vacuo. The residue was purified by column chromatography 
on silica gel (DCM: MeOH: NH3=90:10:1) to afford 5 as a white solid. (1.1 g, 
3.36 mmol, 76.4 % yield);  
1
H NMR (300 MHz, DMSO-d6): 2.99 (s, 3H), 3.67(t, J =4.7 Hz, 1H), 3.76 (t, J 
=4.7Hz, 1H), 4.53(t, J =4.7 Hz, 1H), 4.68 (t, J =4.7Hz, 1H), 4.78 (s, 3H), 6.83 
(d, J =8.8 Hz, 2H), 7.18 (t, J =4.3 Hz, 2H), 7.39 (t, J =5.1 Hz, 2H), 7.63 (d, J 
=8.6 Hz, 2H); 
13
C NMR (75.5 MHz, DMSO-d6): 48.1, 52.0, 81.3, 83.5, 110.7, 
111.9, 117.7, 118.6, 121.8, 121.9, 130.4, 137.0, 142.9, 150.0, 154.2, 170.8.  


















1. (a) Selkoe, D. J., Translating cell biology into therapeutic advances in 
Alzheimer's disease. Nature 1999, 399, A23-31; (b) Ran, C.; Xu, X.; 
Raymond, S. B.; Ferrara, B. J.; Neal, K.; Bacskai, B. J.; Medarova, Z.; Moore, 
A., Design, synthesis, and testing of difluoroboron-derivatized curcumins as 
near-infrared probes for in vivo detection of amyloid-beta deposits. J. Am. 
Chem. Soc. 2009, 131, 15257-15261. 
2. Nordberg, A., PET imaging of amyloid in Alzheimer's disease. Lancet 
Neurol. 2004, 3, 519-527. 
3. Westermark, G. T.; Johnson, K. H.; Westermark, P., Staining methods 
for identification of amyloid in tissue. Methods Enzymol. 1999, 309, 3-25. 
4. Elhaddaoui, A.; Pigorsch, E.; Delacourte, A.; Turrell, S., Competition 
of congo red and thioflavin S binding to amyloid sites in alzheimer's diseased 
tissue. Biospectroscopy 1995, 1, 351-356. 
5. Merrifield, R. B., Solid Phase Peptide Synthesis. I. The Synthesis of a 
Tetrapeptide. J. Am. Chem. Soc. 1963, 85, 2149-2154. 
6. (a) Oh, S.; Jang, H. J.; Ko, S. K.; Ko, Y.; Park, S. B., Construction of a 
polyheterocyclic benzopyran library with diverse core skeletons through 
diversity-oriented synthesis pathway. J. Comb. Chem. 2010, 12, 548-558; (b) 
Das, R. K.; Samanta, A.; Ha, H.-H.; Chang, Y.-T., Solid phase synthesis of 
ultra-photostable cyanine NIR dye library. RSC Adv. 2011, 1, 573-575. 
7. (a) Snellman, A.; Lopez-Picon, F. R.; Rokka, J.; Salmona, M.; Forloni, 
G.; Scheinin, M.; Solin, O.; Rinne, J. O.; Haaparanta-Solin, M., Longitudinal 
amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, 
Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease. J. Nucl. 
Med. 2013, 54, 1434-1441; (b) Mathis, C. A.; Wang, Y.; Holt, D. P.; Huang, 
G.-F.; Debnath, M. L.; Klunk, W. E., Synthesis and Evaluation of 11C-
Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents. J. 









Diversity-oriented fluorescent libraries (DOFL) approach is one of the most 
powerful methods to discover novel fluorescent sensors. Combined with high 
throughput screening, several novel bioimaging probes have been discovered 
in a relatively faster manner. In this thesis, several dye libraries were 
synthesized and sensors for biothiol, neurodegenerative disease and elastin 
fibers were found and investigated in vivo.  
FRET-based fluorophores have been reported in bioimaging and medicinal 
applications. While, most of the reported FRET-based fluorophores were 
limited in applications due to the drawbacks in photopropeties. It is necessary 
to design and synthesize a series of RET-based fluorophore with ideal criteria: 
high ability for light harvesting, no fluorescence leaks from the donor, tunable 
emission wavelength, high quantum yield and large pseudo-stokes shifts.  
Here, we report a new strategy for the ideal RET-based dyes by coupling low 
quantum yield (less than 1%) BODIPY donor (BDN) with tunable high 
quantum yield BODIPY acceptors (BDM). The low quantum yield of donor is 
ascribed to the intramolecular rotation of the phenyl rings, which has been 
proved by controlling the viscosity and temperature of solvent. Upon 
excitation the BNM compounds at the donor absorption wavelength, the 
tunable emissions from 560 nm to 617 nm were obtained, with a high quantum 
yield of up to 0.75. Ultrafast dynamic study demonstrated that the absorbed 
energy was transferred to the acceptor (BDM) with a high energy transfer rate 
before quenched by non-radiative intramolecular rotations. Using dark donor 
makes it possible to avoid fluorescence leaks from donor emission and this 
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concept can be extended to other donor-acceptor systems for well resolved 
fluorescent. Also, the cell imaging shows that the BNM compounds were well 
cell-permeable and can be employed as well resolved fluorescence probe. 
With its unique properties, we believe that BNM compounds can function as 
excellent fluorescent probes for fluorescence labeling in bioimaging. 
Also, one of the BNM compounds were chosen to design and synthesize a 
red-emitting turn-on FRET-based molecular probe 1 for selective detection of 
cysteine and homocysteine. Upon excitation of the donor, emission spectra of 
probe 1 show that there is no emission leakage from donor part before and 
after addition of Cys. This means this type of FRET dye has real advantage 
over other FRET dyes in their applications. The fluorescence sensing 
mechanism of probe 1 was illustrated by fluorescence spectroscopy, kinetic 
measurements, HPLC-MS analysis and DFT calculations. The probe 1 is pH-
independent at the physiological pH range and the live cells imaging 
demonstrated the utility of probe 1 as a biosensor for thiols. 
   In order to explore useful sensors for Aβ oligomers, the DOFL were 
applied to high-throughput screening systems in cell-based screening. 
Oligomeric soluble Aβ is principally responsible for the pathogenesis of AD 
and the content of Aβ oligomer indicates the disease progression. Cell based 
screening using DOFLA has been performed and Aβ oligomer specific sensor 
was discovered. The fluorescence oligomer specific sensor shows good 
selectivity in vitro and the binding proteinaceous aggregated species were 
confirmed by dot blots, pelleting assay and TEM. Also, the sensor can show 
clear A oligomer staining in the brain tissue. 
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   A hight photostability Zwitterionic library, CyZW, was also designed and 
synthesized for bioimaging in vivo. An elastin fibers probe CyZW-599 was 
found by screening these compounds against rat aortas tissue. Further studies 
show that this compound can be used as a fluorescent probe for imaging of 
elastin in aorta sections and outer ear sections in the living animal after an 
intravenous injection or in vitro tissue staining. 
7.2 Future prospectives 
Development of multicolor labeling set compounds 
FRET strategy has attracted much attention for the development of 
fluorescence probes. The multicolor fluorescent labeling also exhibits the 
advantages in bio-imaging techniques development. When we use different 
dyes for different color labeling, it is difficult to find the proper single 
wavelength light. If excited by single wavelength light, the fluorescence 
intensities of the dyes, which emit at longer wavelengths, will be diminished 
due to the less effective energy absorb at the excitation wavelength. Generally, 
BNM compounds give us better choice for multicolor fluorescent labeling. A 
variety of structures of BNM can show a broad range of emission color by 
single excitation wavelength, which can be used as multicolor labeling. For 
example, three different color BNM compounds were chosen corresponding to 
different filters, and modified with different labeling reagent for single 
excitation multicolor labeling. When this set of compounds was used in cell 
imaging or other targeted model, we may get multicolor labeling imaging, 
which can clear show different parts with different colors.  
Development of PET tracers for imaging of Aβ oligomers 
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Alzheimer’s disease (AD) is one of the most studied protein misfolding 
diseases in which amyloid β-peptide (Aβ) aggregates forming extracellular 
neuritic plaques in the brain. In chapter 4, we find two interesting compounds 
which can recognize Aβ oligomeric assemblies over monomers and fibrils. In 
our future plan, we want to try to modify the structures and apply these 
compounds for positron emission tomography (PET) imaging. There has been 
a major interest in the development of tracers suitable for imaging of Aβ 
plaques using PET and there are several examples have been developed. 
However, there is still limited knowledge for tracers for imaging of Aβ 
oligomers. Our first stage of the experiment result proves that the sensors can 
bind with oligomer particularly, which can be modified to PET tracers for 
further study.  
 
